Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 152
Encontrada(s) 2 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fine-mapping genomic loci refines bipolar disorder risk genes

  • Koromina, Maria|||0000-0001-8843-082X
  • Ravi, Ashvin
  • Panagiotaropoulou, Georgia
  • Schilder, Brian M.|||0000-0001-5949-2191
  • Humphrey, Jack
  • Braun, Alice|||0000-0003-1145-0261
  • Bigdeli, Tim B.|||0000-0003-2215-5946
  • Chatzinakos, Chris
  • Coombes, Brandon J.|||0000-0003-4322-5923
  • Kim, Jaeyoung|||0000-0001-6983-7907
  • Liu, Xiaoxi|||0000-0002-1933-8613
  • Terao, Chikashi|||0000-0002-6452-4095
  • O'Connell, Kevin S.|||0000-0002-6865-8795
  • Adams, Mark J
  • Adolfsson, Rolf
  • Alda, Martin|||0000-0001-9544-3944
  • Alfredsson, Lars|||0000-0003-1688-6697
  • Andlauer, Till F. M.|||0000-0002-2917-5889
  • Andreassen, Ole A.|||0000-0002-4461-3568
  • Antoniou, Anastasia
  • Baune, Bernhard T.|||0000-0001-6548-426X
  • Bengesser, Susanne
  • Biernacka, Joanna
  • Boehnke, Michael|||0000-0002-6442-7754
  • Bosch, Rosa|||0000-0002-7596-183X
  • Cairns, Murray J.
  • Carr, Vaughan J.
  • Casas Brugué, Miquel|||0000-0003-3496-8522
  • Catts, Stanley
  • Cichon, Sven|||0000-0002-9475-086X
  • Corvin, Aiden
  • Craddock, Nicholas
  • Dafnas, Konstantinos
  • Dalkner, Nina
  • Dannlowski, Udo|||0000-0002-0623-3759
  • Degenhardt, Franziska
  • Di Florio, Arianna
  • Dikeos, Dimitris
  • Fellendorf, Frederike Tabea
  • Ferentinos, Panagiotis|||0000-0001-8531-5623
  • Forstner, Andreas J.
  • Forty, Liz|||0000-0002-4349-8414
  • Frye, Mark
  • Fullerton, Janice M.|||0000-0003-4014-4490
  • Gawlik, Micha
  • Gizer, Ian R.
  • Gordon-Smith, Katherine
  • Green, Melissa J.
  • Grigoroiu-Serbanescu, Maria
  • Guzman-Parra, Jose|||0000-0002-1463-6435
  • Hahn, Tim|||0000-0002-8929-4134
  • Henskens, Frans
  • Hillert, Jan|||0000-0002-7386-6732
  • Jablensky, Assen V.
  • Jones, Lisa|||0000-0002-5122-8334
  • Jones, Ian
  • Jonsson, Lina
  • Kelsoe, John R.
  • Kircher, Tilo|||0000-0002-2514-2625
  • Kirov, George|||0000-0002-3427-3950
  • Kittel-Schneider, Sarah|||0000-0003-3057-6150
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Landén, Mikael|||0000-0002-4496-6451
  • Leboyer, Marion|||0000-0001-5473-3697
  • Lenger, Melanie
  • Lissowska, Jolanta
  • Lochner, Christine|||0000-0002-4766-3704
  • Loughland, Carmel
  • MacIntyre, Donald J.|||0000-0001-6963-1335
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • Maratou, Eirini
  • Mathews, Carol A.|||0000-0003-2208-7058
  • Mayoral-Cleries, Fermín
  • McElroy, Susan L.
  • McGregor, Nathaniel|||0000-0001-7195-4993
  • McIntosh, Andrew M.|||0000-0002-0198-4588
  • McQuillin, Andrew|||0000-0003-1567-2240
  • Michie, Patricia|||0000-0002-4169-8519
  • Mitchell, Philip B.
  • Moutsatsou, Paraskevi
  • Mowry, Bryan J.|||0000-0002-4115-5645
  • Müller-Myhsok, Bertram
  • Myers, Richard M.
  • Nenadić, Igor|||0000-0002-0749-7473
  • Nievergelt, Caroline M.
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Nurnberger, John
  • O'Donovan, Michael C.|||0000-0001-7073-2379
  • 'Donovan, Claire O.
  • Ophoff, Roel A.
  • Owen, Michael J.
  • Pantelis, Christos|||0000-0002-9565-0238
  • Pato, Carlos|||0000-0002-5858-266X
  • Pato, Michele T.
  • Patrinos, George P.
  • Pawlak, Joanna M.
  • Perlis, Roy H.|||0000-0002-5862-6757
  • Porichi, Evgenia
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Ramos-Quiroga, Josep Antoni|||0000-0003-1622-0350
  • Reif, Andreas|||0000-0002-0992-634X
  • Reininghaus, Eva Z.
  • Ribasés Haro, Marta|||0000-0003-1039-1116
  • Rietschel, Marcella|||0000-0002-5236-6149
  • Schall, Ulrich
  • Schofield, Peter R.|||0000-0003-2967-9662
  • Schulze, Thomas G.
  • Scott, Laura J.|||0000-0002-4886-5084
  • Scott, Rodney J.|||0000-0001-7724-3404
  • Serretti, Alessandro
  • Smoller, Jordan W.|||0000-0002-0381-6334
  • Świątkowska, Beata
  • Soler Artigas, María|||0000-0002-3213-1107
  • Stein, Dan J.|||0000-0001-7218-7810
  • Streit, Fabian|||0000-0003-1080-4339
  • Toma, Claudio|||0000-0003-3901-7507
  • Tooney, Paul
  • Vawter, Marquis P.
  • Vieta, Eduard|||0000-0002-0548-0053
  • Vincent, John B.
  • Waldman, Irwin D.|||0000-0002-6862-1837
  • Weickert, Cynthia Shannon
  • Weickert, Thomas
  • Witt, Stephanie H.|||0000-0002-1571-1468
  • Hong, Kyung Sue
  • Ikeda, Masashi|||0000-0001-6237-2449
  • Iwata, Nakao|||0000-0003-3189-6076
  • Won, Hong Hee
  • Edenberg, Howard J.|||0000-0003-0344-9690
  • Ripke, Stephan|||0000-0003-3622-835X
  • Raj, Towfique|||0000-0002-9355-5704
  • Coleman, Jonathan R.I.
  • Mullins, Niamh
Bipolar disorder is a heritable mental illness with complex etiology. While the largest published genome-wide association study identified 64 bipolar disorder risk loci, the causal SNPs and genes within these loci remain unknown. We applied a suite of statistical and functional fine-mapping methods to these loci and prioritized 17 likely causal SNPs for bipolar disorder. We mapped these SNPs to genes and investigated their likely functional consequences by integrating variant annotations, brain cell-type epigenomic annotations, brain quantitative trait loci and results from rare variant exome sequencing in bipolar disorder. Convergent lines of evidence supported the roles of genes involved in neurotransmission and neurodevelopment, including SCN2A, TRANK1, DCLK3, INSYN2B, SYNE1, THSD7A, CACNA1B, TUBBP5, FKBP2, RASGRP1, FURIN, FES, MED24 and THRA among others in bipolar disorder. These represent promising candidates for functional experiments to understand biological mechanisms and therapeutic potential. Additionally, we demonstrated that fine-mapping effect sizes can improve performance of bipolar disorder polygenic risk scores across diverse populations and present a high-throughput fine-mapping pipeline.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the relationship between ultra-processed food consumption and food addiction at one-year follow-up in older adults with metabolic syndrome

  • Camacho-Barcia, Lucía|||0000-0002-5989-936X
  • Jiménez Murcia, Susana|||0000-0002-3596-8033
  • Granero, Roser|||0000-0001-6308-3198
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Pintó, Xavier|||0000-0002-2216-2444
  • Corella, Dolores|||0000-0002-2366-4104
  • Bes-Rastrollo, Maira|||0000-0002-9139-4206
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Esteve-Luque, Virginia|||0000-0002-7631-8301
  • Forcano, Laura|||0000-0002-8478-1451
  • Vázquez-Lorente, Héctor|||0000-0003-0183-6902
  • Gómez-Martínez, Carlos|||0000-0002-3077-6702
  • Gomis-González, Maria|||0000-0001-9778-4849
  • Fernández Aranda, Fernando|||0000-0002-2968-9898
BACKGROUND: Ultra-processed foods (UPFs) are theorised to exhibit addictive properties within the framework of the Food Addiction (FA) model, attributable to their high palatability, sugars, salt, saturated/trans fats, and caloric density. AIMS: To evaluate the association between UPFs consumption and FA presence, and to examine whether reducing UPFs intake after one year of intervention is associated to decreased FA scores. METHODS: The sample included 429 Mediterranean older adults with overweight/obesity and metabolic syndrome from the PREDIMED-Plus-Cognition sub-study. FA presence was evaluated with the Yale Food Addiction Scale 2.0, and the nutritional information through validated food frequency questionnaires. UPFs was categorised according to the NOVA system and divided into consumption tertiles. Data were analysed using repeated measures ANOVA, structural equation modelling, and logistic regression to compare FA changes across tertiles of UPF reduction after one-year follow-up. RESULTS: Baseline YFAS categorisation into three levels (positive-probable-negative) showed significant differences between the second and third tertile of UPFs consumption, with the highest tertile of consumption having greater likelihood of worse FA status. After one year, the likelihood of change in the FA levels was higher only for individuals within the highest decreases in the UPFs consumption (OR = 1.67, p = 0.040). DISCUSSION AND CONCLUSIONS: These findings indicate that a reduction in the consumption of UPFs may contribute to the improvement of FA symptoms, providing novel insights into the association between UPFs and the presence of FA. Future research should focus on populations with higher UPFs consumption and investigating the long-term effects of dietary quality on FA symptoms.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Pleiotropic contribution of rbfox1 to psychiatric and neurodevelopmental phenotypes in two zebrafish models

  • Antón Galindo, Ester
  • Adel, Maja R.
  • García González, Judit
  • Leggieri, Adele
  • López Blanch, Laura
  • Irimia Martínez, Manuel
  • Norton, William H. J.
  • Brennan, Caroline H.
  • Fernàndez-Castillo, Noèlia
  • Cormand, Bru
RBFOX1 is a highly pleiotropic gene that contributes to several psychiatric and neurodevelopmental disorders. Both rare and common variants in RBFOX1 have been associated with several psychiatric conditions, but the mechanisms underlying the pleiotropic effects of RBFOX1 are not yet understood. Here we found that, in zebrafish, rbfox1 is expressed in spinal cord, mid- and hindbrain during developmental stages. In adults, expression is restricted to specific areas of the brain, including telencephalic and diencephalic regions with an important role in receiving and processing sensory information and in directing behaviour. To investigate the contribution of rbfox1 to behaviour, we used rbfox1sa15940, a zebrafish mutant line with TL background. We found that rbfox1sa15940 mutants present hyperactivity, thigmotaxis, decreased freezing behaviour and altered social behaviour. We repeated these behavioural tests in a second rbfox1 mutant line with a different genetic background (TU), rbfox1del19, and found that rbfox1 deficiency affects behaviour similarly in this line, although there were some differences. rbfox1del19 mutants present similar thigmotaxis, but stronger alterations in social behaviour and lower levels of hyperactivity than rbfox1sa15940 fish. Taken together, these results suggest that mutations in rbfox1 lead to multiple behavioural changes in zebrafish that might be modulated by environmental, epigenetic and genetic background effects, and that resemble phenotypic alterations present in Rbfox1-deficient mice and in patients with different psychiatric conditions. Our study, thus, highlights the evolutionary conservation of rbfox1 function in behaviour and paves the way to further investigate the mechanisms underlying rbfox1 pleiotropy on the onset of neurodevelopmental and psychiatric disorders., Major financial support for this research was received by BC from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (RTI2018-100968-B-100, PID2021-1277760B-I100), the ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (PNSD-2017I050 and PNSD-2020I042), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093), ICREA Academia 2021, ‘Fundació La Marató de TV3’ (202218-31) and the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA) and Eat2beNICE (728018), and received by CHB from the NIH (USA) (5 U01 DA044400-05). E.A-G was supported by the Ministerio de Economía y Competitividad (Spanish Government), the EU H2020 program (Eat2beNICE-728018) and a Margarita Salas postdoctoral grant. M.R.A. was supported by a doctoral scholarship of the ‘Studienstiftung des Deutschen Volkes’. J.G-G. was supported by the Queen Mary Principal’s Research Studentship in the School of Biological and Chemical Sciences.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial

  • Gómez Martínez, Carlos
  • Babio, Nancy
  • Júlvez Calvo, Jordi
  • Nishi, Stephanie
  • Fernández Aranda, Fernando
  • Martínez-González, Miguel Ángel, 1957-
  • Cuenca Royo, Aida Ma, 1981-
  • Fernández, Rebeca
  • Jiménez Murcia, Susana
  • Torre Fornell, Rafael de la
  • Pintó Sala, Xavier
  • Bloemendaal, Mirjam
  • Fitó Colomer, Montserrat
  • Corella, Dolores
  • Arias, Alejandro
  • Salas Salvadó, Jordi
Un erratum d'aquest article s'ha publicat a Int J Behav Nutr Phys Act. 2022 Nov 23;19(1):140. DOI: 10.1186/s12966-022-01373-2, Background: Few studies have analyzed the associations between impulsivity and dietary patterns. Some of them have shown a cross-sectional inverse relationship between impulsivity and healthy diet scores, whereas others reported a positive association with unhealthy dietary assessments. We aimed to examine longitudinal associations of impulsivity trait with adherence to healthy and unhealthy dietary patterns in older participants at high risk of cardiovascular disease over 3 years of follow-up. Methods: A 3-year prospective cohort analysis within the PREDIMED-Plus-Cognition study conducted in 4 PREDIMED-Plus study centers was performed. The PREDIMED-Plus study aimed to test the beneficial effect of a lifestyle intervention on the primary prevention of cardiovascular disease. The participants with overweight or obesity and metabolic syndrome included in the present study (n = 462; mean age of 65.3 years; 51.5% female) completed both the UPPS-P Impulsive Behavior Scale (range: 0-236 points) and the 143-item Food Frequency Questionnaire at baseline, 1-year and 3-years of follow-up. Ten diet scores assessing healthy and unhealthy dietary patterns were evaluated. Linear mixed models were performed adjusting by several confounders to study the longitudinal associations between impulsivity trait and adherence to dietary pattern scores over 3 years of follow-up (also assessing interactions by sex, age, and intervention group). Results: Impulsivity were negatively associated with adherence to the Healthy Plant-Based [β = -0.92 (95%CI -1.67, -0.16)], Mediterranean [β = -0.43 (95%CI -0.79, -0.07)], Energy-Restricted Mediterranean [β = -0.76 (95%CI -1.16, -0.37)], Alternative Healthy Eating Index [β = -0.88 (95%CI -1.52, -0.23)], Portfolio [β = -0.57 (95%CI -0.91, -0.22)], and DASH [β = -0.50 (95%CI -0.79, -0.22)] diet scores over 3 years of follow-up, whereas impulsivity was positively related with adherence to the unhealthy Western diet [β = 1.59 (95%CI 0.59, 2.58)] over time. An interaction by intervention group was found, with those participants in the intervention group with high impulsivity levels having lower adherence to several healthy dietary patterns. Conclusions: Heightened impulsivity was longitudinally associated with lower adherence to healthy dietary patterns and higher adherence to the Western diet over 3 years of follow-up. Furthermore, nutritional intervention programs should consider impulsivity as a relevant factor for the intervention success. Trial registration: Name of registry: Effect of an energy-restricted Mediterranean diet, physical activity and behavioral intervention on the primary prevention of cardiovascular disease. Trial registration number: ISRCTN 89,898,870. Date of registration: 05/28/2014., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO 21/2021 grants from the Generalitat Valenciana, and the grant PID2019-108858RB-I00 funded by AEI 10.13039/501100011033 and by “ERDF A way of making Europe” to DC; the SEMERGEN grant; None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication. We thank CERCA Programme/Generalitat de Catalunya for institutional support and partial support was also provided by SLT006/17/00246, funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS)”. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016–2, Ref 728018; and PRIME/ H2020-SC1-BHC-2018–2020, Ref: 847879). CG-M receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); JS-S, senior author of this paper, is partially supported by ICREA under the ICREA Academia program. SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). JJ holds the Miguel Servet-II contract (CPII19/00015) awarded by the Instituto de Salud Carlos III (co-funded by the European Social Fund “Investing in your future”).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

miRNA signatures associated with vulnerability to food addiction in mice and humans

  • García Blanco, Alejandra
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernández-Castillo, Noèlia
  • Pineda-Cirera, Laura
  • Mayneris Perxachs, Jordi
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Food addiction is characterized by a loss of behavioral control over food intake and is associated with obesity and other eating disorders. The mechanisms underlying this behavioral disorder are largely unknown. We aimed to investigate the changes in miRNA expression promoted by food addiction in animals and humans and their involvement in the mechanisms underlying the behavioral hallmarks of this disorder. We found sharp similitudes between miRNA signatures in the medial prefrontal cortex (mPFC) of our animal cohort and circulating miRNA levels in our human cohort, which allowed us to identify several miRNAs of potential interest in the development of this disorder. Tough decoy (TuD) inhibition of miRNA-29c-3p in the mouse mPFC promoted persistence of the response and enhanced vulnerability to developing food addiction, whereas miRNA-665-3p inhibition promoted compulsion-like behavior and also enhanced food addiction vulnerability. In contrast, we found that miRNA-137-3p inhibition in the mPFC did not lead to the development of food addiction. Therefore, miRNA-29c-3p and miRNA-665-3p could be acting as protective factors with regard to food addiction. We believe the elucidation of these epigenetic mechanisms will lead to advances toward identifying innovative biomarkers and possible future interventions for food addiction and related disorders based on the strategies now available to modify miRNA activity and expression., This work was supported by the Spanish “Ministerio de Ciencia e Innovación (MICIN), Agencia Estatal de Investigación (AEI)” (PID2020-120029GB-I00/MICIN/AEI/10.13039/501100011033, RD21/0009/0019, to RM; SAF2015-68341-R, RTI2018-100968-B-100, and PID2021-1277760B-100, to BC; and SAF2017-84060-R-AEI/FEDER-UE, to LD); the “Generalitat de Catalunya, AGAUR” (2017 SGR-669, to RM; 2017 SGR-734, to JMFR; 2017-SGR-738, to BC); the “ICREA-Acadèmia” (2020, to RM, 2021, to BC, and 2022, to JMFR); the “European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068, to RM; CoCA, H2020-667302, and Eat2beNICE, H2020-728018, to BC); the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (RD16/0017/0020, to RM; FIS PI15/01934, PI18/01022, PI21/01361, to JMFR); the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad, Plan Nacional Sobre Drogas” (PNSD- 2021I076, to RM; PNSD-2019I006, to EMG; PNSD-2017I050, to BC; PNSD-2020I042, to NFC); the “Fundació La Marató-TV3” (2016/20-30, to EMG); the European Regional Development Fund (project no. 01.2.2-LMT-K-718-03-0099) under a grant agreement with the Research Council of Lithuania (LMTLT), to AB; and the Project ThinkGut (EFA345/19), 65% co-financed by the European Regional Development Fund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Metabolic, affective and neurocognitive characterization of metabolic syndrome patients with and without food addiction. Implications for weight progression

  • Camacho Barcia, Lucía
  • Munguía, Lucero
  • Lucas, Ignacio
  • Torre Fornell, Rafael de la
  • Salas Salvadó, Jordi
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Granero, Roser
  • Jiménez Murcia, Susana
  • González Monje, Inmaculada
  • Esteve Luque, Virginia
  • Cuenca Royo, Aida Ma, 1981-
  • Gómez Martínez, Carlos
  • Paz-Graniel, Indira
  • Forcano, Laura
  • Fernández Aranda, Fernando
According to the food addiction (FA) model, the consumption of certain types of food could be potentially addictive and can lead to changes in intake regulation. We aimed to describe metabolic parameters, dietary characteristics, and affective and neurocognitive vulnerabilities of individuals with and without FA, and to explore its influences on weight loss progression. The sample included 448 adults (55-75 years) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus cognition sub-study. Cognitive and psychopathological assessments, as well as dietary, biochemical, and metabolic measurements, were assessed at baseline. Weight progression was evaluated after a 3-year follow up. The presence of FA was associated with higher depressive symptomatology, neurocognitive decline, low quality of life, high body mass index (BMI), and high waist circumference, but not with metabolic comorbidities. No differences were observed in the dietary characteristics except for the saturated and monounsaturated fatty acids consumption. After three years, the presence of FA at baseline resulted in a significantly higher weight regain. FA is associated with worse psychological and neurocognitive state and higher weight regain in adults with metabolic syndrome. This condition could be an indicator of bad prognosis in the search for a successful weight loss process., We thank CERCA Programme/Generalitat de Catalunya for institutional support and partial support was also provided by SLT006/17/00246, funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS)”. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020; Ref: 847879). IP-G receives a grant from the Spanish Ministry of Education, Culture and Sports (FPU 17/01925). C.G.-M. receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); J.S-S. is partially supported by ICREA under the ICREA Academia program.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Metformin use and cognitive function in older adults with type 2 diabetes following a mediterranean diet intervention

  • Soldevila-Domenech, Natalia
  • Cuenca Royo, Aida Ma, 1981-
  • Babio, Nancy
  • Forcano, Laura
  • Nishi, Stephanie
  • Vintró Alcaraz, Cristina
  • Gómez Martínez, Carlos
  • Jiménez Murcia, Susana
  • Fernández-Carrión, Rebeca
  • Gomis González, Maria, 1988-
  • Alvarez-Sala, Andrea
  • Carlos, Silvia
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Díez Espino, Javier
  • Castañer, Olga
  • Fernández Aranda, Fernando
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
Background and Purpose: Both adherence to the Mediterranean diet (MedDiet) and the use of metformin could benefit the cognitive performance of individuals with type 2 diabetes, but evidence is still controversial. We examined the association between metformin use and cognition in older adults with type 2 diabetes following a MedDiet intervention. Methods: Prospective cohort study framed in the PREDIMED-Plus-Cognition sub-study. The PREDIMED-Plus clinical trial aims to compare the cardiovascular effect of two MedDiet interventions, with and without energy restriction, in individuals with overweight/obesity and metabolic syndrome. The present sub-study included 487 cognitively normal subjects (50.5% women, mean ± SD age of 65.2 ± 4.7 years), 30.4% of them (N = 148) with type 2 diabetes. A comprehensive battery of neurocognitive tests was administered at baseline and after 1 and 3 years. Individuals with type 2 diabetes that exhibited a good glycemic control trajectory, either using or not using metformin, were compared to one another and to individuals without diabetes using mixed-effects models with inverse probability of treatment weights. Results: Most subjects with type 2 diabetes (83.1%) presented a good and stable glycemic control trajectory. Before engaging in the MedDiet intervention, subjects using metformin scored higher in executive functions (Cohen's d = 0.51), memory (Cohen's d = 0.38) and global cognition (Cohen's d = 0.48) than those not using metformin. However, these differences were not sustained during the 3 years of follow-up, as individuals not using metformin experienced greater improvements in memory (β = 0.38 vs. β = 0.10, P = 0.036), executive functions (β = 0.36 vs. β = 0.02, P = 0.005) and global cognition (β = 0.29 vs. β = -0.02, P = 0.001) that combined with a higher MedDiet adherence (12.6 vs. 11.5 points, P = 0.031). Finally, subjects without diabetes presented greater improvements in memory than subjects with diabetes irrespective of their exposure to metformin (β = 0.55 vs. β = 0.10, P < 0.001). However, subjects with diabetes not using metformin, compared to subjects without diabetes, presented greater improvements in executive functions (β = 0.33 vs. β = 0.08, P = 0.032) and displayed a higher MedDiet adherence (12.6 points vs. 11.6 points, P = 0.046). Conclusions: Although both metformin and MedDiet interventions are good candidates for future cognitive decline preventive studies, a higher adherence to the MedDiet could even outweigh the potential neuroprotective effects of metformin in subjects with diabetes., Study resulting from the following grants: SLT006/17/00246, SLT002/16/00045 and SLT006/17/00077 funded by the Department of Health of the Generalitat de Catalunya by the calls Acció instrumental de programes de recerca orientats en l'àmbit de la recerca i la innovació en salut and Pla estratègic de recerca i innovació en salut (PERIS). We thank CERCA Programme/Generalitat de Catalunya for institutional support. This project was funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research-with competitive grants leaded by JS-S and Josep Vidal for the periods 2014–2016, 2015–2017, 2017–2019, and 2018–2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, ERDF, a way to build Europe) [grants: PI13/00233, PI13/00728, PI13/01123, PI13/00462, PI16/00533, PI16/00366, PI16/01094, PI16/00501, PI17/01167, PI19/00017, PI19/00781, PI19/01032, PI19/00576]; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council [Advanced Research Grant 2014–2019; agreement #340918] granted to Miguel Ángel Martínez-González; the Recercaixa (number 2013ACUP00194) grant to JS-S. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2; Ref 728018; and PRIME/H2020-SC1-BHC-2018-2020; Ref: 847879), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. This work is also partially supported by ICREA under the ICREA Academia programme. This work was supported by grants from DIUE de la Generalitat de Catalunya 2017 SGR 138 from the Departament d'Economia i Coneixement de la Generalitat de Catalunya (Spain). NS-D has received the FI 2021 predoctoral grant (FI_B2021/00104) from the Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya. CV-A was supported by a predoctoral Grant of the Ministerio de Educación, Cultura y Deporte (FPU16/01453). AA-S has received a post-doctoral grant from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Valencia (APOSTD/2020/003). The Physiopathology of Obesity and Nutrition Networking Biomedical Research Center (CIBEROBN) is an initiative of ISCIII.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A human in vitro neuronal model for studying homeostatic plasticity at the network level

  • Yuan, Xiuming
  • Puvogel, Sofía
  • van Rhijn, Jon-Ruben
  • Ciptasari, Ummi
  • Esteve-Codina, Anna
  • Meijer, Mandy
  • Rouschop, Simon
  • van Hugte, Eline J. H.
  • Oudakker, Astrid
  • Schoenmaker, Chantal
  • Frega, Monica
  • Schubert, Dirk
  • Franke, Barbara
  • Nadif Kasri, Nael
Mechanisms that underlie homeostatic plasticity have been extensively investigated at single-cell levels in animal models, but are less well understood at the network level. Here, we used microelectrode arrays to characterize neuronal networks following induction of homeostatic plasticity in human induced pluripotent stem cell (hiPSC)-derived glutamatergic neurons co-cultured with rat astrocytes. Chronic suppression of neuronal activity through tetrodotoxin (TTX) elicited a time-dependent network re-arrangement. Increased expression of AMPA receptors and the elongation of axon initial segments were associated with increased network excitability following TTX treatment. Transcriptomic profiling of TTX-treated neurons revealed up-regulated genes related to extracellular matrix organization, while down-regulated genes related to cell communication; also astrocytic gene expression was found altered. Overall, our study shows that hiPSC-derived neuronal networks provide a reliable in vitro platform to measure and characterize homeostatic plasticity at network and single-cell levels; this platform can be extended to investigate altered homeostatic plasticity in brain disorders., The work was supported by funding from the European Community’s Horizon 2020 Programme (H2020/2014–2020) under grant agreement no. 728018 (Eat2beNICE) (to B.F.); ERA-NET NEURON-102 SYNSCHIZ grant (NWO) 013-17-003 4538 (to D.S.); China Scholarship Council 201906100038 (to X.Y.); ISCIII /MINECO (PT17/0009/0019) and FEDER (to A.E.C.); and M.M. was supported by an internal grant from the Donders Centre for Medical Neurosciences of the Radboud University Medical Center.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Cuscó Pons, Pol, 1987-
  • García Fernàndez, Jordi
Background: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis

  • Zhang-James, Yanli
  • Helminen, Emily C.
  • Liu, Jinru
  • ENIGMA-ADHD Working Group
  • Franke, Barbara
  • Hoogman, Martine
  • Faraone, Stephen V.
Attention-deficit/hyperactivity disorder (ADHD) affects 5% of children world-wide. Of these, two-thirds continue to have impairing symptoms of ADHD into adulthood. Although a large literature implicates structural brain differences of the disorder, it is not clear if adults with ADHD have similar neuroanatomical differences as those seen in children with recent reports from the large ENIGMA-ADHD consortium finding structural differences for children but not for adults. This paper uses deep learning neural network classification models to determine if there are neuroanatomical changes in the brains of children with ADHD that are also observed for adult ADHD, and vice versa. We found that structural MRI data can significantly separate ADHD from control participants for both children and adults. Consistent with the prior reports from ENIGMA-ADHD, prediction performance and effect sizes were better for the child than the adult samples. The model trained on adult samples significantly predicted ADHD in the child sample, suggesting that our model learned anatomical features that are common to ADHD in childhood and adulthood. These results support the continuity of ADHD's brain differences from childhood to adulthood. In addition, our work demonstrates a novel use of neural network classification models to test hypotheses about developmental continuity., Dr. Faraone is supported by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602805, the European Union’s Horizon 2020 research and innovation programme under grant agreement nos. 667302 & 728018, and NIMH grants 5R01MH101519 and U01 MH109536-01. Dr. Franke is supported by a personal Vici grant (016-130-669) and Dr. Hoogman from a personal Veni grant (91619115), both from the Netherlands Organization for Scientific Research (NWO). The ENIGMA Working Group gratefully acknowledges support from the NIH Big Data to Knowledge (BD2K) award (U54 EB020403 to Paul Thompson). We thank Margaret Mariano and Patricia Forken for administrative assistance and proofreading the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

  • Mallorquí-Bagué, Nuria
  • Cuenca Royo, Aida Ma, 1981-
  • Castañer, Olga
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabetes with executive function (EF); (b) the effect of BMI on both type 2 diabetes and EF; (c) the association between glycaemia control and EF in type 2 diabetes. 6823 older individuals with overweight/obesity and metabolic syndrome participating in the PREDIMED-PLUS study, were assessed with a battery of cognitive tests and a medical interview. ANOVA showed a significantly worse performance on EF in type 2 diabetes vs. non-diabetic individuals. Two complementary models were displayed: (1) in the whole sample, the presence of type 2 diabetes, depressive symptoms and BMI had a direct negative effect on EF, while apnoea had an indirect negative effect; (2) in the diabetes subsample, higher illness duration was associated with worse performance in EF. Participants with type 2 diabetes and HbA1c<53 mmol/mol displayed better cognitive performance when compared to those with HbA1c≥53 mmol/mol. Our results provide a controlled comprehensive model that integrates relevant neuropsychological and physical variables in type 2 diabetes. The model suggests that, to improve treatment adherence and quality of life once diabetes has been diagnosed, cognitive decline prevention strategies need to be implemented while monitoring depressive symptoms, BMI and glycaemia control., This project is funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research - with competitive grants for the periods 2014–2016, 2015–2017, 2017–2019 and 2018–2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund [grants: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728 PI13/01090 PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926] and the European Research Council [Advanced Research Grant 2014–2019; agreement #340918]. Additional grants: Acciones Especiales from ISCIIII, Consejería-Salud, Junta -Andalucía [PI0458/2013, PS0358/2016], Recercaixa-grant 2013 [2013ACUP00194], a SEMERGEN grant, International Nut & Dried Fruit Council – FESNAD No. 201302. Fundación Patrimonio Comunal Olivarero is providing the necessary amounts of olive oil. Nuts were initially and only partially provided by Pistachios Growers and Almond Board of California, for the pilot study. This research was also partially funded by EU-H2020 Grant (Eat2beNICE/H2020-SFS-2016–2; Ref 728018), PI14/00290 y PI17/1167(Co-funded by European Regional Development Fund, ERDF, a way to build Europe), PERIS (Generalitat de Catalunya, SLT006/17/00077), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. We thank CERCA Programme/Generalitat de Catalunya for institutional support. ML-M is supported by a predoctoral Grant of the Ministerio de Educación, Cultura y Deporte (FPU15/02911). None of these funding sources plays any role in the design, collection, analysis, or interpretation of the data or in the decision to submit manuscripts for publication.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Physical activity shifts gut microbiota structure in aged subjects with overweight/obesity and metabolic syndrome

  • Ruiz Limón, Patricia
  • Muralidharan, Jananee
  • Gómez Pérez, Ana María
  • Murri, Mora
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Salas Salvadó, Jordi
  • Torres-Collado, Laura
  • Coltell, Oscar
  • Atzeni, Alessandro
  • Castañer, Olga
  • Bulló, Mònica
  • Bernal López, María Rosa
  • Moreno-Indias, Isabel
  • Tinahones Madueño, Francisco José
We aimed to identify how physical activity (PA), within the context of a Mediterranean diet, affects metabolic variables and gut microbiota in older individuals with overweight/obesity and metabolic syndrome. Observational analysis was conducted as part of the PREDIMED-Plus study with 152 males and 145 females with overweight/obesity and metabolic syndrome. General assessments, anthropometric and biochemical measurements, and gut microbial 16S rRNA sequencing data were analyzed at baseline and 1-year of follow-up. Participants were stratified by tertiles of 1-year change in total PA-related energy expenditure ranging from -98.77 to 1099.99 METs (min/week). The total PA percentage of change was reduced in tertile 1 (-44.83 ± 24.94), increased in tertile 2 (28.96 ± 23.33) and tertile 3 (273.64 ± 221.42). Beta diversity analysis showed differences in the gut microbiota population within each tertile group. Significant differences were found at phylum, family, and genus levels in the gut microbiota of the three tertile groups at baseline and 1-year timepoint. Tertile 3, the group with the greatest increase in PA, was characterized by increases in their levels of Sutterella, Bilophila, and Lachnospira bacteria as well as a reduction in Collinsella. Moreover, this tertile showed a different pattern in its predicted metabolic capacities to the other groups. Our results have demonstrated that changes in PA such as lifestyle and Mediterranean diet induces specific variations in the gut microbiota profile. This modulation of gut microbiome populations and their metabolic capacities may contribute to the health of the aged individuals with overweight/obesity and metabolic syndrome., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (three coordinated FIS projects lead by JS-S: PI13/00462, PI16/00501 and PI19/00576; two led by JV: PI17/01441, PI14/01206; and two led by MRBL: PI14/00696 and PI17/00855); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant (OBN16PE01) to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S. DC obtained grant from the Generalitat Valenciana (PROMETEO 2017/17) and Grant from the Ministry of Science and Innovation/Instituto de Salud Carlos III (reference: PI19/00781). Eat2beNICE project (European Union's Horizon 2020 research and innovation programme under grant agreement No 728018). PRL was supported by a "Sara Borrell" postdoctoral contract (CD19/00216) from the ISCIII-Madrid (Spain), co-financed by the Fondo Europeo de Desarrollo Regional-(FEDER). IMI was supported by the "Miguel Servet Type II" program (CPII21/00013) of the ISCIII-Madrid (Spain), co-financed by the FEDER. JM and AA were supported by the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 713679, cofunded from the Universitat Rovira i Virgili (URV) and Fundació Catalunya La Pedrera. OCN was supported by Juan Rodés program JR17/00022 and PI20/00012. MM is supported by Miguel Servet I program (CP17/00133) from ISCIII and cofunded by FEDER. AMGP was supported by a research contract from Servicio Andaluz de Salud (B-0033-2014). MRBL is supported by Miguel Servet II program (CPII/00014) from ISCIII and by Nicolás Monardes program (C1-0005-2020) from Servicio Andaluz de Salud, both cofunded by FEDER. This work is partially supported by ICREA. Food companies Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) donated extra virgin olive oil; and the Almond Board of California (Modesto, CA, USA), American Pistachio Growers (Fresno, CA, USA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA, USA) donated nuts for the PREDIMED-Pilot study.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín-Peláez, Sandra
  • Lassale, Camille
  • Malcampo, Mireia
  • Val, José Luis del
  • Chillarón Jordan, Juan José
  • Sánchez Villegas, Almudena
Background: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings: Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ≥280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions: Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response. International Standard Randomized Controlled Trial (ISRCTN89898870)., This research was also partially funded by: Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); Generalitat Valenciana (PROMETEO/2017/017); SEMERGEN, CIBEROBN, FEDER and ISCIII (CB06/03); EU-H2020 Grants (Eat2beNICE/h2020-sfs-2016-2, ref.728018; PRIME/h2020-SC1-BHC-2018-2020, ref: 847879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the funding sources took part in the design, collection, analysis or interpretation of the data or in the decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice

  • Cabana-Domínguez, Judit
  • Martín García, Elena, 1975-
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernández-Castillo, Noèlia
  • Comand, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction., This work was supported by the Spanish ‘Ministerio de Economía y Competitividad-MINECO’ (#SAF2017-84060-RAEI/FEDER-UE), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I068) to RM, ‘Fundació La Marató-TV3’ (#2016/20-30) and ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006) to EMG, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100), Spanish ‘Ministerio de Economía y Competitividad’ (#SAF2015-68341-R), ‘AGAURGeneralitat de Catalunya’ (#2017-SGR-738) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I050) to BC and (#PNSD-2020I042) to NFC. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE). JCD was supported by the H2020 CoCA and Eat2beNICE projects
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Interplay between cognition and weight reduction in individuals following a mediterranean diet: three-year follow-up of the PREDIMED-plus trial

  • Soldevila-Domenech, Natalia
  • Forcano, Laura
  • Vintró Alcaraz, Cristina
  • Cuenca Royo, Aida Ma, 1981-
  • Pintó Sala, Xavier
  • Jiménez Murcia, Susana
  • García-Gavilán, Jesús Francisco
  • Nishi, Stephanie
  • Babio, Nancy
  • Gomis González, Maria, 1988-
  • Corella, Dolores
  • Sorlí, José Vicente
  • Fernández-Carrión, Rebeca
  • Martínez-González, Miguel Ángel, 1957-
  • Martí, Amelia
  • Salas-Salvadó, Jordi
  • Castañer, Olga
  • Fernández Aranda, Fernando
  • Torre Fornell, Rafael de la
Background & aims: Some cognitive profiles might facilitate successful weight loss and its maintenance. Also, weight reductions may result in cognitive benefits. However, little work to date has examined the interactions between cognition and weight changes in the context of interventions with the Mediterranean diet (MedDiet). We studied the within-subject longitudinal relationships between cognition, body mass index (BMI), physical activity (PA), and quality of life (QoL), in older adults following a MedDiet. Methods: The PREDIMED-Plus is a primary prevention trial testing the effect of a lifestyle intervention program with an energy-restricted MedDiet (er-MedDiet), weight-loss goals and PA promotion on cardiovascular disease. The PREDIMED-Plus-Cognition sub-study included 487 participants (50% women, mean age 65.2 ± 4.7 years), with overweight/obesity, metabolic syndrome and normal cognitive performance at baseline. A comprehensive neurocognitive test battery was administered at baseline and after 1 and 3 years. Results: Baseline higher performance in verbal memory (OR = 1.5; 95%CI 1.0, 2.1), visuoconstructive praxis and attention (OR = 1.5; 95%CI 0.9, 2.3), and inhibition (OR = 1.3; 95%CI 0.9, 1.9) were associated with a higher odd of achieving at least 8% weight loss after 3 years follow-up in participants randomized to the intervention group. There were moderate improvements in specific tests of memory and executive functions during follow-up. Higher adherence to the er-MedDiet was associated with greater improvements in memory. Women exhibited lower rates of change in global cognition, PA and QoL. Moreover, improvements in memory correlated with reductions in BMI after 1 year (βSTD = -0.14) and with improvements in PA after 3 years (βSTD = 0.13). Finally, participants who experienced greater improvements in executive functions and global cognition also experienced greater improvements in their QoL. Conclusions: This study refines the understanding of the determinants and mutual interrelationships between longitudinally-assessed cognitive performance and weight loss, adding further evidence to the cognitive benefits associated with better adherence to a MedDiet. Our results also suggest that weight loss interventions tailored to the cognitive profile and gender of participants are promising avenues for future studies., Study resulting from the following grants: SLT006/17/00246, SLT002/16/00045 and SLT006/17/00077 funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l'àmbit de la recerca i la innovació en salut” and "Pla estratègic de recerca i innovació en salut (PERIS)". We thank CERCA Programme / Generalitat de Catalunya for institutional support. This project was funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research - with competitive grants leaded by Jordi Salas-Salvadó and Josep Vidal for the periods 2014-2016, 2015-2017, 2017-2019 and 2018-2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, ERDF, a way to build Europe) [grants: PI13/00233, PI13/00728, PI13/01123, PI13/00462, PI16/00533, PI16/00366, PI16/01094, PI16/00501, PI17/01167, PI19/00017, PI19/00781, PI19/01032, PI19/00576]; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to Jordi Salas-Salvadó; the European Research Council [Advanced Research Grant 2014-2019; agreement #340918] granted to Miguel Ángel Martínez-González; the Recercaixa (number 2013ACUP00194) grant to Jordi SalasSalvadó. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020; Ref: 847879), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. This work is also partially supported by ICREA under the ICREA Academia programme. This work was supported by grants from DIUE de la Generalitat de Catalunya 2017 SGR 138 from the Departament d‟Economia i Coneixement de la Generalitat de Catalunya (Spain). CVA are supported by a predoctoral Grant of the Ministerio de Educación, Cultura y Deporte (FPU16/01453). JFG-G has received the Contratos Predoctorales de Formación en Investigación en Salud (PFIS FI17/00255) of the Acción Estratégica en Salud program (AES) from the Carlos III Health Institute (ISCIII), Spanish Ministry of Health. The Physiopathology of Obesity and Nutrition Networking Biomedical Research Center (CIBEROBN) is an initiative of ISCIII. None of these funding sources plays any role in the design, collection, analysis, or interpretation of the data or in the decision to submit manuscripts for publication. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. Conflict of interest Dr. Salas-Salvadó reports non-financial support from Nut and Dried Fruit Foundation, personal fees
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

  • Baenas, Isabel
  • Miranda-Olivos, Romina
  • Granero, Roser
  • Solé Morata, Neus, 1988-
  • Sánchez, Isabel
  • Pastor, Antonio
  • Pino-Gutiérrez, Amparo del
  • Codina, Ester
  • Tinahones Madueño, Francisco José
  • Fernández-Formoso, José A.
  • Vilarrasa, Nuria
  • Guerrero-Pérez, Fernando
  • Lopez-Urdiales, Rafael
  • Virgili, Núria
  • Soriano-Mas, Carles
  • Jiménez Murcia, Susana
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
Background: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence pathophysiology. Then, we aimed to analyze fasting AEA and 2-AG plasma concentrations among individuals with EWC (i.e., anorexia nervosa [AN] and obesity with and without eating disorders [EDs]) compared with healthy controls (HCs), and its association with clinical variables and body mass index (BMI). Methods: The sample included 113 adult women. Fifty-seven belonged to the obesity group, 37 without EDs (OB-ED) and 20 with ED (OB+ED classified within the binge spectrum disorders), 27 individuals from the AN group, and 29 from the HC group. Peripheral blood samples, several clinical variables, and BMI were evaluated. Results: Unlike 2-AG, AEA concentrations showed significant differences between groups (p < 0.001). Increased AEA was observed in the OB-ED and OB+ED compared with both HC and AN group, respectively. Likewise, AEA was differentially associated with emotional dysregulation, general psychopathology, food addiction, and BMI in all clinical groups. Conclusions: These results support the interaction between biological and clinical factors contributing to delineating vulnerability pathways in EWC that could help fit personalized therapeutic approaches., We thank CERCA Programme / Generalitat de Cataluny a for institutional support. This manuscript and research were supported by grants from the Delegación del Gobierno para el Plan Nacional sobre Drogas (2021I031), Ministerio de Ciencia e Innovación (PDI2021-124887OB-I00), Instituto de Salud Carlos III (ISCIII) (FIS PI20/00132) and cofounded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBER Obn, CIBERSAM, and CIBERDEM are initiatives of ISCIII. Additional funding was received by AGAUR- Generalitat de Catalunya (2021-SGR-00824 and 2021 SGR 00253) and European Union’s Horizon 2020 research and innovation program under Grant agreement no. 728018 (H2020-SFS-2016-2, Eat2beNice), no. 847879 (PRIME/H2020, Prevention and Remediation of Insulin Multi morbidity in Europe) and no. 101080219 (eprObes). This study has also been funded by Instituto de Salud Carlos III through the grant CM21/00172 (IB) (Co-funded by European Social Fund. ESF investing in your future). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021-Programme). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Impulsive personality traits predicted weight loss in individuals with type 2 diabetes after 3 years of lifestyle interventions

  • Testa, Giulia
  • Camacho Barcia, Lucía
  • Gómez Martínez, Carlos
  • Mora-Maltas, Bernat
  • Torre Fornell, Rafael de la
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Granero, Roser
  • Cuenca Royo, Aida Ma, 1981-
  • Jiménez Murcia, Susana
  • Babio, Nancy
  • Fernández-Carrión, Rebeca
  • Esteve Luque, Virginia
  • Forcano, Laura
  • Ni, Jiaqi
  • Malcampo, Mireia
  • De Las Heras-Delgado, Sara
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
  • Fernández Aranda, Fernando
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA1c), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA1c. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. We thank CERCA Programme/Generalitat de Catalunya for institutional support. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2; Ref 728018; and PRIME/H2020-SC1-BHC-2018-2020; Ref: 847879). J.S-S. is partially supported by ICREA under the ICREA Academia program. J.N. is supported by a pre-doctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021-Programme). None of the funding sources took part in the design, collection, analysis, or interpretation of the data or in the decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Cell type-specific methylome-wide association studies of childhood ADHD symptoms

  • Meijer, Mandy
  • Cosín Tomàs, Marta
  • Bustamante Pineda, Mariona
  • Ramos González, Juan
  • Sunyer Deu, Jordi
  • van den Oord, Edwin J.C.G.
Studying DNA methylation (DNAm) can provide insights into gene-regulatory mechanisms underlying attention-deficit/hyperactivity disorder (ADHD). While most DNAm studies were performed in bulk tissue, this study used statistical deconvolution to identify cell type-specific DNAm profiles, from five major blood cell types, associated with childhood ADHD symptoms. We performed meta-analyses of methylome-wide association studies (MWAS) for ADHD symptoms (agerange=4-16 years) in peripheral blood collected during childhood and in cord blood. The investigated cohorts included seven array-based methylation datasets assaying up to 450 K CpGs from the Pregnancy And Childhood Epigenetics Consortium (N=2 934 peripheral blood; N=2 546 cord blood) and a sequencing-based methylation dataset assaying nearly all 28 million CpGs in blood from the Great Smoky Mountain Study (GSMS; N=583). The meta-analyses resulted in methylome-wide significant (FDR<0.05) ADHD associations in CD8T cells (RPL31P11 and KCNJ5) for peripheral blood, and, in cord blood, in monocytes (PDE6B), CD8T cells (KCNA3 and HAND2), and NK cells (KIFC1). Notably, several significant sites detected in peripheral blood (RPL31P11 and KCNJ5) were also detected in cord blood. Furthermore, extended MWAS of all sites available for GSMS detected 69 and 17 additional CpGs in monocytes and granulocytes, respectively. In this first cell type-specific MWAS for ADHD, we identified DNAm associations for ADHD symptoms; some associations were seen in both peripheral blood and cord blood, suggesting potential susceptibility markers for increased ADHD risk. These findings show that cell type-specific analyses and sequencing-based approaches can increase insights into the epigenetic patterns associated with ADHD symptoms in childhood., This work was supported by an internal grant from the Donders Centre for Medical Neuroscience of the Radboudumc and by funding for the Dutch National Science Agenda NeurolabNL project (grant 400–17–602). Support was also received from the European Commission’s Horizon 2020 Programme (H2020/2014–2020) under grant agreement n◦ 728018 (Eat2beNICE). This work reflects only the view of the authors, and the European Commission is not responsible for any use that may be made of the information. This research was supported by the National Institutes of Health (1R01MH104576 to E.J.C.G.v.d.O). In addition, the following personal grants made this work possible: MK was supported by grants from the Netherlands Organisation for Scientific Research (NWO, grant nos. 45219212 and 09150162010073). AH was supported by the HERCULES Center (NIEHS P30ES019776). MCT is funded by a Beatriu de Pinos ´ Postdoctoral Contract awarded by eneralitat de Catalunya-AGAUR and European Commission- Horizon 2020 (2019 BP 00107). BiB is supported by a Wellcome programme grant (WT223601/Z/21/Z) ’Born in Bradford: Age of Wonder’ and a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): R/N024391/1. The work of CAMC, RHM, and JFF is supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause; grant agreement No 848158). The work of CAM is supported by the European Research Council (TEMPO; grant agreement No 101039672). CLR. is funded by the MRC MC_UU_00011/5). DJS and HJZ are supported by the South African Medical Research Council (SAMRC). A complete overview of all funding sources and acknowledgements can be found in the
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Differential expression of miR-1249-3p and miR-34b-5p between vulnerable and resilient phenotypes of cocaine addiction

  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Cormand, Bru
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Cocaine addiction is a complex brain disorder involving long-term alterations that lead to loss of control over drug seeking. The transition from recreational use to pathological consumption is different in each individual, depending on the interaction between environmental and genetic factors. Epigenetic mechanisms are ideal candidates to study psychiatric disorders triggered by these interactions, maintaining persistent malfunctions in specific brain regions. Here we aim to study brain-region-specific epigenetic signatures following exposure to cocaine in a mouse model of addiction to this drug. Extreme subpopulations of vulnerable and resilient phenotypes were selected to identify miRNA signatures for differential vulnerability to cocaine addiction. We used an operant model of intravenous cocaine self-administration to evaluate addictive-like behaviour in rodents based on the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition criteria to diagnose substance use disorders. After cocaine self-administration, we performed miRNA profiling to compare two extreme subpopulations of mice classified as resilient and vulnerable to cocaine addiction. We found that mmu-miR-34b-5p was downregulated in the nucleus accumbens of vulnerable mice with high motivation for cocaine. On the other hand, mmu-miR-1249-3p was downregulated on vulnerable mice with high levels of motor disinhibition. The elucidation of the epigenetic profile related to vulnerability to cocaine addiction is expected to help find novel biomarkers that could facilitate the interventions to battle this devastating disorder., This work was supported by the Spanish “Ministerio de Economía y Competitividad-MINECO” (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2017 SGR-669), “ICREA-Acadèmia” (#2015) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad”, “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068) to RM; “Fundació La Marató-TV3” (#2016/20-30), “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2019I006) and NEURON-ERA-NET: MCIN/AEI/UE - PCI2021-122073-2A to E.M-G.; Spanish “Ministerio de Ciencia, Innovación y Universidades” (#RTI2018–100968-B-100), Spanish “Ministerio de Ciencia e Innovación (#PID2021-1277760B-100), “AGAUR-Generalitat de Catalunya” (#2017-SGR-738), “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I050) and ICREA Acadèmia 2021 to BC and “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2020I042) to N.F-C. The research leading to these results was also supported by the European Union H2020 Program [H2020/2014–2020] under grant agreements no 667302 (CoCA) and 728018 (Eat2beNICE) and by the “ECNP network on ADHD across the lifespan” to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and NF-C by “Centro de Investigación Biomédica en Red de Enfermedades Raras” (CIBERER).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Faecal microbiota composition and impulsivity in a cohort of older adults with metabolic syndrome

  • Konstanti, Prokopis
  • Gómez Martínez, Carlos
  • Muralidharan, Jananee
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Tinahones Madueño, Francisco José
  • Torres-Collado, Laura
  • Coltell, Oscar
  • Castañer, Olga
  • Moreno-Indias, Isabel
  • Atzeni, Alessandro
  • Ruiz-Canela, Miguel
  • Salas Salvadó, Jordi
  • Belzer, Clara
Impulsivity is an important determinant of human behaviour, affecting self-control, reasonable thinking and food choices. Recent evidence suggests a role for gut microbiota in human behaviour, but the relationship between gut microbiota and impulsive behaviours remains largely unexplored. To address this knowledge gap, the present study aims to explore the associations between faecal microbiota composition with trait and behavioural impulsivity, in a subcohort of the PREDIMED-Plus trial, including older adults presenting overweight/obesity. Fecal samples (n = 231) were profiled for their microbiota composition using 16 S rRNA amplicon sequencing and impulsivity was determined through four different assessments. Adherence to different dietary patterns was estimated through questionnaires. Beta diversity analyses showed a significant association with the Conner's Performance Test (CPT) in multivariate-adjusted models, and, in total, 13 bacterial genera associated with CPT. Erysipelotrichaceae UCG 003 showed the highest association with CPT and known butyrate producers such as Butyricicoccus spp., Roseburia spp., and Eubacterium hallii were among the identified bacteria. The bacteria Lachnospiraceae UCG 001, Anaerostipes and Blautia were associated with CPT and also the adherence to healthy and unhealthy plant-based diets. In addition, functional analysis showed a significant negative association between the CPT and the glucuronate and galacturonate metabolic pathways. From the other impulsivity assessments, two more associations were identified, for the genus Phascolarctobacterium with the Stroop test, and the genus Lachnospiraceae GAG 54 with the positive urgency subscore of UPPS-P Impulsive Behaviour Scale. Overall, our findings suggest potential links between the faecal microbiota composition and function with behavioural impulsive inattention as determined by the CPT., This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2, Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020, Ref: 847879) and by the Generalitat Valenciana: Grant PROMETEO 21/2021. Carlos Gómez-Martínez receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); Dr. Salas-Salvadó gratefully acknowledges the financial support by ICREA under the ICREA Academia program.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome

  • Mallorquí Bagué, Joaquim
  • Lozano Madrid, María
  • Vintró Alcaraz, Cristina
  • Forcano, Laura
  • Díaz López, Andrés
  • Galera, Ana
  • Fernández-Carrión, Rebeca
  • Granero, Roser
  • Jiménez Murcia, Susana
  • Corella, Dolores
  • Pintó Sala, Xavier
  • Cuenca Royo, Aida Ma, 1981-
  • Bulló, Mònica
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study examines if overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms, and if these variables could be modified after 1 year of a multimodal intervention (diet, physical activity, psychosocial support). 342 adults (55-75 years) with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus Cognition study were randomized to the intervention or to the control group (lifestyle recommendations). Cognitive and psychopathological assessments were performed at baseline and after 1-year follow-up. At baseline, higher impulsivity was linked to higher food addiction and depressive symptoms, but not to body mass index (BMI). Food addiction not only predicted higher BMI and depressive symptoms, but also achieved a mediational role between impulsivity and BMI/depressive symptoms. After 1 year, patients in both groups reported significant decreases in BMI, food addiction and impulsivity. BMI reduction and impulsivity improvements were higher in the intervention group. Higher BMI decrease was achieved in individuals with lower impulsivity. Higher scores in food addiction were also related to greater post-treatment impulsivity. To conclude, overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms in mid/old age individuals with MetS. Our results also highlight the modifiable nature of the studied variables and the interest of promoting multimodal interventions within this population., This project was funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research—with competitive grants leaded by Jordi Salas-Salvadó and Josep Vidal for the periods 2014–2016, 2015–2017, 2017–2019 and 2018–2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund [grants: PI13/00233, PI13/00728, PI13/01123, PI13/00462, PI16/00533, PI16/00366, PI16/01094, PI16/00501, PI19/00017, PI19/00781, PI19/01032, PI19/00576]; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to Jordi Salas-Salvadó; the European Research Council [Advanced Research Grant 2014–2019; agreement #340918] granted to Miguel Ángel Martínez-González; the Recercaixa (number 2013ACUP00194) grant to Jordi Salas-Salvadó. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2; Ref 728018; and PRIME/H2020-SC1-BHC-2018-2020; Ref: 847879) and Instituto Salud Carlos III (Fondo Investigación Sanitario, FIS: PI17/01167), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. This work is also partially supported by ICREA under the ICREA Academia programme.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

  • Bouzas, Cristina
  • Goday Arnó, Albert
  • Muñoz Pérez, Miguel Ángel
  • Satorres, Alba
  • Fitó Colomer, Montserrat
  • Tur, J. Antoni
Aims To assess the comparative effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), 4-dipeptidyl peptidase inhibitors (DPP-4I), and metformin treatment during one year on metabolic syndrome (MetS) components and severity in MetS patients. Methods Prospective study (n = 6165 adults) within the frame of PREDIMED-Plus trial. The major end-point was changes on MetS components and severity after one- year treatment of GLP-1RA, DPP-4I, and metformin. Anthropometric measurements (weight, height and waist circumference), body mass index (BM), and blood pressure were registered. Blood samples were collected after overnight fasting. Plasma glucose, glycosylated hemoglobin (HbA1c), plasma triglycerides and cholesterol were measured. Dietary intakes as well as physical activity were assessed through validated questionnaires. Results MetS parameters improved through time. The treated groups improved glycaemia compared with untreated (glycaemia ∆ untreated: −1.7 mg/dL(± 13.5); ∆ metformin: − 2.5(± 23.9) mg/dL; ∆ DPP-4I: − 4.5(± 42.6); mg/dL ∆ GLP-1RA: − 4.3(± 50.9) mg/dL; and HbA1c: ∆ untreated: 0.0(± 0.3) %; ∆ metformin: − 0.1(± 0.7) %; ∆ DPP-4I: − 0.1(± 1.0) %; ∆ GLP-1RA: − 0.2(± 1.2) %. Participants decreased BMI and waist circumference. GLP-1RA and DPP-4I participants registered the lowest decrease in BMI (∆ untreated: −0.8(± 1.6) kg/m2; ∆ metformin: − 0.8(± 1.5) kg/m2; ∆ DPP-4I: − 0.6(± 1.3) kg/m2; ∆ GLP-1RA: − 0.5(± 1.2) kg/m2. and their waist circumference (∆ untreated: −2.8(± 5.2) cm; ∆ metformin: − 2.6(± 15.2) cm; ∆ DPP-4I: − 2.1(± 4.8) cm; ∆ GLP-1RA: − 2.4(± 4.1) cm. Conclusion In patients with MetS and healthy lifestyle intervention, those treated with GLP-1RA and DPP-4I obtained better glycemic profile. Anthropometric improvements were modest., The PREDIMED-Plus trial was supported by the European Research Council (Advanced Research Grant 2013–2018, 340918) to M.Á.M.-G and the official funding agency for biomedical research of the Spanish Government, ISCIII, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (five coordinated FIS projects led by J.S.-S. and J.Vid., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158), the Especial Action Project entitled: Implementación y evaluación de una intervención intensive sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S., the Recercaixa Grant to J.S.-S. (2013ACUP00194), Grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and PI0137/2018), a Grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN Grant, EU-COST Action CA16112, a Grant of support to research groups no. 35/2011 from the Balearic Islands Government, Grants (FOLIUM, PRIMUS, SYNERGIA, and LIBERI) from Balearic Islands Health Research Institute (IDISBA), funds from the European Regional Development Fund (CIBEROBN CB06/03 and CB12/03) and from the European Commission (EAT2BENICE_H2020_SFS2016). Fundació La Marató TV3 (project ref. 201630.10). Cristina Bouzas received a Fernando Tarongí Bauzà Grant, Margalida Comas Grant (DG R+D+I, Balearic Ils Govn, and Juan de la Cierva Grant (Ministry of Science, Spain). The funding sponsors had no role in the design of the study, in the collection, analyses, or interpretation of the data; in the writing of the manuscript, and in the decision to publish the results.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention

  • Soldevila-Domenech, Natalia
  • Fagundo, Beatriz
  • Cuenca Royo, Aida Ma, 1981-
  • Forcano, Laura
  • Gomis González, Maria, 1988-
  • Boronat Rigol, Anna, 1990-
  • Pastor, Antonio
  • Castañer, Olga
  • Zomeño Fajardo, María Dolores
  • Goday Arnó, Albert
  • Dierssen, Mara
  • Baghizadeh Hosseini, Khashayar
  • Ros, Emilio
  • Corella, Dolores
  • Martínez-González, Miguel Ángel, 1957-
  • Salas Salvadó, Jordi
  • Fernández Aranda, Fernando
  • Fitó Colomer, Montserrat
  • Torre Fornell, Rafael de la
Background: The Mediterranean diet (MedDiet) has demonstrated efficacy in preventing age-related cognitive decline and modulating plasma concentrations of endocannabinoids (eCBs) and N-acylethanolamines (NAEs, or eCB-like compounds), which are lipid mediators involved in multiple neurological disorders and metabolic processes. Hypothesizing that eCBs and NAEs will be biomarkers of a MedDiet intervention and will be related to the cognitive response, we investigated this relationship according to sex and apolipoprotein E (APOE) genotype, which may affect eCBs and cognitive performance. Methods: This was a prospective cohort study of 102 participants (53.9% women, 18.8% APOE-ɛ4 carriers, aged 65.6 ± 4.5 years) from the PREDIMED-Plus-Cognition substudy, who were recruited at the Hospital del Mar Research Institute (Barcelona). All of them presented metabolic syndrome plus overweight/obesity (inclusion criteria of the PREDIMED-Plus) and normal cognitive performance at baseline (inclusion criteria of this substudy). A comprehensive battery of neuropsychological tests was administered at baseline and after 1 and 3 years. Plasma concentrations of eCBs and NAEs, including 2-arachidonoylglycerol (2-AG), anandamide (AEA), oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and N-docosahexaenoylethanolamine (DHEA), were also monitored. Baseline cognition, cognitive changes, and the association between eCBs/NAEs and cognition were evaluated according to gender (crude models), sex (adjusted models), and APOE genotype. Results: At baseline, men had better executive function and global cognition than women (the effect size of gender differences was - 0.49, p = 0.015; and - 0.42, p = 0.036); however, these differences became nonsignificant in models of sex differences. After 3 years of MedDiet intervention, participants exhibited modest improvements in memory and global cognition. However, greater memory changes were observed in men than in women (Cohen's d of 0.40 vs. 0.25; p = 0.017). In men and APOE-ε4 carriers, 2-AG concentrations were inversely associated with baseline cognition and cognitive changes, while in women, cognitive changes were positively linked to changes in DHEA and the DHEA/AEA ratio. In men, changes in the OEA/AEA and OEA/PEA ratios were positively associated with cognitive changes. Conclusions: The MedDiet improved participants' cognitive performance but the effect size was small and negatively influenced by female sex. Changes in 2-AG, DHEA, the OEA/AEA, the OEA/PEA and the DHEA/AEA ratios were associated with cognitive changes in a sex- and APOE-dependent fashion. These results support the modulation of the endocannabinoid system as a potential therapeutic approach to prevent cognitive decline in at-risk populations. Trial registration: ISRCTN89898870., Study resulting from the following grants: SLT006/17/00246, SLT002/16/00045 and SLT006/17/00077 funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS)”. We thank CERCA Programme / Generalitat de Catalunya for institutional support. This project was funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research - with competitive grants leaded by Jordi Salas-Salvadó and Josep Vidal for the periods 2014 to 2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, ERDF, a way to build Europe) [grants: PI13/00233, PI13/00728, PI13/01123, PI13/00462, PI16/00533, PI16/00366, PI16/01094, PI16/00501, PI17/01167, PI19/00017, PI19/00781, PI19/01032, PI19/00576]; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to Jordi Salas-Salvadó; the European Research Council [Advanced Research Grant 2014–2019; agreement #340918] granted to Miguel Ángel Martínez-González; the Recercaixa (number 2013ACUP00194) grant to Jordi Salas-Salvadó. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020; Ref: 847879), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. This work is also partially supported by ICREA under the ICREA Academia programme. This work was supported by grants from DIUE de la Generalitat de Catalunya 2017 SGR 138 from the Departament d‟Economia i Coneixement de la Generalitat de Catalunya (Spain). Natalia Soldevila-Domenech is supported by the FI 2021 predoctoral grant (FI_B2021/00104) from the Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya. This research was supported by CIBER -Consorcio Centro de Investigación Biomédica en Red- (CIBEROBN, CIBERER), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and European Union. None of these funding sources plays any role in the design, collection, analysis, or interpretation of the data or in the decision to submit manuscripts for publication. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian disorders presenting with hyperactivity and/or inattention

  • Fernàndez-Castillo, Noèlia
  • Cabana-Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico, Bàrbara
  • Weber, Keike
  • Lesch, Klaus-Peter
  • Lao Grueso, Oscar, 1976-
  • Reif, Andreas
  • Cormand, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD. We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders., This work was supported mainly by funding from the European Union H2020 Program [H2020/2014–2020, grant agreements n° 667302, 643051 and 728018, corresponding to projects CoCA, coca-project.eu/; Eat2BeNice: newbrainnutrition.com/ (accessed on 16 December 2021); and MiND; www.mind-project.eu (accessed on 16 December 2021), respectively], and from the ‘ECNP network on ADHD across the lifespan’. NC-F received funding from ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health‘ [PNSD-2020I042] and was supported by a contract of the ‘Centro de Investigación Biomédica en Red de Enfermedades Raras' (CIBERER). BC received funding from the Spanish ‘Ministerio de Economía y Competitividad’ [SAF2015-68341-R, RTI2018-100968-B-100 and PID2021-1277760B-I100], ‘Plan Nacional sobre Drogas of the Spanish Ministry of Health’ [PNSD-2017I050] and AGAUR, ‘Generalitat de Catalunya’ [2017-SGR-738]. JC-D and BT were supported by the H2020 CoCA (n° 667302) and Eat2beNICE (n° 728018) projects. DBK was supported by the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 643051 (MiND) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq-148273/2016-5). OL acknowledges the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020, Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness)—RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00 and Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study

  • Nishi, Stephanie
  • Fitó Colomer, Montserrat
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Water intake and hydration status have been suggested to impact cognition; however, longitudinal evidence is limited and often inconsistent. This study aimed to longitudinally assess the association between hydration status and water intake based on current recommendations, with changes in cognition in an older Spanish population at high cardiovascular disease risk. Methods A prospective analysis was conducted of a cohort of 1957 adults (aged 55–75) with overweight/obesity (BMI between ≥ 27 and < 40 kg/m2) and metabolic syndrome from the PREDIMED-Plus study. Participants had completed bloodwork and validated, semiquantitative beverage and food frequency questionnaires at baseline, as well as an extensive neuropsychological battery of 8 validated tests at baseline and 2 years of follow-up. Hydration status was determined by serum osmolarity calculation and categorized as < 295 mmol/L (hydrated), 295–299.9 mmol/L (impending dehydration), and ≥ 300 mmol/L (dehydrated). Water intake was assessed as total drinking water intake and total water intake from food and beverages and according to EFSA recommendations. Global cognitive function was determined as a composite z-score summarizing individual participant results from all neuropsychological tests. Multivariable linear regression models were fitted to assess the associations between baseline hydration status and fluid intake, continuously and categorically, with 2-year changes in cognitive performance. Results The mean baseline daily total water intake was 2871 ± 676 mL/day (2889 ± 677 mL/day in men; 2854 ± 674 mL/day in women), and 80.2% of participants met the ESFA reference values for an adequate intake. Serum osmolarity (mean 298 ± 24 mmol/L, range 263 to 347 mmol/L) indicated that 56% of participants were physiologically dehydrated. Lower physiological hydration status (i.e., greater serum osmolarity) was associated with a greater decline in global cognitive function z-score over a 2-year period (β: − 0.010; 95% CI − 0.017 to − 0.004, p-value = 0.002). No significant associations were observed between water intake from beverages and/or foods with 2-year changes in global cognitive function. Conclusions Reduced physiological hydration status was associated with greater reductions in global cognitive function over a 2-year period in older adults with metabolic syndrome and overweight or obesity. Future research assessing the impact of hydration on cognitive performance over a longer duration is needed. Trial registration International Standard Randomized Controlled Trial Registry, ISRCTN89898870. Retrospectively registered on 24 July 2014, This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO 17/2017 and PROMETEO 21/2021 grant from the Generalitat Valenciana; the SEMERGEN grant; and the Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2) and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). S.K.N. is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). CG-M is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). IP-G is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Fondo Social Europeo-FSE. CB is supported by a Juan de la Cierva postdoctoral grant from Ministerio de Ciencia, Innovación y Universidades. JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program. Publication of this work is supported by a conference award grant from Hydration for Health presented by the Danone Global Research & Innovation Center (#2022-08514) awarded to S.K.N. for being the conference attendee voted recipient of the Early Career Researcher Award. None of the funding sources took part in the design, collection, analysis, interpretation of the data; writing of the report; or the decision to submit the manuscript for publication.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller Cucala, Paula
  • Maceda Porto, Iago, 1986-
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao Grueso, Oscar, 1976-
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Glycated hemoglobin, type 2 diabetes, and poor diabetes control are positively associated with impulsivity changes in aged individuals with overweight or obesity and metabolic syndrome

  • Gómez Martínez, Carlos
  • Babio, Nancy
  • Camacho Barcia, Lucía
  • Júlvez Calvo, Jordi
  • Nishi, Stephanie
  • Vázquez, Zenaida
  • Forcano, Laura
  • Álvarez-Sala, Andrea
  • Cuenca Royo, Aida Ma, 1981-
  • Torre Fornell, Rafael de la
  • Fanlo Maresma, Marta
  • Tello, Susanna
  • Corella, Dolores
  • Arias Vásquez, Alejandro
  • Dalsgaard, Søren
  • Franke, Barbara
  • Fernández Aranda, Fernando
  • Salas Salvadó, Jordi
Impulsivity has been proposed to have an impact on glycemic dysregulation. However, it remains uncertain whether an unfavorable glycemic status could also contribute to an increase in impulsivity levels. This study aims to analyze associations of baseline and time-varying glycemic status with 3-year time-varying impulsivity in older adults at high risk of cardiovascular disease. A 3-year prospective cohort design was conducted within the PREDIMED-Plus-Cognition substudy. The total population includes 487 participants (mean age = 65.2 years; female = 50.5%) with overweight or obesity and metabolic syndrome. Insulin resistance (HOMA-IR), glycated hemoglobin (HbA1c), presence of type 2 diabetes mellitus, and type 2 diabetes control were evaluated. Impulsivity was measured using the Impulsive Behavior Scale questionnaire and various cognitive measurements. Impulsivity z-scores were generated to obtain Global, Trait, and Behavioral Impulsivity domains. Linear mixed models were used to study the longitudinal associations across baseline, 1-year, and 3-year follow-up visits. HOMA-IR was not significantly related to impulsivity. Participants with higher HbA1c levels, type 2 diabetes, and poor control of diabetes showed positive associations with the Global Impulsivity domain over time, and those with higher HbA1c levels were further related to increases in the Trait and Behavioral Impulsivity domains over the follow-up visits. These results suggest a potential positive feedback loop between impulsivity and glycemic-related dysregulation., We thank the PREDIMED-Plus participants and staff members for their participation, as well as the primary care centers that took part in the study. Furthermore, we thank the CERCA Program of the Generalitat de Catalunya and the CIBEROBN, CIBERESP, and CIBERDEM initiatives of Instituto de Salud Carlos III in Spain. This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (six coordinated FIS projects leaded by J.S.-S., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01133, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01306, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01130, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01326, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S.; the Recercaixa (number 2013ACUP00194) grant to J.S.-S.; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO/21/2021 grants from the Generalitat Valenciana, and the grant PID2019-108858RB-I00 funded by AEI 10.13039/501100011033 and by “ERDF A way of making Europe” to D.C.; the APOSTD2020-164 from the Generalitat Valenciana to A.A.-S.; the SEMERGEN grant; C.G.-M. receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); J.S.-S., senior author of this paper, is partially supported by ICREA under the ICREA Academia program; L.C.-B. was supported by Sara Borrell fellowship CD22/00171 funded by the Instituto de Salud Carlos III (ISCIII) and cofounded by the European Union; J.J. holds the Miguel Servet-II contract (CPII19/00015) awarded by the Instituto de Salud Carlos III (cofunded by the European Social Fund “Investing in your future”). S.K.N. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). F.F.-A. obtained from Generalitat de Catalunya the 2021 SGR 00824 grant, and from Instituto de Salud Carlos II the FORT23/00032 and the PI20/132 grants. None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication. We thank CERCA Programme/Generalitat de Catalunya for institutional support and partial support was also provided by SLT006/17/00246, funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS).” This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2, Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020, Ref: 847879).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Transdiagnostic perspective of impulsivity and compulsivity in obesity: from cognitive profile to self-reported dimensions in clinical samples with and without diabetes

  • Testa, Giulia
  • Fitó Colomer, Montserrat
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
Impulsive and compulsive behaviors have both been observed in individuals with obesity. The co-occurrence of obesity and type 2 diabetes (T2D) is more strongly associated with impulsivity, although there are no conclusive results yet. A multidimensional assessment of impulsivity and compulsivity was conducted in individuals with obesity in the absence or presence of T2D, compared with healthy, normal-weight individuals, with highly impulsive patients (gambling disorders), and with highly compulsive patients (anorexia nervosa). Decision making and novelty seeking were used to measure impulsivity, and cognitive flexibility and harm avoidance were used for compulsivity. For impulsivity, patients with obesity and T2D showed poorer decision-making ability compared with healthy individuals. For compulsivity, individuals with only obesity presented less cognitive flexibility and high harm avoidance; these dimensions were not associated with obesity with T2D. This study contributes to the knowledge of the mechanisms associated with diabetes and its association with impulsive-compulsive behaviors, confirming the hypothesis that patients with obesity and T2D would be characterized by higher levels of impulsivity., This manuscript and research were supported by grants from the Instituto de Salud Carlos III (ISCIII) (FIS PI14/00290, PI17/01167 and PI20/132) and (PI13/00462, PI16/00501, PI19/00576), by the SLT006/17/00246 grant, funded by the Department of Health of the Generalitat de Catalunya by the call “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” (PERIS) and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERObn is an initiative of ISCIII. This research was also partially funded by EU-H2020 grants (Eat2beNICE/H2020-SFS-2016-2, Ref 728018; PRIME/H2020-SC1-BHC-2018-2020, Ref: 847879). CG-M receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Vilar-Ribó, Laura
  • Cabana-Domínguez, Judit
  • Martorell, Lourdes
  • Ramos-Quiroga, Josep Antoni
  • Sanchez-Roige, Sandra
  • Palmer, Abraham A.
  • Vilella, Elisabet
  • Ribasés, Marta
  • Muntané, Gerard
  • Soler Artigas, María
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

  • Gómez Pérez, Ana María
  • Ruiz Limón, Patricia
  • Salas Salvadó, Jordi
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Atzeni, Alessandro
  • Torres-Collado, Laura
  • Álvarez-Sala, Andrea
  • Martínez, María Ángeles
  • Goday Arnó, Albert
  • Benaiges Foix, David
  • García-Gavilán, Jesús Francisco
  • Bernal López, María Rosa
  • Moreno-Indias, Isabel
  • Tinahones Madueño, Francisco José
To evaluate the changes in the gut microbiota associated with changes in the biochemical markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the Mediterranean diet. Participants (n = 297) from two centers of PREDIMED-Plus trial (Prevención con Dieta Mediterránea) were divided into three different groups based on the change tertile in the Hepatic Steatosis Index (HSI) or the Fibrosis-4 score (FIB-4) between baseline and one year of intervention. One-year changes in HSI were: tertile 1 (T1) (-24.9 to -7.51), T2 (-7.5 to -1.86), T3 (-1.85 to 13.64). The most significant differences in gut microbiota within the year of intervention were observed in the T1 and T3. According to the FIB-4, participants were categorized in non-suspected fibrosis (NSF) and with indeterminate or suspected fibrosis (SF). NSF participants showed higher abundances of Alcaligenaceae, Bacteroidaceae, Bifidobacteriaceae, Clostridiaceae, Enterobacteriaceae, Peptostreptococcaceae, Verrucomicrobiaceae compared to those with SF. Then, participants were divided depending on the FIB-4 tertile of change: T1 (-89.60 to -5.57), T2 (-5.56 to 11.4), and T3 (11.41 to 206.24). FIB-4 T1 showed a decrease in Akkermansia and an increase in Desulfovibrio. T2 had an increase in Victivallaceae, Clostridiaceae, and Desulfovibrio. T3 showed a decrease in Enterobacteriaceae, and an increase in Sutterella, Faecalibacterium, and Blautia. A relation between biochemical index changes of NAFLD/NASH (HSI and FIB-4) and gut microbiota changes were found. These observations highlight the importance of lifestyle intervention in the modulation of gut microbiota and the management of metabolic syndrome and its hepatic manifestations., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (three coordinated FIS projects lead by JS-S: PI13/00462, PI16/00501 and PI19/00576; two led by JV: PI17/01441, PI14/01206; three led by AG: PI13/00233, PI16/00533, PI19/00017; and two led by MRBL: PI14/00696 and PI17/00855); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant (OBN16PE01) to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S. DC obtained grant from the Generalitat Valenciana (PROMETEO 2017/17 and PROMETEO 2021/21) and Grant from the Ministry of Science and Innovation/ISCIII (reference: PI19/00781). Eat2beNICE project (European Union’s Horizon 2020 research and innovation programme under grant agreement No 728018). PRL was supported by a “Sara Borrell” postdoctoral contract (CD19/00216) from the ISCIII-Madrid (Spain), co-financed by the Fondo Europeo de Desarrollo Regional-FEDER. IMI was supported by the “Miguel Servet Type II” program (CPII21/00013) of the ISCIII-Madrid (Spain), co-financed by the FEDER. AMGP was supported by a research contract from Servicio Andaluz de Salud (B-0033–2014). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Generalitat Valenciana. MRBL is supported by Miguel Servet II program (CPII/00014) from ISCIII and by Nicolás Monardes program (C1-0005-2020) from Servicio Andaluz de Salud, both cofunded by FEDER funds. This work is partially supported by ICREA under the ICREA Academia programme. Food companies Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) donated extra virgin olive oil; and the Almond Board of California (Modesto, CA, USA), American Pistachio Growers (Fresno, CA, USA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA, USA) donated nuts for the PREDIMED-Pilot study.
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Mendelian randomization analysis for attention deficit/hyperactivity disorder: studying a broad range of exposures and outcomes

  • Soler Artigas, María
  • Rovira, Paula
Background: Attention deficit/hyperactivity disorder (ADHD) is a highly prevalent neurodevelopmental disorder caused by a combination of genetic and environmental factors and is often thought as an entry point into a negative life trajectory, including risk for comorbid disorders, poor educational achievement or low income. In the present study, we aimed to clarify the causal relationship between ADHD and a comprehensive range of related traits. Methods: We used genome-wide association study (GWAS) summary statistics for ADHD (n¼53 293) and 124 traits related to anthropometry, cognitive function and intelligence, early life exposures, education and employment, lifestyle and environment, longevity, neurological, and psychiatric and mental health or personality and psychosocial factors available in the MR-Base database (16 067 n 766 345). To investigate their causal relationship with ADHD, we used two-sample Mendelian randomization (MR) with a range of sensitivity analyses, and validated MR findings using causal analysis using summary effect estimates (CAUSE), aiming to avoid potential false-positive results. Results: Our findings strengthen previous evidence of a causal effect of ADHD liability on smoking and major depression, and are consistent with a causal effect on odds of decreased average total household income [odds ratio (OR)¼0.966, 95% credible interval (CrI)¼(0.954, 0.979)] and increased lifetime number of sexual partners [OR¼1.023, 95% CrI¼(1.013, 1.033)]. We also found evidence for a causal effect on ADHD for liability of arm predicted mass and weight [OR¼1.452, 95% CrI¼(1.307, 1.614) and OR¼1.430, 95% CrI¼(1.326, 1.539), respectively] and time spent watching television [OR¼1.862, 95% CrI¼(1.545, 2.246)], and evidence for a bidirectional effect for age of first sexual intercourse [beta¼ 0.058, 95% CrI¼( 0.072, 0.044) and OR¼0.413, 95% CrI¼(0.372, 0.457), respectively], odds of decreased age completed full-time education [OR¼0.972, 95% CrI¼(0.962, 0.981) and OR¼0.435, 95% CrI¼(0.356, 0.533), respectively] and years of schooling [beta¼-0.036, 95% CrI¼( 0.048, 0.024) and OR¼0.458, 95% CrI¼(0.411, 0.511), respectively]. Conclusions: Our results may contribute to explain part of the widespread co-occurring traits and comorbid disorders across the lifespan of individuals with ADHD and may open new opportunities for developing preventive strategies for ADHD and for negative ADHD trajectories., European Union H2020 Programme (H2020/2014-2020) 667302 728018 848228 2020604, Instituto de Salud Carlos III European Commission PI18/01788 PI19/00721 P19/01224 PI20/00041 FI18/00285 CD15/00199 CP09/00119 CPII15/00023, Pla estrategic de recerca i innovacio en salut (PERIS), Generalitat de Cata-lunya (METAL-Cat) SLT006/17/287, Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR), Generalitat de Catalunya 2017SGR1461 2016FI_B00899, Ministry of Science, Innovation and Universities IJC2018-035346-I, European Commission, `la Marato' de TV3 092330/31, ECNP Network `ADHD across the Lifespan'
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Transdiagnostic Perspective of Impulsivity and Compulsivity in Obesity: From Cognitive Profile to Self-Reported Dimensions in Clinical Samples with and without Diabetes

  • Testa, Giulia
  • Mora Maltas, Bernat
  • Camacho Barcia, Lucía
  • Granero, Roser
  • Lucas, Ignacio
  • Agüera, Zaida
  • Jiménez-Murcia, Susana
  • Baños, Rosa
  • Bertaina Anglade, Valerie
  • Botella, Cristina
  • Bulló, Mònica
  • Casanueva, Felipe F.
  • Dalsgaard, Søren
  • Fernandez Real, José Manuel
  • Franke, Barbara
  • Fruehbeck, Gema
  • Fitó Colomer, Montserrat
  • Gómez Martínez, Carlos
  • Pintó Sala, Xavier
  • Poelmans, Geert
  • Tinahones, Francisco J.
  • Torre, Rafael de la
  • Salas Salvadó, Jordi
  • Serra Majem, Lluís
  • Vos, Stephanie
  • Wimberley, Theresa
  • Fernández Aranda, Fernando
Impulsive and compulsive behaviors have both been observed in individuals with obesity. The co-occurrence of obesity and type 2 diabetes (T2D) is more strongly associated with impulsivity, although there are no conclusive results yet. A multidimensional assessment of impulsivity and compulsivity was conducted in individuals with obesity in the absence or presence of T2D, compared with healthy, normal-weight individuals, with highly impulsive patients (gambling disorders), and with highly compulsive patients (anorexia nervosa). Decision making and novelty seeking were used to measure impulsivity, and cognitive flexibility and harm avoidance were used for compulsivity. For impulsivity, patients with obesity and T2D showed poorer decision-making ability compared with healthy individuals. For compulsivity, individuals with only obesity presented less cognitive flexibility and high harm avoidance; these dimensions were not associated with obesity with T2D. This study contributes to the knowledge of the mechanisms associated with diabetes and its association with impulsive-compulsive behaviors, confirming the hypothesis that patients with obesity and T2D would be characterized by higher levels of impulsivity.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Metformin Use and Cognitive Function in Older Adults With Type 2 Diabetes Following a Mediterranean Diet Intervention

  • Soldevila Domenech, Natalia
  • Cuenca Royo, Aida
  • Babio, Nancy
  • Forcano, Laura
  • Nishi, Stephanie K.
  • Vintró Alcaraz, Cristina
  • Gómez Martínez, Carlos
  • Jiménez-Murcia, Susana
  • Fernández Carrión, Rebeca
  • Gomis González, Maria
  • Alvarez Sala, Andrea
  • Carlos, Silvia
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Díez Espino, Javier
  • Castañer, Olga
  • Fernández Aranda, Fernando
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
Background and Purpose: Both adherence to the Mediterranean diet (MedDiet) and the use of metformin could benefit the cognitive performance of individuals with type 2 diabetes, but evidence is still controversial. We examined the association between metformin use and cognition in older adults with type 2 diabetes following a MedDiet intervention. Methods: Prospective cohort study framed in the PREDIMED-Plus-Cognition sub-study. The PREDIMED-Plus clinical trial aims to compare the cardiovascular effect of two MedDiet interventions, with and without energy restriction, in individuals with overweight/obesity and metabolic syndrome. The present sub-study included 487 cognitively normal subjects (50.5% women, mean ± SD age of 65.2 ± 4.7 years), 30.4% of them (N = 148) with type 2 diabetes. A comprehensive battery of neurocognitive tests was administered at baseline and after 1 and 3 years. Individuals with type 2 diabetes that exhibited a good glycemic control trajectory, either using or not using metformin, were compared to one another and to individuals without diabetes using mixed-effects models with inverse probability of treatment weights. Results: Most subjects with type 2 diabetes (83.1%) presented a good and stable glycemic control trajectory. Before engaging in the MedDiet intervention, subjects using metformin scored higher in executive functions (Cohen's d = 0.51), memory (Cohen's d = 0.38) and global cognition (Cohen's d = 0.48) than those not using metformin. However, these differences were not sustained during the 3 years of follow-up, as individuals not using metformin experienced greater improvements in memory (β = 0.38 vs. β = 0.10, P = 0.036), executive functions (β = 0.36 vs. β = 0.02, P = 0.005) and global cognition (β = 0.29 vs. β = −0.02, P = 0.001) that combined with a higher MedDiet adherence (12.6 vs. 11.5 points, P = 0.031). Finally, subjects without diabetes presented greater improvements in memory than subjects with diabetes irrespective of their exposure to metformin (β = 0.55 vs. β = 0.10, P < 0.001). However, subjects with diabetes not using metformin, compared to subjects without diabetes, presented greater improvements in executive functions (β = 0.33 vs. β = 0.08, P = 0.032) and displayed a higher MedDiet adherence (12.6 points vs. 11.6 points, P = 0.046). Conclusions: Although both metformin and MedDiet interventions are good candidates for future cognitive decline preventive studies, a higher adherence to the MedDiet could even outweigh the potential neuroprotective effects of metformin in subjects with diabetes.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian Disorders presenting with hyperactivity and/or inattention

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico Avilés, Bàrbara
  • Weber, Heike
  • Lesch, Klaus-Peter
  • Lao, Oscar
  • Reif, Andreas
  • Cormand Rifà, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD.We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

  • Rovira, Paula
  • Demontis, Ditte
  • Sánchez Mora, Cristina
  • Zayats, Tetyana
  • Klein, Marieke
  • Roth Mota, Nina
  • Weber, Heike
  • Garcia-Martínez, Iris
  • Pagerols Teixidó, Mireia
  • Vilar, Laura
  • Arribas, Lorena
  • Richarte, Vanesa
  • Corrales, Montserrat
  • Fadeuilhe, Christian
  • Bosch, Rosa
  • Español, Gemma
  • Grevet, Eugenio Horacio
  • Halmøy, Anne
  • Hutz, Mara
  • Knappskog, Per M.
  • Lundervold, Aastri J.
  • Rovaris, Diego Luiz
  • Santos da Silva, Bruna
  • Sprooten, Emma
  • ADHD Working Group of the Psychiatric Genomics Consortium
  • Arias Vasquez, Alejandro
  • Sonuga-Barke, Edmund
  • Asherson, Philip
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Haavik, Jan
  • Johansson, Stefan E.
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Reif, Andreas
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

  • Mallorquí-Bagué, Núria
  • Lozano Madrid, María
  • Toledo Atucha, Estefanía
  • Corella Piquer, Dolores
  • Salas Salvadó, Jordi
  • Cuenca Royo, Aida
  • Vioque, Jesús
  • Romaguera, Dora
  • Martínez, J. Alfredo, 1957-
  • Wärnberg, Julia
  • López Miranda, José
  • Estruch Riba, Ramon
  • Bueno Cavanillas, Aurora
  • Alonso Gómez, Ángel M.
  • Tur Marí, Josep A. (Josep Antoni)
  • Tinahones, Francisco J.
  • Serra Majem, Lluís
  • Martín Sánchez, Vicente
  • Lapetra, José
  • Vázquez, Clotilde
  • Pintó Sala, Xavier
  • Vidal i Cortada, Josep
  • Daimiel, Lidia
  • Gaforio, José J.
  • Matía Martín, Pilar
  • Ros Rahola, Emilio
  • Granero, Roser
  • Buil Cosiales, Pilar
  • Barragán, Rocío
  • Bulló, Mònica
  • Castañer, Olga
  • García de la Hera, Manuela
  • Yáñez, Aina M.
  • Abete, Itziar
  • García Ríos, Antonio
  • Ruiz Canela, Miguel
  • Díaz López, Andrés
  • Jiménez-Murcia, Susana
  • Martínez-González, Miguel Ángel, 1957-
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabetes with executive function (EF); (b) the effect of BMI on both type 2 diabetes and EF; (c) the association between glycaemia control and EF in type 2 diabetes. 6823 older individuals with overweight/obesity and metabolic syndrome participating in the PREDIMED-PLUS study, were assessed with a battery of cognitive tests and a medical interview. ANOVA showed a significantly worse performance on EF in type 2 diabetes vs. non-diabetic individuals. Two complementary models were displayed: (1) in the whole sample, the presence of type 2 diabetes, depressive symptoms and BMI had a direct negative effect on EF, while apnoea had an indirect negative effect; (2) in the diabetes subsample, higher illness duration was associated with worse performance in EF. Participants with type 2 diabetes and HbA1c<53 mmol/mol displayed better cognitive performance when compared to those with HbA1c≥53 mmol/mol. Our results provide a controlled comprehensive model that integrates relevant neuropsychological and physical variables in type 2 diabetes. The model suggests that, to improve treatment adherence and quality of life once diabetes has been diagnosed, cognitive decline prevention strategies need to be implemented while monitoring depressive symptoms, BMI and glycaemia control.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

A multimodal MRI study of the neural mechanisms of emotion regulation impairment in women with obesity

  • Steward, Trevor
  • Picó Pérez, Maria
  • Mestre-Bach, Gemma
  • Martínez Zalacaín, Ignacio
  • Suñol, Maria
  • Jiménez-Murcia, Susana
  • Fernández Formoso, Jose A.
  • Vilarrasa, Nuria
  • García Ruiz de Gordejuela, Amador
  • Veciana de las Heras, Misericordia
  • Custal, Nuria
  • Virgili, Núria
  • López Urdiales, Rafael
  • Menchón Magriñá, José Manuel
  • Granero, Roser
  • Soriano Mas, Carles
  • Fernández Aranda, Fernando
Maladaptive emotion regulation contributes to overeating and impedes weight loss. Our study aimed to compare the voluntary downregulation of negative emotions by means of cognitive reappraisal in adult women with obesity (OB) and female healthy controls (HC) using a data-driven, multimodal magnetic resonance imaging (MRI) approach. Women with OB (n = 24) and HC (n = 25) carried out an emotion regulation task during functional MRI scanning. Seed-to-voxel resting-state connectivity patterns derived from activation peaks identified by this task were compared between groups. Diffusion tensor imaging (DTI) was used to examine white matter microstructure integrity between regions exhibiting group differences in resting-state functional connectivity. Participants in the OB group presented reduced activation in the ventromedial prefrontal (vmPFC) cortex in comparison to the HC group when downregulating negative emotions, along with heightened activation in the extrastriate visual cortex (p < 0.05, AlphaSim-corrected). Moreover, vmPFC peak activity levels during cognitive reappraisal were negatively correlated with self-reported difficulties in emotion regulation. OB patients exhibited decreased functional connectivity between the vmPFC and the temporal pole during rest (peak-pFWE = 0.039). Decreased fractional white-matter track volume in the uncinate fasciculus, which links these two regions, was also found in participants with OB. Taken together, our findings are indicative of emotion regulation deficits in OB being underpinned by dysfunctional hypoactivity in the vmPFC and hyperactivity in the extrastriate visual cortex. Our results provide a potential target circuit for neuromodulatory interventions to improve emotion regulation skills and weight-loss intervention outcomes.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

What Difference Does it Make? Risk-Taking Behavior in Obesity after a Loss is Associated with Decreased Ventromedial Prefrontal Cortex Activity

  • Steward, Trevor
  • Juaneda-Seguí, Asier
  • Mestre-Bach, Gemma
  • Martínez Zalacaín, Ignacio
  • Vilarrasa, Nuria
  • Jiménez-Murcia, Susana
  • Fernández Formoso, Jose A.
  • Veciana de las Heras, Misericordia
  • Custal, Nuria
  • Virgili, Núria
  • López Urdiales, Rafael
  • García Ruiz de Gordejuela, Amador
  • Menchón Magriñá, José Manuel
  • Soriano Mas, Carles
  • Fernández Aranda, Fernando
Altered activity in decision-making neural circuitry may underlie the maladaptive food choices found in obesity. Here, we aimed to identify the brain regions purportedly underpinning risk-taking behavior in individuals with obesity. Twenty-three adult women with obesity and twenty-three healthy weight controls completed the Risky Gains Task during functional magnetic resonance imaging (fMRI). This task allows participants to choose between a safe option for a small, guaranteed monetary reward and risky options with larger rewards. fMRI analyses comparing losing trials to winning trials found that participants with obesity presented decreased activity in the left anterior insula in comparison to controls (p < 0.05, AlphaSim corrected). Moreover, left insula activation during losses vs. wins was negatively correlated with UPPS-P questionnaire sensation seeking scores. During safe vs. risky trials following a loss, the control group exhibited increased activation in the ventromedial prefrontal cortex (vmPFC) (p < 0.05, AlphaSim corrected) in comparison to the OB group. Moreover, vmPFC response in the obesity group during post-loss trials was negatively correlated with risky choices on the task overall. As a whole, our findings support that diminished tuning of the insula towards interoceptive signals may lead to a lack of input to the vmPFC when weighing the costs and benefits of risky choices.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Clinical factors predicting impaired executive functions in eating disorders: The role of illness duration

  • Miranda Olivos, Romina
  • Testa, Giulia
  • Lucas, Ignacio
  • Sánchez, Isabel
  • Sánchez González, Jéssica
  • Granero, Roser
  • Jiménez-Murcia, Susana
  • Fernández Aranda, Fernando
Poor performance in executive functions is observed in individuals with eating disorders (EDs). These impairments have usually been associated with the presence of comorbid psychopathology or with higher severity of EDs. However, few studies have explored the interaction between illness duration and deficits in executive functions. The present study investigates the association between ED duration and performance in decision-making, inhibitory control, and cognitive flexibility in the anorexia nervosa restrictive subtype (AN-R), bulimic/purging subtype (AN-BP), and binge spectrum disorders (BSDs) (namely, bulimia nervosa and binge eating disorder) among 116 women with EDs compared with 123 women healthy controls (HCs). Using cumulative survival analysis, we estimated the risk of deficits related to illness duration. Predictors of executive dysfunctions were assessed by regression analysis, including as potential predictors illness duration, severity of general psychopathology, and ED symptomatology. Results showed poor decision-making and cognitive flexibility in participants with EDs compared with HCs. ED duration was associated with poor inhibitory control in the AN-BP group and poor cognitive flexibility in the BSD group. The illness duration increased the risk of presenting early deficits in executive function. In decision-making and inhibitory control, the AN-R group showed the earliest deficits, whereas in cognitive flexibility it was the BSD group. ED duration predicted impaired cognitive flexibility in the BSD group and impaired inhibitory control in the AN-BP group, whereas the severity of general psychopathological symptoms was a predictor of impaired cognitive flexibility in individuals with AN-R. These results highlight the relevance of illness duration in executive dysfunctions in EDs.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome

  • Mallorquí-Bagué, Núria
  • Lozano Madrid, María
  • Vintró Alcaraz, Cristina
  • Forcano, Laura
  • Díaz López, Andrés
  • Galera, Ana
  • Fernández Carrión, Rebeca
  • Granero, Roser
  • Jiménez-Murcia, Susana
  • Corella Piquer, Dolores
  • Pintó Sala, Xavier
  • Cuenca Royo, Aida
  • Bulló, Mònica
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study examines if overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms, and if these variables could be modified after 1 year of a multimodal intervention (diet, physical activity, psychosocial support). 342 adults (55-75 years) with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus Cognition study were randomized to the intervention or to the control group (lifestyle recommendations). Cognitive and psychopathological assessments were performed at baseline and after 1-year follow-up. At baseline, higher impulsivity was linked to higher food addiction and depressive symptoms, but not to body mass index (BMI). Food addiction not only predicted higher BMI and depressive symptoms, but also achieved a mediational role between impulsivity and BMI/depressive symptoms. After 1 year, patients in both groups reported significant decreases in BMI, food addiction and impulsivity. BMI reduction and impulsivity improvements were higher in the intervention group. Higher BMI decrease was achieved in individuals with lower impulsivity. Higher scores in food addiction were also related to greater post-treatment impulsivity. To conclude, overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms in mid/old age individuals with MetS. Our results also highlight the modifiable nature of the studied variables and the interest of promoting multimodal interventions within this population.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine seeking behavior in Plcb1+/- mice

  • Cabana Domínguez, Judit
  • Martín-García, Elena
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial

  • Gómez Martínez, Carlos
  • Babio, Nancy
  • Julvez, Jordi
  • Nishi, Stephanie K.
  • Fernández Aranda, Fernando
  • Martínez-González, Miguel Ángel, 1957-
  • Cuenca Royo, Aida
  • Fernández, Rebeca
  • Jiménez-Murcia, Susana
  • de la Torre, Rafael
  • Pintó Sala, Xavier
  • Bloemendaal, Mirjam
  • Fitó Colomer, Montserrat
  • Corella Piquer, Dolores
  • Arias, Alejandro
  • Salas Salvadó, Jordi
Background: Few studies have analyzed the associations between impulsivity and dietary patterns. Some of them have shown a cross-sectional inverse relationship between impulsivity and healthy diet scores, whereas others reported a positive association with unhealthy dietary assessments. We aimed to examine longitudinal associations of impulsivity trait with adherence to healthy and unhealthy dietary patterns in older participants at high risk of cardiovascular disease over 3 years of follow-up. Methods: A 3-year prospective cohort analysis within the PREDIMED-Plus-Cognition study conducted in 4 PREDIMED-Plus study centers was performed. The PREDIMED-Plus study aimed to test the beneficial effect of a lifestyle intervention on the primary prevention of cardiovascular disease. The participants with overweight or obesity and metabolic syndrome included in the present study (n = 462; mean age of 65.3 years; 51.5% female) completed both the UPPS-P Impulsive Behavior Scale (range: 0-236 points) and the 143-item Food Frequency Questionnaire at baseline, 1-year and 3-years of follow-up. Ten diet scores assessing healthy and unhealthy dietary patterns were evaluated. Linear mixed models were performed adjusting by several confounders to study the longitudinal associations between impulsivity trait and adherence to dietary pattern scores over 3 years of follow-up (also assessing interactions by sex, age, and intervention group). Results: Impulsivity were negatively associated with adherence to the Healthy Plant-Based [β = -0.92 (95%CI -1.67, -0.16)], Mediterranean [β = -0.43 (95%CI -0.79, -0.07)], Energy-Restricted Mediterranean [β = -0.76 (95%CI -1.16, -0.37)], Alternative Healthy Eating Index [β = -0.88 (95%CI -1.52, -0.23)], Portfolio [β = -0.57 (95%CI -0.91, -0.22)], and DASH [β = -0.50 (95%CI -0.79, -0.22)] diet scores over 3 years of follow-up, whereas impulsivity was positively related with adherence to the unhealthy Western diet [β = 1.59 (95%CI 0.59, 2.58)] over time. An interaction by intervention group was found, with those participants in the intervention group with high impulsivity levels having lower adherence to several healthy dietary patterns. Conclusions: Heightened impulsivity was longitudinally associated with lower adherence to healthy dietary patterns and higher adherence to the Western diet over 3 years of follow-up. Furthermore, nutritional intervention programs should consider impulsivity as a relevant factor for the intervention success.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Metabolic, Affective and Neurocognitive Characterization of Metabolic Syndrome Patients with and without Food Addiction. Implications for Weight Progression

  • Camacho Barcia, Lucía
  • Munguía, Lucero
  • Lucas, Ignacio
  • Torre Fornell, Rafael de la
  • Salas Salvadó, Jordi
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Granero, Roser
  • Jiménez-Murcia, Susana
  • González Monje, Inmaculada
  • Esteve Luque, Virginia
  • Cuenca Royo, Aida
  • Gómez Martínez, Carlos
  • Paz Graniel, Indira
  • Forcano, Laura
  • Fernández Aranda, Fernando
According to the food addiction (FA) model, the consumption of certain types of food could be potentially addictive and can lead to changes in intake regulation. We aimed to describe metabolic parameters, dietary characteristics, and affective and neurocognitive vulnerabilities of individuals with and without FA, and to explore its influences on weight loss progression. The sample included 448 adults (55-75 years) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus cognition sub-study. Cognitive and psychopathological assessments, as well as dietary, biochemical, and metabolic measurements, were assessed at baseline. Weight progression was evaluated after a 3-year follow up. The presence of FA was associated with higher depressive symptomatology, neurocognitive decline, low quality of life, high body mass index (BMI), and high waist circumference, but not with metabolic comorbidities. No differences were observed in the dietary characteristics except for the saturated and monounsaturated fatty acids consumption. After three years, the presence of FA at baseline resulted in a significantly higher weight regain. FA is associated with worse psychological and neurocognitive state and higher weight regain in adults with metabolic syndrome. This condition could be an indicator of bad prognosis in the search for a successful weight loss process.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia
  • Camacho Barcia, Lucía
  • Gómez Martínez, Carlos
  • Mora Maltas, Bernat
  • Torre, Rafael de la
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Granero, Roser
  • Cuenca-royo, Aida
  • Jiménez-Murcia, Susana
  • Babio, Nancy
  • Fernández Carrión, Rebeca
  • Esteve Luque, Virginia
  • Forcano, Laura
  • Ni, Jiaqi
  • Malcampo, Mireia
  • Heras Delgado, Sara de las
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
  • Fernández Aranda, Fernando
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA(1c)), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA(1c). In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures

  • Roth Mota, Nina
  • Poelmans, Geert
  • Klein, Marieke
  • Torrico, Bàrbara
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
  • Reif, Andreas
  • Franke, Barbara
  • Arias Vasquez, Alejandro
Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD-BMI overlapping genes with brain volumes (primary GWAS data N = 10,720-10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10−3) and BMI (P = 1.63 × 10−5); the circadian rhythm was associated with BMI (P = 1.28 × 10−3). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD-BMI and ADHD-obesity results. The ADHD-BMI overlapping genes were associated with putamen volume (P = 7.7 × 10−3; replication data P = 3.9 × 10−2) a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD-obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Characterisation of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Vicente García, Cristina
  • Mirra, Serena
  • Burguera Hernández, Demian
  • Fernàndez Castillo, Noèlia
  • Ferrán, José Luis
  • López Mayorga, Macarena
  • Alaiz Noya, Marta
  • Suárez Pereira, Irene
  • Antón Galindo, Ester
  • Ulloa Darquea, Fausto Alexander
  • Herrera Úbeda, Carlos
  • Cuscó, Pol
  • Falcón Moya, Rafael
  • Rodríguez Moreno, Antonio
  • D&apos;Aniello, Salvatore
  • Cormand Rifà, Bru
  • Marfany i Nadal, Gemma
  • Soriano García, Eduardo
  • Carrión, Ángel M.
  • Carvajal, Jaime J.
  • Garcia Fernández, Jordi
Background One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín-Peláez, Sandra
  • Serra Majem, Lluís
  • Cano Ibáñez, Naomi
  • Martínez-González, Miguel Ángel, 1957-
  • Salas Salvadó, Jordi
  • Corella Piquer, Dolores
  • Lassale, Camille
  • Martínez, J. Alfredo, 1957-
  • Alonso Gómez, Ángel M.
  • Wärnberg, Julia
  • Vioque, Jesús
  • Romaguera, Dora
  • López Miranda, José
  • Estruch Riba, Ramon
  • Tinahones, Francisco J.
  • Lapetra, José
  • Fernández Aranda, Fernando
  • Bueno Cavanillas, Aurora
  • Tur Marí, Josep A. (Josep Antoni)
  • Martín Sánchez, Vicente
  • Pintó Sala, Xavier
  • Delgado Rodriguez, Miguel
  • Matía Martín, Pilar
  • Vidal i Cortada, Josep
  • Vázquez, Clotilde
  • Daimiel, Lidia
  • Ros Rahola, Emilio
  • Toledo Atucha, Estefanía
  • Nishi, Stephanie K.
  • Sorlí, José V.
  • Malcampo, Mireia
  • Zulet, M. Angeles
  • Moreno Rodríguez, Anai
  • Cueto Galán, Raquel
  • Vivancos Aparicio, Diego
  • Colom, Antoni
  • García Ríos, Antonio
  • Casas Rodríguez, Rosa M.
  • Bernal López, M. Rosa
  • Santos Lozano, José Manuel
  • Vázquez Ruiz, Zenaida
  • Gómez Martínez, Carlos
  • Ortega Azorín, Carolina
  • Del Val, Jose Luís
  • Abete, Itziar
  • Goikoetxea Bahon, Amaia
  • Pascual, Elena
  • Becerra Tomás, Nerea
  • Chillarón, Juan J.
  • Sánchez-Villegas, Almudena
Background: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings: Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ≥280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions: Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response. International Standard Randomized Controlled Trial (ISRCTN89898870).
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder

  • Demontis, Ditte
  • Walters, Raymond
  • Rajagopal, Veera M.
  • Waldman, Irwin D.
  • Grove, Jakob
  • Als, Thomas D.
  • Dalsgaard, Soren
  • Ribasés Haro, Marta
  • Grauholm, Jonas
  • Bækvad-Hansen, Maria
  • Werge, Thomas
  • Nordentoft, Merete
  • Mors, Ole
  • Mortensen, Preben Bo
  • Psychiatric Genomics Consortium (PGC)
  • Cormand Rifà, Bru
  • Hougaard, David M.
  • Neale, Benjamin M.
  • Franke, Barbara
  • Faraone, Stephen V.
  • Børglum, Anders D.
Attention-Deficit/Hyperactivity Disorder (ADHD) is a childhood psychiatric disorder often comorbid with disruptive behavior disorders (DBDs). Here, we report a GWAS meta-analysis of ADHD comorbid with DBDs (ADHD + DBDs) including 3802 cases and 31,305 controls. We identify three genome-wide significant loci on chromosomes 1, 7, and 11. A meta-analysis including a Chinese cohort supports that the locus on chromosome 11 is a strong risk locus for ADHD + DBDs across European and Chinese ancestries (rs7118422, P = 3.15×10-10, OR = 1.17). We find a higher SNP heritability for ADHD + DBDs (h2SNP = 0.34) when compared to ADHD without DBDs (h2SNP = 0.20), high genetic correlations between ADHD + DBDs and aggressive (rg = 0.81) and anti-social behaviors (rg = 0.82), and an increased burden (polygenic score) of variants associated with ADHD and aggression in ADHD + DBDs compared to ADHD without DBDs. Our results suggest an increased load of common risk variants in ADHD + DBDs compared to ADHD without DBDs, which in part can be explained by variants associated with aggressive behavior.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

  • Baenas, Isabel
  • Etxandi, Mikel
  • Munguía, Lucero
  • Granero, Roser
  • Mestre Bach, Gemma
  • Sánchez, Isabel
  • Ortega Martínez de Victoria, Emilio
  • Andreu, Alba
  • Moize, Violeta L.
  • Fernández Real, Jose Manuel
  • Tinahones, Francisco J.
  • Diéguez, Carlos
  • Frühbeck, Gema
  • Le Grange, Daniel
  • Tchanturia, Kate
  • Karwautz, Andreas
  • Zeiler, Michael
  • Imgart, Hartmut
  • Zanko, Annika
  • Favaro, Angela
  • Claes, Laurence
  • Shekriladze, Ia
  • Serrano Troncoso, Eduardo
  • Cecilia Costa, Raquel
  • Rangil, Teresa
  • Loran Meler, Maria Eulalia
  • Soriano Pacheco, José
  • Carceller Sindreu, Mar
  • Navarrete, Rosa
  • Lozano, Meritxell
  • Linares, Raquel
  • Gudiol González, Carlota
  • Carratalà, Jordi
  • Plana, Maria Teresa
  • Graell, Montserrat
  • González Parra, David
  • Gómez del Barrio, José A.
  • Sepúlveda, Ana R.
  • Sánchez González, Jéssica
  • Machado, Paulo P. P.
  • Håkansson, Anders
  • Túry, Ferenc
  • Pászthy, Bea
  • Stein, Daniel
  • Papezová, Hana
  • Gricova, Jana
  • Bax, Brigita
  • Borisenkov, Mikhail F.
  • Popov, Sergey V.
  • Gubin, Denis G.
  • Petrov, Ivan M.
  • Isakova, Dilara
  • Mustafina, Svetlana V.
  • Kim, Youl-Ri
  • Nakazato, Michiko
  • Godart, Nathalie
  • Van Voren, Robert
  • Ilnytska, Tetiana
  • Chen, Jue
  • Rowlands, Katie
  • Voderholzer, Ulrich
  • Monteleone, Alessio M.
  • Treasure, Janet
  • Jiménez-Murcia, Susana
  • Fernández Aranda, Fernando
Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general psychopathology during lockdown in patients with an ED from various European and Asian countries; and (2) to assess differences related to diagnostic ED subtypes, age, and geography. Methods. The sample comprised 829 participants, diagnosed with an ED according to DSM-5 criteria from specialized ED units in Europe and Asia. Participants were assessed using the COVID-19 Isolation Scale (CIES). Results. Patients with binge eating disorder (BED) experienced the highest impact on weight and ED symptoms in comparison with other ED subtypes during lockdown, whereas individuals with other specified feeding and eating disorders (OFSED) had greater deterioration in general psychological functioning than subjects with other ED subtypes. Finally, Asian and younger individuals appeared to be more resilient. Conclusions. The psychopathological changes in ED patients during the COVID-19 lockdown varied by cultural context and individual variation in age and ED diagnosis. Clinical services may need to target preventive measures and adapt therapeutic approaches for the most vulnerable patients.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Differential expression of miR-1249-3p and miR-34b-5p between vulnerable and resilient phenotypes of cocaine addiction

  • Domingo-Rodriguez, Laura
  • Cabana Domínguez, Judit
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
  • Martín-García, Elena
  • Maldonado, Rafael, 1961-
Cocaine addiction is a complex brain disorder involving long-term alterations that leadto loss of control over drug seeking. The transition from recreational use to pathologi-cal consumption is different in each individual, depending on the interaction betweenenvironmental and genetic factors. Epigenetic mechanisms are ideal candidates tostudy psychiatric disorders triggered by these interactions, maintaining persistentmalfunctions in specific brain regions. Here we aim to study brain-region-specific epi-genetic signatures following exposure to cocaine in a mouse model of addiction tothis drug. Extreme subpopulations of vulnerable and resilient phenotypes wereselected to identify miRNA signatures for differential vulnerability to cocaine addic-tion. We used an operant model of intravenous cocaine self-administration to evalu-ate addictive-like behaviour in rodents based on the Diagnostic and StatisticalManual of Mental Disorders Fifth Edition criteria to diagnose substance use disor-ders. After cocaine self-administration, we performed miRNA profiling to comparetwo extreme subpopulations of mice classified as resilient and vulnerable to cocaineaddiction. We found that mmu-miR-34b-5p was downregulated in the nucleusaccumbens of vulnerable mice with high motivation for cocaine. On the other hand,mmu-miR-1249-3p was downregulated on vulnerable mice with high levels of motordisinhibition. The elucidation of the epigenetic profile related to vulnerability to cocaine addiction is expected to help find novel biomarkers that could facilitate theinterventions to battle this devastating disorder.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Andres D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). High-performance computer capacity for handling and statistical analysis of iPSYCH and PGC data on the GenomeDK HPC facility was provided by the Center for Genomics and Personalized Medicine, Aarhus University and Central Region Denmark, and Centre for Integrative Sequencing, iSEQ, Aarhus University (grant to A.D.B.). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas, Enrique
  • Vicente-García, Cristina
  • Mirra, Serena
  • Burguera, Demian
  • Fernández-Castillo, Noèlia
  • Ferrán, José Luis
  • López-Mayorga, Macarena
  • Alaiz-Noya, Marta
  • Suárez-Pereira, Irene
  • Antón-Galindo, Ester
  • Ulloa, Fausto
  • Herrera-Úbeda, Carlos
  • Cuscó, Pol
  • Falcón-Moya, Rafael
  • Rodríguez-Moreno, Antonio
  • D’Aniello, Salvatore
  • Cormand, Bru
  • Marfany, Gemma
  • Soriano, Eduardo
  • Carrión Rodríguez, Ángel Manuel
  • Carvajal, Jaime J.
  • Garcia-Fernàndez, Jordi
[Background]: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood., [Results]: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes., [Conclusions]: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”). S.M. was first supported by a contract with the “Centro de Investigación Biomédica en Enfermedades Neurodegenerativas,” and later by “Centro de Investigación Biomédica en Red de Enfermedades Raras” (CIBERER). N.F.C. is also under contract by CIBERER.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolic syndrome features and excess weight were inversely associated with nut consumption after 1-year follow-up in the PREDIMED-plus study

  • Julibert, Alicia
  • Martínez, J. Alfredo
  • Daimiel, Lidia
PREDIMED-PLUS investigators: et al., [Background]: High nut consumption has been previously associated with decreased prevalence of metabolic syndrome (MetS) regardless of race and dietary patterns., [Objectives]: The aim of this study was to assess whether changes in nut consumption over a 1-y follow-up are associated with changes in features of MetS in a middle-aged and older Spanish population at high cardiovascular disease risk., [Methods]: This prospective 1-y follow-up cohort study, conducted in the framework of the PREvención con DIeta MEDiterránea (PREDIMED)-Plus randomized trial, included 5800 men and women (55–75 y old) with overweight/obesity [BMI (in kg/m2) ≥27 and <40] and MetS. Nut consumption (almonds, pistachios, walnuts, and other nuts) was assessed using data from a validated FFQ. The primary outcome was the change from baseline to 1 y in features of MetS [waist circumference (WC), glycemia, HDL cholesterol, triglyceride (TG), and systolic and diastolic blood pressure] and excess weight (body weight and BMI) according to tertiles of change in nut consumption. Secondary outcomes included changes in dietary and lifestyle characteristics. A generalized linear model was used to compare 1-y changes in features of MetS, weight, dietary intakes, and lifestyle characteristics across tertiles of change in nut consumption., [Results]: As nut consumption increased, between each tertile there was a significant decrease in WC, TG, systolic blood pressure, weight, and BMI (P < 0.05), and a significant increase in HDL cholesterol (only in women, P = 0.044). The interaction effect between time and group was significant for total energy intake (P < 0.001), adherence to the Mediterranean diet (MedDiet) (P < 0.001), and nut consumption (P < 0.001). Across tertiles of increasing nut consumption there was a significant increase in extra virgin olive oil intake and adherence to the MedDiet; change in energy intake, on the other hand, was inversely related to consumption of nuts., [Conclusions]: Features of MetS and excess weight were inversely associated with nut consumption after a 1-y follow-up in the PREDIMED-Plus study cohort. This trial was registered at isrctn.com as ISRCTN89898870., The PREDIMED-Plus trial was supported by the official funding agency for biomedical research of the Spanish government, Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is cofunded by the European Regional Development Fund (5 coordinated FIS projects led by JS-S and J Vidal, including projects PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, and PI19/01332); the Special Action Project entitled Implementación y evaluación de una intervención intensive sobre la actividad física Cohorte PREDIMED-Plus grant (to JS-S); European Research Council Advanced Research Grant 2013–2018, 340918 (to MÁM-G); Recercaixa Grant 2013ACUP00194 (to JS-S); Consejería de Salud de la Junta de Andalucía grants PI0458/2013, PS0358/2016, and PI0137/2018; Generalitat Valenciana grant PROMETEO/2017/017; a SEMERGEN grant; EU-COST Action CA16112; Balearic Islands Government grant of support to research groups 35/2011; Balearic Islands Health Research Institute (IdISBa) grants; European Regional Development Fund funds CIBEROBN CB06/03 and CB12/03; and European Commission fund EAT2BENICE_H2020_SFS2016. PH-A is supported by Juan de la Cierva-Formación postdoctoral fellowship FJCI-2017-32205. AC is supported by IdISBa “TECH” fellowship TECH18/03, funded by the 2018 Sustainable Tourism Tax annual plan. LG-A is supported by a FPU PhD program from the Spanish Ministry of Education., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mapping genomic loci implicates genes and synaptic biology in schizophrenia

  • Trubetskoy, Vassily
  • Pardiñas, Antonio F.
  • Qi, Ting
  • Panagiotaropoulou, Georgia
  • Awasthi, Swapnil
  • Bigdeli, Tim B.
  • Bryois, Julien
  • Chen, Chia-Yen
  • Dennison, Charlotte A.
  • Hall, Lynsey S.
  • Lam, Max
  • Curtis, Charles
  • Nikitina-Zake, Liene
  • Davidson, Michael
  • Joa, Inge
  • Davis, Kenneth L.
  • Yolken, Robert
  • Murray, Robin M.
  • de Haan, Lieuwe
  • Legge, Sophie E.
  • Serretti, Alessandro
  • van Os, Jim
  • Smoller, Jordan W.
  • Agartz, Ingrid
  • Alizadeh, Behrooz Z.
  • Degenhardt, Franziska
  • DeLisi, Lynn E.
  • Demontis, Ditte
  • Dickerson, Faith
  • Zai, Clement C.
  • Dikeos, Dimitris
  • Dinan, Timothy
  • Henskens, Frans A.
  • Vaaler, Arne
  • Noto, Cristiano
  • Nimgaonkar, Vishwajit
  • Rautanen, Anna
  • Lehrer, Douglas S.
  • Djurovic, Srdjan
  • Duan, Jubao
  • Julià, Antonio
  • Stahl, Eli A.
  • Zhou, Wei
  • Vawter, Marquis P.
  • Toncheva, Draga
  • Webb, Bradley T.
  • Ducci, Giuseppe
  • Dudbridge, Frank
  • Eriksson, Johan G.
  • Fañanas Saura, Lourdes
  • Goldstein, Jacqueline I.
  • Faraone, Stephen V.
  • Lencer, Rebecca
  • Moreno, Carmen
  • Bacanu, Silviu A.
  • Fiorentino, Alessia
  • Calkins, Monica E.
  • Mitjans, Marina
  • Forstner, Andreas
  • Nuechterlein, Keith H.
  • Frank, Josef
  • Tsuang, Debby W.
  • Freimer, Nelson B.
  • Tooney, Paul A.
  • Belangero, Sintia Iole
  • Weinberger, Daniel R.
  • Fromer, Menachem
  • Ge,Tian
  • Adolfsson, Rolf
  • Hakonarson, Hakon
  • Zhu, Feng
  • Frustaci, Alessandra
  • Nöthen, Markus M.
  • Gadelha, Ary
  • Genovese, Giulio
  • Gershon, Elliot S.
  • Quattrone, Diego
  • Kähler, Anna K.
  • Kam-Thong, Tony
  • van Amelsvoort, Therese
  • Vilella, Elisabet
  • Molden, Espen
  • O'Brien, Niamh Louise
  • Zimprich, Fritz
  • Kamatani, Yoichiro
  • Braun, Alice
  • Melegh, Bela
  • Pirinen, Matti
  • Karachanak-Yankova, Sena
  • Ophoff, Roel A.
  • Kebir, Oussama
  • Lerer, Bernard
  • Nordentoft, Merete
  • Fanous, Ayman H.
  • Reichenberg, Abraham
  • Li, Miaoxin
  • Periyasamy, Sathish
  • Lieberman, Jeffrey
  • Werge, Thomas
  • Light, Gregory A.
  • Limborska, Svetlana
  • Tosato, Sarah
  • Liu, Chih-Min
  • Olincy, Ann
  • Magnusson, Sigurdur
  • Gareeva, Anna
  • Bressan, Rodrigo Affonseca
  • Lönnqvist, Jouko
  • Roe, Cheryl
  • Cheng, Wei
  • Athanasiu, Lavinia
  • Gutiérrez, Blanca
  • Harvey, Carol
  • Loughland, Carmel M.
  • Lubinski, Jan
  • Luykx, Jurjen J.
  • Lynham, Amy
  • Gawlik, Micha
  • Macek, Milan
  • Mackinnon, Andrew
  • Buxbaum, Joseph D.
  • Tura, Gian Battista
  • Bromet, Evelyn J.
  • Atbaşoğlu, Eşref Cem
  • Roffman, Joshua L.
  • Magnusson, Patrik K. E.
  • Maher, Brion S.
  • Ota, Vanessa Kiyomi
  • Paciga, Sara A.
  • Gejman, Pablo V.
  • Arango, Celso
  • Forti, Marta Di
  • Maier, Wolfgang
  • Richards, Alexander L.
  • Malaspina, Dolores
  • Mallet, Jacques
  • Metspalu, Andres
  • Marder, Stephen R.
  • Li, Zhiqiang
  • Takahashi, Atsushi
  • Marsal, Sara
  • Kučinskiene, Zita Ausrele
  • Suvisaari, Jaana
  • Martin, Alicia R.
  • Turetsky, Bruce I.
  • Martorell, Lourdes
  • Palotie, Aarno
  • Mattheisen, Manuel
  • Baune, Bernhard T.
  • Saka, Meram C.
  • McCarley, Robert W.
  • Giusti-Rodríguez, Paola
  • Riley, Brien P.
  • Murphy, Kieran C.
  • Gill, Michael
  • McDonald, Colm
  • Bruggeman, Richard
  • McGrath, John J.
  • Sidorenko, Julia
  • Medeiros, Helena
  • Pantelis, Christos
  • Grove, Jakob
  • Campion, Dominique
  • Pato, Carlos N.
  • Svrakic, Dragan M.
  • Üçok, Alp
  • Glatt, Stephen J.
  • Papadimitriou, George N.
  • Khrunin, Andrey
  • Straub, Richard E.
  • Parellada, Mara
  • Buckley, Peter F.
  • Paunio, Tiina
  • Roth, Julian
  • Morgan, Vera A.
  • Wildenauer, Dieter B.
  • Ayub, Muhammad
  • Rothermundt, Matthias
  • Weiser, Mark
  • Rutten, Bart P. F.
  • Saker-Delye, Safaa
  • Salomaa, Veikko
  • Børglum, Anders D.
  • Sanjuán, Julio
  • van Winkel, Ruud
  • González Peñas, Javier
  • Yu, Xin
  • Kim, Sung-Wan
  • Santoro, Marcos Leite
  • Benner, Christian
  • Ikeda, Masashi
  • Morley, Christopher P.
  • Zeng, Jian
  • Savitz, Adam
  • Schall, Ulrich
  • Scott, Rodney J.
  • Voloudakis, Georgios
  • Yue, Weihua
  • Seidman, Larry J.
  • Sharp, Sally Isabel
  • Alptekin, Köksal
  • Klovins, Janis
  • Amin, Farooq
  • Bertolino, Alessandro
  • Shi, Jianxin
  • Siever, Larry J.
  • Atkinson, Elizabeth G.
  • Buckner, Randy L.
  • Holmans, Peter A.
  • Rivera, Margarita
  • Sigurdsson, Engilbert
  • González-Pinto, Ana
  • Sim, Kang
  • Skarabis, Nora
  • Stroup, T Scott
  • Slominsky, Petr
  • Guillin, Olivier
  • Wang, Shi-Heng
  • So, Hon-Cheong
  • Quested, Digby
  • Sobell, Janet L.
  • Braff, David
  • Zhang, Wen
  • Bybjerg-Grauholm, Jonas
  • Söderman, Erik
  • Rujescu, Dan
  • Chambert, Kimberley D.
  • Stain, Helen J.
  • Melle, Ingrid
  • Carr, Vaughan J.
  • Pocklington, Andrew J.
  • Steen, Nils Eiel
  • Harwood, Janet
  • Steixner-Kumar, Agnes A.
  • Gopal, Srihari
  • Stögmann, Elisabeth
  • Veijola, Juha
  • Watanabe, Kyoko
  • Sham, Pak C.
  • Cahn, Wiepke
  • Bramon, Elvira
  • Roussos, Panos
  • Waddington, John
  • Perkins, Diana O.
  • Pato, Michele T.
  • Walter, Henrik
  • Kondratiev, Nikolay
  • Waterreus, Anna
  • Al Eissa, Mariam
  • Bobes, Julio
  • Golimbet, Vera
  • Black, Donald W.
  • Als, Thomas D.
  • Bray, Nicholas J.
  • Breen, Gerome
  • Buccola, Nancy G.
  • Sanders, Alan R.
  • Byerley, William F.
  • Cervilla, Jorge A.
  • Michie, Patricia T.
  • Pfuhlmann, Bruno
  • Chen, Wei J.
  • Hong, Kyung Sue
  • O'Neill, F Anthony
  • Terao, Chikashi
  • Green, Michael F.
  • Cloninger, C. Robert
  • Crespo-Facorro, Benedicto
  • Donohoe, Gary
  • Gülöksüz, Sinan
  • Freedman, Robert
  • Albus, Margot
  • Hayward, Caroline
  • Pietiläinen, Olli
  • Herms, Stefan
  • Hultman, Christina M.
  • Galletly, Cherrie
  • Gandal, Michael J.
  • Hahn, Eric
  • Konte, Bettina
  • Castle, David
  • Gennarelli, Massimo
  • Milani, Lili
  • Hougaard, David M.
  • Hwu, Hai-Gwo
  • Pulver, Ann E.
  • Jablensky, Assen V.
  • Molina, Esther
  • Qin, Shengying
  • McCarroll, Steven A.
  • Moran, Jennifer L.
  • Azevedo, Maria Helena
  • Gur, Rachel E.
  • Kraft, Julia
  • Mors, Ole
  • Catts, Stanley V.
  • Lazzeroni, Laura C.
  • Mortensen, Preben B.
  • Streit, Fabian
  • Kusumawardhani, Agung
  • Alexander, Madeline
  • Godard, Stephanie
  • Müller-Myhsok, Bertram
  • Milanova, Vihra
  • Neil, Amanda L.
  • Cichon, Sven
  • Giannitelli, Marianna
  • Cheung, Eric F. C.
  • Kubo, Michiaki
  • Schwab, Sibylle G.
  • Collier, David A.
  • Williams, Nigel M.
  • Morris, Derek W.
  • Corvin, Aiden
  • Pimm, Jonathan
  • Curtis, David
  • Haroutunian, Vahram
  • Keller, Matthew C.
  • Vassos, Evangelos
  • Hyman, Steven E.
  • Iwata, Nakao
  • Jönsson, Erik G.
  • Kahn, René S.
  • Chan, Raymond C. K.
  • Kennedy, James L.
  • Shi, Yongyong
  • Adams, Mark
  • Witt, Stephanie H.
  • Khusnutdinova, Elza
  • Verhage, Matthijs
  • Xu, Shuhua
  • Wu, Yang
  • Kirov, George
  • Arolt, Volker
  • Knowles, James A.
  • Moltó, Maria Dolores
  • Krebs, Marie-Odile
  • Hartmann, Annette M.
  • Nestadt, Gerald
  • Wormley, Brandon K.
  • Bass, Nicholas J.
  • Laurent-Levinson, Claudine
  • Lee, Jimmy
  • Muntané, Gerard
  • Porteous, David
  • Kuzelova-Ptackova, Hana
  • Lencz, Todd
  • Subramaniam, Mythily
  • Levinson, Douglas F.
  • Li, Qingqin S.
  • Liu, Jianjun
  • Swerdlow, Neal R.
  • Cairns, Murray J.
  • Malhotra, Anil K.
  • Malhotra, Dheeraj
  • Iyegbe, Conrad
  • Mondelli, Valeria
  • Kim, Minsoo
  • Arrojo, Manuel
  • Landi, Stefano
  • McIntosh, Andrew M.
  • Petryshen, Tracey L.
  • Radant, Allen D.
  • Frei, Oleksandr
  • Mesholam-Gately, Raquelle I.
  • McQuillin, Andrew
  • Sugar, Catherine A.
  • Menezes, Paulo Rossi
  • St Clair, David
  • Meier, Sandra
  • Powell, John
  • Chaumette, Boris
  • Stefansson, Hreinn
  • Domenici, Enrico
  • Bonassi, Stefano
  • Stefánsson, Kári
  • Wu, Jing Qin
  • Tsuang, Ming T.
  • Myin-Germeys, Inez
  • Pellegrino, Renata
  • Visscher, Peter M.
  • Yang, Jian
  • Posthuma, Danielle
  • Andreassen, Ole A.
  • Koopmans, Frank
  • Kendler, Kenneth S.
  • Chong, Siow Ann
  • Gur, Ruben C.
  • Ehrenreich, Hannelore
  • Owen, Michael J.
  • Rietschel, Marcella
  • Gratten, Jacob
  • Wray, Naomi R.
  • Hoffmann, Per
  • Daly, Mark J.
  • Szatkiewicz, Jin P.
  • Huang, Hailiang
  • Nenadić, Igor
  • Torretta, Silvia
  • Escott-Price, Valentina
  • Neale, Benjamin M.
  • Begemann, Martin
  • Thibaut, Florence
  • Agerbo, Esben
  • Rampino, Antonio
  • Sullivan, Patrick F.
  • Schulze, Thomas G.
  • Ripke, Stephan
  • Walters, James T. R.
  • O'Donovan, Michael C.
  • Kučinskas, Vaidutis
  • Belliveau, Richard A.
  • Bene, Judit
  • Oh, Sang-Yun
  • Ta, Thi Minh Tam
  • Greenwood, Tiffany A.
  • Howrigan, Daniel P.
  • Rapaport, Mark H.
  • Benyamin, Beben
  • Mowry, Bryan J.
  • Giegling, Ina
  • Strengman, Eric
  • Bergen, Sarah E.
  • Silverman, Jeremy M.
  • Blasi, Giuseppe
  • Cohen, David
  • Stone, William S.
  • Xu, Zhida
  • Lee, Phil H.
  • Consoli, Angèle
  • Kelly, Brian
  • Cordeiro, Quirino
  • Esko, Tõnu
  • Costas, Javier
Schizophrenia has a heritability of 60-80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies., The work at Cardiff University was additionally supported by Medical Research Council Centre grant no. MR/L010305/1 and program grant no. G0800509. S. Xu also gratefully acknowledges the support of the National Natural Science Foundation of China (NSFC) grants (31525014, 91731303, 31771388, 31961130380 and 32041008), the UK Royal Society-Newton Advanced Fellowship (NAF\R1\191094), the Key Research Program of Frontier Sciences (QYZDJ-SSW-SYS009) and the Strategic Priority Research Program (XDB38000000) of the Chinese Academy of Sciences, and the Shanghai Municipal Science and Technology Major Project (2017SHZDZX01). O. A. Andreassen was supported by the Research Council of Norway (283798, 262656, 248980, 273291, 248828, 248778, 223273); KG Jebsen Stiftelsen, South-East Norway Health Authority, EU H2020 no. 847776. B. Melegh was supported in part by the National Scientific Research Program (NKFIH) K 138669. S. V. Faraone is supported by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602805, the European Union’s Horizon 2020 research and innovation programme under grant agreements 667302 and 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. S. I. Belangero was supported by FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paulo), grant numbers: 2010/08968-6; 2014/07280-1 2011/50740-5 (including R. A. Bressan). The Singapore team (J. Lee, J. Liu, K. Sim, S. A. Chong and M. Subramanian) acknowledges the National Medical Research Council Translational and Clinical Research Flagship Programme (grant no.: NMRC/TCR/003/2008). M. Macek was supported by LM2018132, CZ.02.1.01/0.0/0.0/18_046/0015515 and IP6003 –VZFNM00064203. C. Arango has been funded by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012, PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM, Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds, European Union Seventh Framework Program and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement no 115916, project PRISM; and grant agreement no. 777394, project AIMS-2-TRIALS), Fundación Familia Alonso and Fundación Alicia Koplowitz. E. Bramon acknowledges support from the National Institute of Health Research UK (grant NIHR200756); Mental Health Research UK John Grace QC Scholarship 2018; an ESRC collaborative award 2020; BMA Margaret Temple Fellowship 2016; Medical Research Council New Investigator Award (G0901310); MRC Centenary Award (G1100583); MRC project grant G1100583; National Institute of Health Research UK post-doctoral fellowship (PDA/02/06/016); NARSAD Young Investigator awards 2005 and 2008; Wellcome Trust Research Training Fellowship; Wellcome Trust Case Control Consortium awards (085475/B/08/Z, 085475/Z/08/Z); European Commission Horizon 2020 (747429); NIHR Biomedical Research Centre for Mental Health at the South London and Maudsley NHS Foundation Trust and King’s College London; and NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust and University College London (UCLH BRC - Mental Health Theme). D. Molto is funded by the European Regional Development Fund (ERDF)–Valencian Community 2014–2020, Spain. E. G. Atkinson was supported by the NIMH K01MH121659., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genetic variants associated with longitudinal changes in brain structure across the lifespan

  • Brouwer, Rachel M.
  • Tordesillas-Gutiérrez, Diana
  • Crespo-Facorro, Benedicto
  • Hulshoff Pol, Hilleke E.
et al., Human brain structure changes throughout the lifespan. Altered brain growth or rates of decline are implicated in a vast range of psychiatric, developmental and neurodegenerative diseases. In this study, we identified common genetic variants that affect rates of brain growth or atrophy in what is, to our knowledge, the first genome-wide association meta-analysis of changes in brain morphology across the lifespan. Longitudinal magnetic resonance imaging data from 15,640 individuals were used to compute rates of change for 15 brain structures. The most robustly identified genes GPR139, DACH1 and APOE are associated with metabolic processes. We demonstrate global genetic overlap with depression, schizophrenia, cognitive functioning, insomnia, height, body mass index and smoking. Gene set findings implicate both early brain development and neurodegenerative processes in the rates of brain changes. Identifying variants involved in structural brain changes may help to determine biological pathways underlying optimal and dysfunctional brain development and aging., The ENIGMA-Plasticity Working Group is part of the ENIGMA World Aging Center, funded by NIA grants R56 AG058854 and R01 AG058854. The ENIGMA Consortium core funding was supported by NIH Consortium Grant U54 EB020403, supported by a cross-NIH alliance that funds Big Data to Knowledge Centers of Excellence. 1000BRAINS: 1000BRAINS is a population-based cohort based on the Heinz-Nixdorf Recall Study and is supported, in part, by the German National Cohort. We thank the Heinz Nixdorf Foundation (Germany) for their generous support in terms of the Heinz Nixdorf Study. The authors are supported by the Initiative and Networking Fund of the Helmholtz Association (Svenja Caspers) and the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 785907 (Human Brain Project SGA2; Svenja Caspers, Sven Cichon and Katrin Amunts). This work was further supported by the German Federal Ministry of Education and Research (BMBF) through the Integrated Network IntegraMent (Integrated Understanding of Causes and Mechanisms in Mental Disorders) under the auspices of the e:Med Program (grant 01ZX1314A; Sven Cichon) and by the Swiss National Science Foundation (SNSF, grant 156791; Sven Cichon). The authors acknowledge grants supporting their work from the European Union’s Horizon 2020 Research and Innovation Programme (H2020/2014–2020) under grant agreements 667302 (CoCA), 728018 (Eat2beNICE), 785907 (HBP SGA2) and 772376 (EScORIAL) and the Netherlands ALS Foundation.Additional support is received from the European Community’s Seventh Framework Programme (FP7/2007—2013) under grant agreements n° 602805 (Aggressotype), n° 603016 (MATRICS), n° 602450 (IMAGEMEND) and n° 278948 (TACTICS) and from the European Community’s Horizon 2020 Programme (H2020/2014—2020) under grant agreements n° 643051 (MiND) and n° 667302 (CoCA). FP7 Ideas: the European Research Council (ERC-230374 to D.B.). This work was supported by Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III (SAM16PE07CP1, PI16/02012 and PI19/024), co-financed by ERDF Funds from the European Commission, ‘A way of making Europe’, CIBERSAM; Madrid Regional Government (B2017/BMD-3740 AGES-CM-2), European Union Structural Funds; European Union Seventh Framework Program under grant agreements FP7- HEALTH-2013-2.2.1-2-603196 (Project PSYSCAN) and European Union H2020 Program under the Innovative Medicines Initiative 2 Joint Undertaking (grant agreement 115916, Project PRISM and grant agreement 777394, Project AIMS-2-TRIALS), Fundación Familia Alonso, Fundación Alicia Koplowitz and Fundación Mutua Madrileña. The Horizon 2020 funded ERC Advanced Grant ‘STRATIFY’ (Brain network based stratification of reinforcement-related disorders) (695313). The FP7 project MATRICS (603016). The research leading to these results also received support from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement 278948 (TACTICS), 602805 (Aggressotype), 603016 (MATRICS) and 602450 (Imagemend) and the Innovation Medicine Initiative grants 115300 (EU-AIMS) and 777394 (AIMS-2-TRIALS).PAFIP: PAFIP was supported by the Instituto de Salud Carlos III (PI14/00639, PI14/00918 and PI17/01056) and Fundación Instituto de Investigación Marqués de Valdecilla (NCT0235832 and NCT025KG Jebsen Stiftelsen and H2020 CoMorMent (847776).34363). European Union Marie Curie Research Training Network (MRTN-CT-2006-035987)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Virtual ontogeny of cortical growth preceding mental illness

  • Patel, Yash
  • Shin, Jean
  • Abé, Christoph
  • Agartz, Ingrid
  • Alloza, Clara
  • Alnæs, Dag
  • Ambrogi, Sonia
  • Antonucci, Linda A.
  • Arango, Celso
  • Arolt, Volker
  • Auzias, Guillaume
  • Gruber, Oliver
  • Haavik, Jan
  • McDonald, Colm
  • Hahn, Tim
  • Harrison, Ben J.
  • Heindel, Walter
  • Henskens, Frans
  • Heslenfeld, Dirk J.
  • Hilland, Eva
  • King, Joseph A.
  • Vernooij, Meike W.
  • Hoekstra, Pieter J.
  • Hohmann, Sarah
  • Holz, Nathalie
  • Howells, Fleur M.
  • McIntosh, Andrew
  • Ipser, Jonathan C.
  • Meinert, Susanne
  • Hoogman, Martine
  • Kircher, Tilo
  • Kochunov, Peter
  • Vieta, Eduard
  • Koopowitz, Sheri-Michelle
  • Landén, Mikael
  • Landrø, Nils Inge
  • Lawrie, Stephen
  • Michie, Patricia T.
  • Ayesa Arriola, Rosa
  • Mitchell, Philip
  • Moreno-Alcázar, Ana
  • Franke, Barbara
  • Mowry, Bryan
  • Bau, Claiton H. D.
  • Muratori, Filippo
  • Nabulsi, Leila
  • Nenadić, Igor
  • O'Gorman Tuura, Ruth
  • Oosterlaan, Jaap
  • Overs, Bronwyn
  • Pantelis, Christos
  • Banaj, Nerisa
  • Parellada, Mara
  • van Rooij, Daan
  • Vilarroya, Oscar
  • Pariente, Jose C.
  • Pauli, Paul
  • Pergola, Giulio
  • Piarulli, Francesco Maria
  • Picon, Felipe
  • Piras, Fabrizio
  • Pomarol-Clotet, Edith
  • Pretus, Clara
  • Quidé, Yann
  • Banaschewski, Tobias
  • Weickert, Cynthia
  • Buitelaar, Jan
  • Radua, Joaquim
  • Ramos-Quiroga, J. Antoni
  • Rasser, Paul E.
  • Reif, Andreas
  • Retico, Alessandra
  • Roberts, Gloria
  • Rossell, Susan
  • Rovaris, Diego Luiz
  • Rubia, Katya
  • Weickert, Thomas
  • Sacchet, Matthew
  • Ching, Christopher R. K.
  • Bandeira, Cibele
  • Salavert, Josep
  • Salvador, Raymond
  • Sarró, Salvador
  • Sawa, Akira
  • Schall, Ulrich
  • Scott, Rodney
  • Selvaggi, Pierluigi
  • Westlye, Lars T.
  • Silk, Tim
  • Sim, Kang
  • Andreassen, Ole A.
  • Skoch, Antonin
  • Başgöze, Zeynep
  • Spalletta, Gianfranco
  • Spaniel, Filip
  • Stein, Dan J.
  • Steinsträter, Olaf
  • Stolicyn, Aleks
  • Whalley, Heather
  • Takayanagi, Yoichiro
  • Tamm, Leanne
  • Tavares, Maria
  • Pozzi, Elena
  • Teumer, Alexander
  • Thiel, Katharina
  • Cupertino, Renata Basso
  • Thomopoulos, Sophia I.
  • Tomecek, David
  • Tomyshev, Alexander S.
  • Willinger, David
  • Tordesillas-Gutiérrez, Diana
  • Tosetti, Michela
  • Uhlmann, Anne
  • Van Rheenen, Tamsyn
  • Veltman, Dick
  • Vázquez-Bourgon, Javier
  • Schmaal, Lianne
  • Jahanshad, Neda
  • Winter, Alexandra
  • Wittfeld, Katharina
  • Yang, Tony T.
  • Yoncheva, Yuliya
  • Bauer, Jochen
  • Zijlmans, Jendé L.
  • Baumeister, Sarah
  • Lebedeva, Irina
  • van Erp, Theo G. M.
  • Turner, Jessica
  • Jakobi, Babette
  • Castellanos, F. Xavier
  • Pausova, Zdenka
  • Thompson, Paul
  • Paus, Tomas
  • Bernardoni, Fabio
  • Bertolino, Alessandro
  • Bonnin, Caterina Del Mar
  • Brandeis, Daniel
  • Luna, Beatriz
  • Brem, Silvia
  • Jansen, Andreas
  • Bruggemann, Jason
  • Bülow, Robin
  • Bustillo, Juan R.
  • Calderoni, Sara
  • Calvo, Rosa
  • Canales-Rodríguez, Erick J.
  • Cannon, Dara M.
  • Carmona, Susanna
  • Carr, Vaughan J.
  • Lundervold, Astri J.
  • Janssen, Joost
  • Catts, Stanley V.
  • Chenji, Sneha
  • Chew, Qian Hui
  • Coghill, David
  • Connolly, Colm G.
  • Conzelmann, Annette
  • Craven, Alexander R.
  • Crespo-Facorro, Benedicto
  • Cullen, Kathryn
  • Dahl, Andreas
  • Jonassen, Rune
  • MacMaster, Frank P.
  • Dannlowski, Udo
  • Davey, Christopher G.
  • Deruelle, Christine
  • Díaz-Caneja, Covadonga M.
  • Dohm, Katharina
  • Ehrlich, Stefan
  • Epstein, Jeffery
  • Erwin-Grabner, Tracy
  • Eyler, Lisa T.
  • Kaiser, Anna
  • Fedor, Jennifer
  • Maglanoc, Luigi A.
  • Fitzgerald, Jacqueline
  • Foran, William
  • Ford, Judith M.
  • Fortea, Lydia
  • Fuentes-Claramonte, Paola
  • Fullerton, Janice
  • Furlong, Lisa
  • Gallagher, Louise
  • Kaleda, Vasiliy
  • Gao, Bingchen
  • Gao, Si
  • Mathalon, Daniel H.
  • Goikolea, Jose M.
  • Gotlib, Ian H.
  • Goya-Maldonado, Roberto
  • Grabe, Hans J.
  • Green, Melissa
  • Grevet, Eugenio H.
  • Groenewold, Nynke A.
  • Karantonis, James
  • Grotegerd, Dominik.
[Background]: Morphology of the human cerebral cortex differs across psychiatric disorders, with neurobiology and developmental origins mostly undetermined. Deviations in the tangential growth of the cerebral cortex during pre/perinatal periods may be reflected in individual variations in cortical surface area later in life., [Methods]: Interregional profiles of group differences in surface area between cases and controls were generated using T1-weighted magnetic resonance imaging from 27,359 individuals including those with attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depressive disorder, schizophrenia, and high general psychopathology (through the Child Behavior Checklist). Similarity of interregional profiles of group differences in surface area and prenatal cell-specific gene expression was assessed., [Results]: Across the 11 cortical regions, group differences in cortical area for attention-deficit/hyperactivity disorder, schizophrenia, and Child Behavior Checklist were dominant in multimodal association cortices. The same interregional profiles were also associated with interregional profiles of (prenatal) gene expression specific to proliferative cells, namely radial glia and intermediate progenitor cells (greater expression, larger difference), as well as differentiated cells, namely excitatory neurons and endothelial and mural cells (greater expression, smaller difference). Finally, these cell types were implicated in known pre/perinatal risk factors for psychosis. Genes coexpressed with radial glia were enriched with genes implicated in congenital abnormalities, birth weight, hypoxia, and starvation. Genes coexpressed with endothelial and mural genes were enriched with genes associated with maternal hypertension and preterm birth., [Conclusions]: Our findings support a neurodevelopmental model of vulnerability to mental illness whereby prenatal risk factors acting through cell-specific processes lead to deviations from typical brain development during pregnancy., This work was supported by the German Research Foundation (DFG Grant Nos. HA7070/2-2, HA7070/3, HA7070/4 [to TH]) and IZKF of the medical faculty of Münster (Grants No. Dan3/012/17 [to UD] and MzH 3/020/20 [to TH]), and NHMRC projects (Grant No. 1064643 [to BJH] and 1024570 [to CGD]). The CIAM study was supported by the University of Cape Town Research Committee, South African National Research Foundation, and the South African Medical Research Council (principal investigator [PI], Fleur M. Howells) and Grant No. R01MH117601 (to NJ). This work was funded by the German Research Foundation (Grant Nos. FOR2107 JA 1890/7-1 and FOR2107 JA 1890/7-2 [to AJ]) and Swinburne University scholarship/Australian Postgraduate Award (to JK). Collection of the COGSBD cohort was funded by the Jack Brockhoff Foundation, University of Melbourne, Barbara Dicker Brain Sciences Foundation, Rebecca L Cooper Foundation, and the Society of Mental Health Research (to JK). This work was funded by the German Research Foundation (Grant Nos. FOR2107 KI588/14-1 and FOR2107 KI588/14-2 [to TK]). The St. Göran study was supported by grants from the Swedish Research Council (Grant No. 2018-02653 [to ML]), the Swedish foundation for Strategic Research (Grant No. KF10-0039 [to ML]), the Swedish Brain foundation (Grant No. FO2020-0261 [to ML]), and the Swedish Government under the LUA/ALF agreement (Grant Nos. ALF 20170019 and ALFGBG-716801 [to ML]). This work was supported by RFBR (Grant No. 20-013-00748 [to IL, AST]) and funded by the Health Research Board (Grant No. HRA_POR/2011/100 [to CM]). The Australian Schizophrenia Research Bank (ASRB) was supported by the NHMRC (Enabling Grant No. 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation, and the Schizophrenia Research Institute. Chief investigators for ASRB were VC, US, RSc, AJ, BM, PTM, SVC, FH, and CPa. This work was supported by Deutsche Forschungsgemeinschaft (Grant Nos. DFG NE 2254/2-1, NE 2254/3-1, NE2254/4-1 [to IN]), the University Research Priority Program “Integrative Human Physiology” at the University of Zurich (to ROT), an NHMRC Senior Principal Research Fellowship (Grant No. 1105825 [to CPa]), an NHMRC L3 Investigator Grant (Grant No. 1196508 [to CPa]), and NHMRC Program Grant (Grant No. 1150083 [to CPa]). ASRB was supported by the NHMRC (Enabling Grant No. 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation and the Schizophrenia Research Institute. Chief investigators for ASRB were VC, US, RSc, AJ, BM, PTM, SVC, FH, and CPa. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant (Agreement No. 798181 [to GP]). ASRB was supported by the NHMRC (Enabling Grant, ID 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation and the Schizophrenia Research Institute. Chief investigators for ASRB were VC, US, RSc, AJ, BM, PTM, SVC, FH, and CPa. The Imaging Genetics in Psychosis study was funded by Project Grants from the NHMRC (Grant Nos. APP630471 and APP1081603 [to YQ]) and the Macquarie University’s Australian Research Council (ARC) Centre of Excellence in Cognition and its Disorders (Grant No. CE110001021 [to YQ]). This work was supported by the Spanish Ministry of Science, Innovation and Universities/Economy and Competitiveness/Instituto de Salud Carlos III (Grant Nos. PI11/01766 and CPII19/00009 [to JR]), co-financed by European Regional Development Fund funds from the European Commission (“A Way of Making Europe”). ASRB was supported by the NHMRC (Enabling Grant No. 386500), the Pratt Foundation, Ramsay Health Care, the Viertel Charitable Foundation, and the Schizophrenia Research Institute. Chief investigators for ASRB were VC, US, RSc, AJ, BM, PTM, SVC, FH, and CPa. SR was supported by an NHMRC Senior Fellowship (Grant No. GNT1154651). Collection of the COGSBD cohort was funded by the Jack Brockhoff Foundation, University of Melbourne, Barbara Dicker Brain Sciences Foundation, Rebecca L Cooper Foundation, and the Society of Mental Health Research (to SR). This work was supported by NIHR; MRC (to KR), NIH (Grant Nos. MH-094268, MH-105660, and MH-107730 [to ASS]). The Neuroimaging of the Children's Attention Project cohort was funded by NHMRC, Australia (Grant No. 1065895). Earlier funding for the cohort as also provided by NHMRC (Grant No. 1008522) and a grant from the Collier Foundation. The ACPU cohort was funded by NHMRC, Australia (Project Grant Nos. 384419 and 569533 [to TS]). This work was supported by research grants from the National Healthcare Group, Singapore (Grant Nos. SIG/05004, SIG/05028, and SIG /1103), and the Singapore Bioimaging Consortium (RP C009/2006 [to KS]), and the Ministry of Health, Czech Republic - conceptual development of research organization (“Institute for Clinical and Experimental Medicine - IKEM, IN 00023001” [to ASk]). This study was supported by the Italian Ministry of Health (Grant No. RC/17-18-19-20-21/A [to GS]) and Ministry of Health of the Czech Republic (Grant No. NU20-04-00393 [to FS]). The Drakenstein Child Health Study (DCHS) cohort is funded by the Bill and Melinda Gates Foundation (Grant No. OPP 1017641) and the South African Medical Research Council. This DCHS contribution was made possible in part by a grant from Carnegie Corporation of New York. The statements made and views expressed are solely the responsibility of the author (DJS). STRADL study was supported and funded by the Wellcome Trust Strategic Award “Stratifying Resilience and Depression Longitudinally” (Grant No. 104036/Z/14/Z), and the Medical Research Council Mental Health Pathfinder Award “Leveraging routinely collected and linked research data to study the causes and consequences of common mental disorders” (MRC, Grant No. MC_PC_17209). Scottish Bipolar Family Study (SBFS) was supported by National Health Service Research Scotland, through the Scottish Mental Health Research Network (www.smhrn.org.uk), who provided assistance with subject recruitment and assessments. SBFS was conducted at the Brain Research Imaging Centre (http://www.bric.ed.ac.uk), which is supported by SINAPSE (Scottish Imaging Network, a Platform for Scientific Excellence, http://www.sinapse.ac.uk). Processing of the datasets used the resources provided by the Edinburgh Compute and Data Facility (http://www.ecdf.ed.ac.uk/) (ASt). TVR was supported by an NHMRC Early Career Fellowship (Grant No. GNT1088785). Collection of the COGSBD cohort was funded by the Jack Brockhoff Foundation, University of Melbourne, Barbara Dicker Brain Sciences Foundation, Rebecca L Cooper Foundation, and the Society of Mental Health Research (to TVR). EV was supported by the Spanish Ministry of Science and Innovation (PI18/00805) integrated into the Plan Nacional de I+D+I and co-financed by the ISCIII-Subdirección General de Evaluación and the FEDER; the Instituto de Salud Carlos III; the CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental); by the CERCA Programme/Generalitat de Catalunya and the Secretaria d’Universitats i Recerca del Departament d’Economia I Coneixement (Grant No. 2017SGR1355). This study was also supported by the Departament de Salut de la Generalitat de Catalunya, Pla Estratègic de Recerca i Innovació en Salut (PERIS) 2016-2020 (Grant No. SLT006/17/00345) and the European Union Horizon 2020 research and innovation program (EU.3.1.1. Understanding health, wellbeing and disease: Grant Nos. 754907 and EU.3.1.3 [to EB]; Treating and managing disease: Grant No. 945151 [to EV]). This study was supported by the National Center for Complementary and Integrative Health (Grant Nos. R21AT009173 and R61AT009864 [to TTY]); by the National Center for Advancing Translational Sciences (CTSI), National Institutes of Health, through UCSF-CTSI (Grant No. UL1TR001872 [to TTY]); by the American Foundation for Suicide Prevention (Grant No. SRG-1-141-18 [to TTY]); by UCSF Research Evaluation and Allocation Committee (REAC) and J. Jacobson Fund (to TTY); by the NIMH (Grant No. R01MH085734 [to TTY]); and by the Brain and Behavior Research Foundation (formerly NARSAD) (to TTY). This work was supported by a personal Veni grant to MH from the Netherlands Organization for Scientific Research (NWO, Grant No. 91619115 [to MH]) and European Community’s Horizon 2020 Programme (H2020/2014 – 2020) (Grant Agreements Nos. 667302 [CoCA], 728018 [Eat2beNICE], and 847879 [PRIME] [to BF]). JBu has been supported by the EU-AIMS (European Autism Interventions) and AIMS-2-TRIALS programmes, which receive support from Innovative Medicines Initiative Joint Undertaking Grant Nos. 115300 and 777394, the resources of which are composed of financial contributions from the European Union’s FP7 and Horizon 2020 Programmes, and from the European Federation of Pharmaceutical Industries and Associations companies’ in-kind contributions, and AUTISM SPEAKS, Autistica and SFARI; and by the Horizon 2020–supported programme CANDY (Grant No. 847818 [to JBu]). This work is supported by Grant No. NIA T32AG058507 and NIH Grant No. U54EB020403 from the Big Data to Knowledge (BD2K) Program (to CRKC). ENIGMA MDD work is supported by NIH (Grant Nos. U54 EB020403 [to PT], R01 MH116147 [to PT], and R01 MH117601 [to NJ and LS]). LS was supported by an NHMRC Career Development Fellowship (Grant No. 1140764). This work was supported by the National Center for Research Resources at the NIH (Grant Nos. NIH 1 U24 RR021992 [Function Biomedical Informatics Research Network], NIH 1 U24 RR025736-01 [Biomedical Informatics Research Network Coordinating Center; http://www.birncommunity.org]). TGMvE is supported by ENIGMA’s NIH BD2K initiative (Grant No. U54 EB020403), ENIGMA Sex Differences (Grant No. R01MH116147), and ENIGMA-COINSTAC: Advanced Worldwide Transdiagnostic Analysis of Valence System Brain Circuits (Grant No. R01MH121246). This work was supported by the NIH (Grant No. R01MH121246 [to JT, Calhoun, and TGMvE]). This work was supported in part by NIH (Grant No. U54 EB020403 [to PT])., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Vilar-Ribó, Laura
  • Cabana-Domínguez, Judit
  • Martorell, Lourdes
  • Ramos-Quiroga, Josep Antoni
  • Sanchez-Roige, Sandra
  • Palmer, Abraham A.
  • Vilella, Elisabet
  • Ribasés, Marta
  • Muntané, Gerard
  • Soler Artigas, María
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/., There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulėnaitė, Solveiga
  • García-Blanco, Alejandra
  • Mayneris-Perxachs, Jordi
  • Domingo-Rodríguez, Laura
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus
  • Espinosa-Carrasco, Jose
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández-Real, Jose Manuel
  • Maldonado, Rafael
  • Martín-García, Elena
Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish ’Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)’ (PID2020- 120029GB-I00/ MICIU/ AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ’Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ’Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ’La Marató de TV3’ #20221830, ’ICREA-Acadèmia’ (#2015) and the Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073- 2A to EM-G. Spanish-MINECO (#SAF2017-84060- R- AEI/ FEDER-UE) to LD-R, Spanish ’Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968- B- 100, #PID2021-127776OB- I00), ’AGAUR-Generalitat de Catalunya’ (#2017-SGR- 738, #2021-SGR- 01093) and Spanish ’Ministerio de Sanidad, Servicios Sociales e Igualdad, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ’Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT- K- 718- 03- 0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), ’La Marató de TV3’ #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB- I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the ’CERCA Programme/Generalitat de Catalunya’., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genomic analysis of intracranial and subcortical brain volumes yields polygenic scores accounting for variation across ancestries

  • García-Marín, Luis M.
  • Campos, Adrian I.
  • Diaz-Torres, Santiago
  • Crespo-Facorro, Benedicto
  • Romero García, Rafael
  • Tordesillas-Gutiérrez, Diana
  • Vázquez-Bourgon, Javier
García-Marín, Luis M.; Campos, Adrian I.; Diaz-Torres, Santiago; et al., Subcortical brain structures are involved in developmental, psychiatric and neurological disorders. Here we performed genome-wide association studies meta-analyses of intracranial and nine subcortical brain volumes (brainstem, caudate nucleus, putamen, hippocampus, globus pallidus, thalamus, nucleus accumbens, amygdala and the ventral diencephalon) in 74,898 participants of European ancestry. We identified 254 independent loci associated with these brain volumes, explaining up to 35% of phenotypic variance. We observed gene expression in specific neural cell types across differentiation time points, including genes involved in intracellular signaling and brain aging-related processes. Polygenic scores for brain volumes showed predictive ability when applied to individuals of diverse ancestries. We observed causal genetic effects of brain volumes with Parkinson's disease and attention-deficit/hyperactivity disorder. Findings implicate specific gene expression patterns in brain development and genetic variants in comorbid neuropsychiatric disorders, which could point to a brain substrate and region of action for risk genes implicated in brain diseases., This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Specific Grant Agreement 945539 (Human Brain Project SGA3). This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643417, No 640643, and No 667375 and 754517. IMAGEN was funded by the European Union-funded FP6 Integrated Project IMAGEN (LSHM-CT- 2007-037286). The MCIC study was supported by the National Institutes of Health (NIH/NCRR P41RR14075 and R01EB005846), the Department of Energy (DE-FG02-99ER62764). NeuroIMAGE also received funding from the European Community’s Seventh Framework Programme (FP7/2007– 2013) under grant agreements n° 602805 (Aggressotype), n° 278948 (TACTICS), and n° 602450 (IMAGEMEND), and from the European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grantagreements n°643051(MiND), n° 667302 (CoCA), and n° 728018 (Eat2beNICE). Additional support is received from the European Community's Seventh Framework Programme (FP7/2007– 2013) under grant agreements nº 602805 (Aggressotype), nº 603016 (MATRICS), nº 602450 (IMAGEMEND), and nº 278948 (TACTICS), and from the European Community's Horizon 2020 Programme (H2020/2014– 2020) under grant agreements nº 643051 (MiND) and nº 667302(CoCA). Erasmus Rucphen family study (ERF): The ERF study as a part of EUROSPAN (European Special Populations Research Network) was supported by European Commission FP6 STRP grant number 018947 (LSHG-CT-2006-01947) and also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413 by the European Commission under the programme "Quality of Life and Management of the Living Resources" of 5th Framework Programme (no.QLG2-CT-2002-01254). the European Science Foundation (ESF, EU/QLRT-2001-01254), the European Community’s Seventh Framework Programme (FP7- HEALTH-F4-2007-2013, grant 01413: ENGAGE and grant 602768: ACTION); the European Research Council (ERC Starting 284167, ERC Consolidator 771057, ERC Advanced 230374). The Horizon 2020 supported programme CANDY Grant No. 847818). European Community’s Horizon 2020 Programme (H2020/2014– 2020) under grant agreement n° 847879 (PRIME). European Research Council under the European Union's Horizon 2020 research and Innovation program (ERC StG, Grant 802998). This work was supported by Fundación Marqués de Valdecilla, Instituto de investigación sanitaria Valdecilla., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Deficiency of the ywhaz gene, involved in neurodevelopmental disorders, alters brain activity and behaviour in zebrafish

  • Antón Galindo, Ester
  • Dalla Vecchia, Luisa Felix
  • Gómez Orlandi, Javier
  • Castro Olvera, Gustavo
  • Guasch Piqueras, Marc
  • Arenas Sola, Concepción|||0000-0002-6489-4934
  • García Fernandez, Jordi
  • Gualda Manzano, Emilio José|||0000-0001-5948-5493
  • Herrera Úbeda, Carlos
  • Aguado Tomas, Fernando
  • Loza Álvarez, Pablo
  • Cormand, Bru
  • Norton, William H.J.
  • Fernández Castillo, Noelia
  • Young, Andrew M.J.
Genetic variants in YWHAZ contribute to psychiatric disorders such as autism spectrum disorder and schizophrenia, and have been related to an impaired neurodevelopment in humans and mice. Here, we have used zebrafish to investigate the mechanisms by which YWHAZ contributes to neurodevelopmental disorders. We observed that ywhaz expression was pan-neuronal during developmental stages and restricted to Purkinje cells in the adult cerebellum, cells that are described to be reduced in number and size in autistic patients., GCaMP6s albino zebrafish embryos were generated by the National Institute of Genetics (Japan) and obtained from Dr. Matt Parker from the University of Portsmouth, UK. The Tg(aldoca:gap43-Venus) line was obtained from Masahiko Hibi from the Bioscience and Biotechnology Center of Nagoya University, Japan. Tg(olig2:egfp)vu12 brains were obtained from the Center for Developmental Biology, UMR 5547 CNRS, Toulouse, France. Major financial support for this research was received by BC from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (RTI2018-100968-B-100, PID2021-1277760B-I100), the ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (PNSD-2017I050 and PNSD-2020I042), ‘Generalitat de Catalunya/AGAUR’ (2017-SGR-738), ICREA Academia 2021, and the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA) and Eat2beNICE (728018). E.A-G was supported by the Ministerio de Economía y Competitividad (Spanish Government) and the EU H2020 program (Eat2beNICE-728018). G.C., E.G. and P.L-A acknowledge financial support from the Spanish Ministerio de Economía y Competitividad (MINECO) through the “Severo Ochoa” program for Centres of Excellence in R&D CEX2019-000910-S), MINECO/FEDER Ramon y Cajal program (RYC-2015-17935); Laserlab-Europe EU-H2020 GA no. 871124, Fundació Privada Cellex, Fundación Mig-Puig and from the Generalitat de Catalunya through the CERCA program. F.A. acknowledges financial support from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (PID2019-107738RB-I00, MICINN/FEDER) and SGR (2017SGR1255).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metformin Use and Cognitive Function in Older Adults With Type 2 Diabetes Following a Mediterranean Diet Intervention

  • Soldevila Domenech, Natalia
  • Cuenca Royo, Aida
  • Babio, Nancy
  • Forcano, Laura
  • Nishi, Stephanie K.
  • Vintró Alcaraz, Cristina
  • Gómez Martínez, Carlos
  • Jiménez-Murcia, Susana
  • Fernández Carrión, Rebeca
  • Gomis González, Maria
  • Alvarez Sala, Andrea
  • Carlos, Silvia
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Díez Espino, Javier
  • Castañer, Olga
  • Fernández Aranda, Fernando
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
Background and Purpose: Both adherence to the Mediterranean diet (MedDiet) and the use of metformin could benefit the cognitive performance of individuals with type 2 diabetes, but evidence is still controversial. We examined the association between metformin use and cognition in older adults with type 2 diabetes following a MedDiet intervention. Methods: Prospective cohort study framed in the PREDIMED-Plus-Cognition sub-study. The PREDIMED-Plus clinical trial aims to compare the cardiovascular effect of two MedDiet interventions, with and without energy restriction, in individuals with overweight/obesity and metabolic syndrome. The present sub-study included 487 cognitively normal subjects (50.5% women, mean ± SD age of 65.2 ± 4.7 years), 30.4% of them (N = 148) with type 2 diabetes. A comprehensive battery of neurocognitive tests was administered at baseline and after 1 and 3 years. Individuals with type 2 diabetes that exhibited a good glycemic control trajectory, either using or not using metformin, were compared to one another and to individuals without diabetes using mixed-effects models with inverse probability of treatment weights. Results: Most subjects with type 2 diabetes (83.1%) presented a good and stable glycemic control trajectory. Before engaging in the MedDiet intervention, subjects using metformin scored higher in executive functions (Cohen's d = 0.51), memory (Cohen's d = 0.38) and global cognition (Cohen's d = 0.48) than those not using metformin. However, these differences were not sustained during the 3 years of follow-up, as individuals not using metformin experienced greater improvements in memory (β = 0.38 vs. β = 0.10, P = 0.036), executive functions (β = 0.36 vs. β = 0.02, P = 0.005) and global cognition (β = 0.29 vs. β = −0.02, P = 0.001) that combined with a higher MedDiet adherence (12.6 vs. 11.5 points, P = 0.031). Finally, subjects without diabetes presented greater improvements in memory than subjects with diabetes irrespective of their exposure to metformin (β = 0.55 vs. β = 0.10, P < 0.001). However, subjects with diabetes not using metformin, compared to subjects without diabetes, presented greater improvements in executive functions (β = 0.33 vs. β = 0.08, P = 0.032) and displayed a higher MedDiet adherence (12.6 points vs. 11.6 points, P = 0.046). Conclusions: Although both metformin and MedDiet interventions are good candidates for future cognitive decline preventive studies, a higher adherence to the MedDiet could even outweigh the potential neuroprotective effects of metformin in subjects with diabetes.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller-Cucala, Paula
  • Maceda, Iago
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand Rifà, Bru
  • Lao, Oscar
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

  • Bouzas, Cristina
  • Goday Arnó, Albert
  • Muñoz Pérez, Miguel Ángel
  • Satorres, Alba
  • Fitó Colomer, Montserrat
  • Tur, J. Antoni
Aims To assess the comparative effects of glucagon-like peptide-1 receptor agonists (GLP-1RA), 4-dipeptidyl peptidase inhibitors (DPP-4I), and metformin treatment during one year on metabolic syndrome (MetS) components and severity in MetS patients. Methods Prospective study (n = 6165 adults) within the frame of PREDIMED-Plus trial. The major end-point was changes on MetS components and severity after one- year treatment of GLP-1RA, DPP-4I, and metformin. Anthropometric measurements (weight, height and waist circumference), body mass index (BM), and blood pressure were registered. Blood samples were collected after overnight fasting. Plasma glucose, glycosylated hemoglobin (HbA1c), plasma triglycerides and cholesterol were measured. Dietary intakes as well as physical activity were assessed through validated questionnaires. Results MetS parameters improved through time. The treated groups improved glycaemia compared with untreated (glycaemia ∆ untreated: −1.7 mg/dL(± 13.5); ∆ metformin: − 2.5(± 23.9) mg/dL; ∆ DPP-4I: − 4.5(± 42.6); mg/dL ∆ GLP-1RA: − 4.3(± 50.9) mg/dL; and HbA1c: ∆ untreated: 0.0(± 0.3) %; ∆ metformin: − 0.1(± 0.7) %; ∆ DPP-4I: − 0.1(± 1.0) %; ∆ GLP-1RA: − 0.2(± 1.2) %. Participants decreased BMI and waist circumference. GLP-1RA and DPP-4I participants registered the lowest decrease in BMI (∆ untreated: −0.8(± 1.6) kg/m2; ∆ metformin: − 0.8(± 1.5) kg/m2; ∆ DPP-4I: − 0.6(± 1.3) kg/m2; ∆ GLP-1RA: − 0.5(± 1.2) kg/m2. and their waist circumference (∆ untreated: −2.8(± 5.2) cm; ∆ metformin: − 2.6(± 15.2) cm; ∆ DPP-4I: − 2.1(± 4.8) cm; ∆ GLP-1RA: − 2.4(± 4.1) cm. Conclusion In patients with MetS and healthy lifestyle intervention, those treated with GLP-1RA and DPP-4I obtained better glycemic profile. Anthropometric improvements were modest., The PREDIMED-Plus trial was supported by the European Research Council (Advanced Research Grant 2013–2018, 340918) to M.Á.M.-G and the official funding agency for biomedical research of the Spanish Government, ISCIII, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (five coordinated FIS projects led by J.S.-S. and J.Vid., including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158), the Especial Action Project entitled: Implementación y evaluación de una intervención intensive sobre la actividad física Cohorte PREDIMED-Plus grant to J.S.-S., the Recercaixa Grant to J.S.-S. (2013ACUP00194), Grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, and PI0137/2018), a Grant from the Generalitat Valenciana (PROMETEO/2017/017), a SEMERGEN Grant, EU-COST Action CA16112, a Grant of support to research groups no. 35/2011 from the Balearic Islands Government, Grants (FOLIUM, PRIMUS, SYNERGIA, and LIBERI) from Balearic Islands Health Research Institute (IDISBA), funds from the European Regional Development Fund (CIBEROBN CB06/03 and CB12/03) and from the European Commission (EAT2BENICE_H2020_SFS2016). Fundació La Marató TV3 (project ref. 201630.10). Cristina Bouzas received a Fernando Tarongí Bauzà Grant, Margalida Comas Grant (DG R+D+I, Balearic Ils Govn, and Juan de la Cierva Grant (Ministry of Science, Spain). The funding sponsors had no role in the design of the study, in the collection, analyses, or interpretation of the data; in the writing of the manuscript, and in the decision to publish the results.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gut microbiota signature in treatment-naïve attention-deficit/hyperactivity disorder

  • Richarte Fernández, Vanesa
  • Sanchez Mora, Cristina P
  • Corrales De la Cruz, Montserrat
  • Fadeuilhe Grau, Christian
  • Vilar Ribo, Laura
  • Arribas Garcia, Lorena
  • Garcia Gea, Estela
  • Rosales Ortiz, Silvia Karina
  • Soler Artigas, Maria
  • Ribases Haro, Marta
  • Ramos-Quiroga, Josep Antoni
TDAH; Comunitat científica, TDAH; Comunidad científica, ADHD; Scientific community, Compelling evidence supports alterations in gut microbial diversity, bacterial composition, and/or relative abundance of several bacterial taxa in attention-deficit/hyperactivity disorder (ADHD). However, findings for ADHD are inconsistent among studies, and specific gut microbiome signatures for the disorder remain unknown. Given that previous studies have mainly focused on the pediatric form of the disorder and involved small sample sizes, we conducted the largest study to date to compare the gastrointestinal microbiome composition in 100 medication-naïve adults with ADHD and 100 sex-matched healthy controls. We found evidence that ADHD subjects have differences in the relative abundance of several microbial taxa. At the family level, our data support a lower relative abundance of Gracilibacteraceae and higher levels of Selenomonadaceae and Veillonellaceae in adults with ADHD. In addition, the ADHD group showed higher levels of Dialister and Megamonas and lower abundance of Anaerotaenia and Gracilibacter at the genus level. All four selected genera explained 15% of the variance of ADHD, and this microbial signature achieved an overall sensitivity of 74% and a specificity of 71% for distinguishing between ADHD patients and healthy controls. We also tested whether the selected genera correlate with age, body mass index (BMI), or scores of the ADHD rating scale but found no evidence of correlation between genera relative abundance and any of the selected traits. These results are in line with recent studies supporting gut microbiome alterations in neurodevelopment disorders, but further studies are needed to elucidate the role of the gut microbiota on the ADHD across the lifespan and its contribution to the persistence of the disorder from childhood to adulthood.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Analysis of structural brain asymmetries in attention-deficit/hyperactivity disorder in 39 datasets

  • Postema, Merel C.
  • Vilarroya, Óscar
  • Francks, Clyde
Objective: Some studies have suggested alterations of structural brain asymmetry in attention-deficit/hyperactivity disorder (ADHD), but findings have been contradictory and based on small samples. Here, we performed the largest ever analysis of brain left-right asymmetry in ADHD, using 39 datasets of the ENIGMA consortium. Methods: We analyzed asymmetry of subcortical and cerebral cortical structures in up to 1,933 people with ADHD and 1,829 unaffected controls. Asymmetry Indexes (AIs) were calculated per participant for each bilaterally paired measure, and linear mixed effects modeling was applied separately in children, adolescents, adults, and the total sample, to test exhaustively for potential associations of ADHD with structural brain asymmetries. Results: There was no evidence for altered caudate nucleus asymmetry in ADHD, in contrast to prior literature. In children, there was less rightward asymmetry of the total hemispheric surface area compared to controls (t = 2.1, p = .04). Lower rightward asymmetry of medial orbitofrontal cortex surface area in ADHD (t = 2.7, p = .01) was similar to a recent finding for autism spectrum disorder. There were also some differences in cortical thickness asymmetry across age groups. In adults with ADHD, globus pallidus asymmetry was altered compared to those without ADHD. However, all effects were small (Cohen's d from -0.18 to 0.18) and would not survive study-wide correction for multiple testing. Conclusion: Prior studies of altered structural brain asymmetry in ADHD were likely underpowered to detect the small effects reported here. Altered structural asymmetry is unlikely to provide a useful biomarker for ADHD, but may provide neurobiological insights into the trait.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Evidence for similar structural brain anomalies in youth and adult attention-deficit/hyperactivity disorder: a machine learning analysis

  • Zhang-James, Yanli
  • Helminen, Emily C.
  • Liu, Jinru
  • ENIGMA-ADHD Working Group
  • Franke, Barbara
  • Hoogman, Martine
  • Faraone, Stephen V.
Attention-deficit/hyperactivity disorder (ADHD) affects 5% of children world-wide. Of these, two-thirds continue to have impairing symptoms of ADHD into adulthood. Although a large literature implicates structural brain differences of the disorder, it is not clear if adults with ADHD have similar neuroanatomical differences as those seen in children with recent reports from the large ENIGMA-ADHD consortium finding structural differences for children but not for adults. This paper uses deep learning neural network classification models to determine if there are neuroanatomical changes in the brains of children with ADHD that are also observed for adult ADHD, and vice versa. We found that structural MRI data can significantly separate ADHD from control participants for both children and adults. Consistent with the prior reports from ENIGMA-ADHD, prediction performance and effect sizes were better for the child than the adult samples. The model trained on adult samples significantly predicted ADHD in the child sample, suggesting that our model learned anatomical features that are common to ADHD in childhood and adulthood. These results support the continuity of ADHD's brain differences from childhood to adulthood. In addition, our work demonstrates a novel use of neural network classification models to test hypotheses about developmental continuity., Dr. Faraone is supported by the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 602805, the European Union’s Horizon 2020 research and innovation programme under grant agreement nos. 667302 & 728018, and NIMH grants 5R01MH101519 and U01 MH109536-01. Dr. Franke is supported by a personal Vici grant (016-130-669) and Dr. Hoogman from a personal Veni grant (91619115), both from the Netherlands Organization for Scientific Research (NWO). The ENIGMA Working Group gratefully acknowledges support from the NIH Big Data to Knowledge (BD2K) award (U54 EB020403 to Paul Thompson). We thank Margaret Mariano and Patricia Forken for administrative assistance and proofreading the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Martorell, Lourdes
  • Sanchez-Roige, Sandra
  • Palmer, Abraham
  • Vilar-Ribo, Laura
  • Cabana-Dominguez, Judit
  • Ribases, Marta
  • Soler Artigas, María
  • Ramos-Quiroga, Josep Antoni
Shared genetic architecture; Attention-deficit and hyperactivity disorder; Lifespan, Arquitectura genética compartida; Trastorno por déficit de atención e hiperactividad; Esperanza de vida, Arquitectura genètica compartida; Trastorn per dèficit d'atenció i hiperactivitat; Esperança de vida, There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cell type-specific methylome-wide association studies of childhood ADHD symptoms

  • Meijer, Mandy
  • Cosín Tomàs, Marta
  • Bustamante Pineda, Mariona
  • Ramos González, Juan
  • Sunyer Deu, Jordi
  • van den Oord, Edwin J.C.G.
Studying DNA methylation (DNAm) can provide insights into gene-regulatory mechanisms underlying attention-deficit/hyperactivity disorder (ADHD). While most DNAm studies were performed in bulk tissue, this study used statistical deconvolution to identify cell type-specific DNAm profiles, from five major blood cell types, associated with childhood ADHD symptoms. We performed meta-analyses of methylome-wide association studies (MWAS) for ADHD symptoms (agerange=4-16 years) in peripheral blood collected during childhood and in cord blood. The investigated cohorts included seven array-based methylation datasets assaying up to 450 K CpGs from the Pregnancy And Childhood Epigenetics Consortium (N=2 934 peripheral blood; N=2 546 cord blood) and a sequencing-based methylation dataset assaying nearly all 28 million CpGs in blood from the Great Smoky Mountain Study (GSMS; N=583). The meta-analyses resulted in methylome-wide significant (FDR<0.05) ADHD associations in CD8T cells (RPL31P11 and KCNJ5) for peripheral blood, and, in cord blood, in monocytes (PDE6B), CD8T cells (KCNA3 and HAND2), and NK cells (KIFC1). Notably, several significant sites detected in peripheral blood (RPL31P11 and KCNJ5) were also detected in cord blood. Furthermore, extended MWAS of all sites available for GSMS detected 69 and 17 additional CpGs in monocytes and granulocytes, respectively. In this first cell type-specific MWAS for ADHD, we identified DNAm associations for ADHD symptoms; some associations were seen in both peripheral blood and cord blood, suggesting potential susceptibility markers for increased ADHD risk. These findings show that cell type-specific analyses and sequencing-based approaches can increase insights into the epigenetic patterns associated with ADHD symptoms in childhood., This work was supported by an internal grant from the Donders Centre for Medical Neuroscience of the Radboudumc and by funding for the Dutch National Science Agenda NeurolabNL project (grant 400–17–602). Support was also received from the European Commission’s Horizon 2020 Programme (H2020/2014–2020) under grant agreement n◦ 728018 (Eat2beNICE). This work reflects only the view of the authors, and the European Commission is not responsible for any use that may be made of the information. This research was supported by the National Institutes of Health (1R01MH104576 to E.J.C.G.v.d.O). In addition, the following personal grants made this work possible: MK was supported by grants from the Netherlands Organisation for Scientific Research (NWO, grant nos. 45219212 and 09150162010073). AH was supported by the HERCULES Center (NIEHS P30ES019776). MCT is funded by a Beatriu de Pinos ´ Postdoctoral Contract awarded by eneralitat de Catalunya-AGAUR and European Commission- Horizon 2020 (2019 BP 00107). BiB is supported by a Wellcome programme grant (WT223601/Z/21/Z) ’Born in Bradford: Age of Wonder’ and a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): R/N024391/1. The work of CAMC, RHM, and JFF is supported by the European Union’s Horizon 2020 Research and Innovation Programme (EarlyCause; grant agreement No 848158). The work of CAM is supported by the European Research Council (TEMPO; grant agreement No 101039672). CLR. is funded by the MRC MC_UU_00011/5). DJS and HJZ are supported by the South African Medical Research Council (SAMRC). A complete overview of all funding sources and acknowledgements can be found in the
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Transdiagnostic perspective of impulsivity and compulsivity in obesity: from cognitive profile to self-reported dimensions in clinical samples with and without diabetes

  • Testa, Giulia
  • Fitó Colomer, Montserrat
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
Impulsive and compulsive behaviors have both been observed in individuals with obesity. The co-occurrence of obesity and type 2 diabetes (T2D) is more strongly associated with impulsivity, although there are no conclusive results yet. A multidimensional assessment of impulsivity and compulsivity was conducted in individuals with obesity in the absence or presence of T2D, compared with healthy, normal-weight individuals, with highly impulsive patients (gambling disorders), and with highly compulsive patients (anorexia nervosa). Decision making and novelty seeking were used to measure impulsivity, and cognitive flexibility and harm avoidance were used for compulsivity. For impulsivity, patients with obesity and T2D showed poorer decision-making ability compared with healthy individuals. For compulsivity, individuals with only obesity presented less cognitive flexibility and high harm avoidance; these dimensions were not associated with obesity with T2D. This study contributes to the knowledge of the mechanisms associated with diabetes and its association with impulsive-compulsive behaviors, confirming the hypothesis that patients with obesity and T2D would be characterized by higher levels of impulsivity., This manuscript and research were supported by grants from the Instituto de Salud Carlos III (ISCIII) (FIS PI14/00290, PI17/01167 and PI20/132) and (PI13/00462, PI16/00501, PI19/00576), by the SLT006/17/00246 grant, funded by the Department of Health of the Generalitat de Catalunya by the call “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” (PERIS) and co-funded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBERObn is an initiative of ISCIII. This research was also partially funded by EU-H2020 grants (Eat2beNICE/H2020-SFS-2016-2, Ref 728018; PRIME/H2020-SC1-BHC-2018-2020, Ref: 847879). CG-M receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial

  • Gómez Martínez, Carlos
  • Babio, Nancy
  • Julvez, Jordi
  • Nishi, Stephanie K.
  • Fernández Aranda, Fernando
  • Martínez-González, Miguel Ángel, 1957-
  • Cuenca Royo, Aida
  • Fernández, Rebeca
  • Jiménez-Murcia, Susana
  • de la Torre, Rafael
  • Pintó Sala, Xavier
  • Bloemendaal, Mirjam
  • Fitó Colomer, Montserrat
  • Corella Piquer, Dolores
  • Arias, Alejandro
  • Salas Salvadó, Jordi
Background: Few studies have analyzed the associations between impulsivity and dietary patterns. Some of them have shown a cross-sectional inverse relationship between impulsivity and healthy diet scores, whereas others reported a positive association with unhealthy dietary assessments. We aimed to examine longitudinal associations of impulsivity trait with adherence to healthy and unhealthy dietary patterns in older participants at high risk of cardiovascular disease over 3 years of follow-up. Methods: A 3-year prospective cohort analysis within the PREDIMED-Plus-Cognition study conducted in 4 PREDIMED-Plus study centers was performed. The PREDIMED-Plus study aimed to test the beneficial effect of a lifestyle intervention on the primary prevention of cardiovascular disease. The participants with overweight or obesity and metabolic syndrome included in the present study (n = 462; mean age of 65.3 years; 51.5% female) completed both the UPPS-P Impulsive Behavior Scale (range: 0-236 points) and the 143-item Food Frequency Questionnaire at baseline, 1-year and 3-years of follow-up. Ten diet scores assessing healthy and unhealthy dietary patterns were evaluated. Linear mixed models were performed adjusting by several confounders to study the longitudinal associations between impulsivity trait and adherence to dietary pattern scores over 3 years of follow-up (also assessing interactions by sex, age, and intervention group). Results: Impulsivity were negatively associated with adherence to the Healthy Plant-Based [β = -0.92 (95%CI -1.67, -0.16)], Mediterranean [β = -0.43 (95%CI -0.79, -0.07)], Energy-Restricted Mediterranean [β = -0.76 (95%CI -1.16, -0.37)], Alternative Healthy Eating Index [β = -0.88 (95%CI -1.52, -0.23)], Portfolio [β = -0.57 (95%CI -0.91, -0.22)], and DASH [β = -0.50 (95%CI -0.79, -0.22)] diet scores over 3 years of follow-up, whereas impulsivity was positively related with adherence to the unhealthy Western diet [β = 1.59 (95%CI 0.59, 2.58)] over time. An interaction by intervention group was found, with those participants in the intervention group with high impulsivity levels having lower adherence to several healthy dietary patterns. Conclusions: Heightened impulsivity was longitudinally associated with lower adherence to healthy dietary patterns and higher adherence to the Western diet over 3 years of follow-up. Furthermore, nutritional intervention programs should consider impulsivity as a relevant factor for the intervention success.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples

  • Esteller Cucala, Paula
  • Maceda Porto, Iago, 1986-
  • Børglum, Anders D.
  • Demontis, Ditte
  • Faraone, Stephen V.
  • Cormand, Bru
  • Lao Grueso, Oscar, 1976-
Attention-deficit/hyperactivity disorder (ADHD) is an impairing neurodevelopmental condition highly prevalent in current populations. Several hypotheses have been proposed to explain this paradox, mainly in the context of the Paleolithic versus Neolithic cultural shift but especially within the framework of the mismatch theory. This theory elaborates on how a particular trait once favoured in an ancient environment might become maladaptive upon environmental changes. However, given the lack of genomic data available for ADHD, these theories have not been empirically tested. We took advantage of the largest GWAS meta-analysis available for this disorder consisting of over 20,000 individuals diagnosed with ADHD and 35,000 controls, to assess the evolution of ADHD-associated alleles in European populations using archaic, ancient and modern human samples. We also included Approximate Bayesian computation coupled with deep learning analyses and singleton density scores to detect human adaptation. Our analyses indicate that ADHD-associated alleles are enriched in loss of function intolerant genes, supporting the role of selective pressures in this early-onset phenotype. Furthermore, we observed that the frequency of variants associated with ADHD has steadily decreased since Paleolithic times, particularly in Paleolithic European populations compared to samples from the Neolithic Fertile Crescent. We demonstrate this trend cannot be explained by African admixture nor Neanderthal introgression, since introgressed Neanderthal alleles are enriched in ADHD risk variants. All analyses performed support the presence of long-standing selective pressures acting against ADHD-associated alleles until recent times. Overall, our results are compatible with the mismatch theory for ADHD but suggest a much older time frame for the evolution of ADHD-associated alleles compared to previous hypotheses., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, the Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, the co-funding by the Spanish Ministry of Science and Innovation with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. O.L. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - RYC-2013-14797, BFU2015-68759-P and PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia) - GRC 2017 SGR 937, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302 and EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051. P.E.-C. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - FI_B1_00113. I.M. gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d'Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants) - GRC 2014 SGR 615. A.D.B. and D.D. were supported by the Lundbeck Foundation (grant numbers R102-A9118 and R155-2014-1724). S.V.F. was supported by the European Union’s Seventh Framework Programme for Research, Technological Development and Demonstration under grant agreement - 602805, the European Union’s Horizon 2020 Research and Innovation Programme under grant agreements 667302 & 728018 and NIMH grants 5R01MH101519 and U01 MH109536-01. B.C. gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) - SAF2015-68341-R and RTI2018-100968-B-100, Generalitat de Catalunya | Agaur (Government of Catalonia) - GRC 2017 SGR 738, EC | EU Horizon 2020 Research and Innovation Programme (Personalising Health and Care) - 667302, EC | EU Horizon 2020 Research and Innovation Programme (Marie Sklodowska-Curie Action: Innovative Training Networks, ITN) - 643051 and EC | EU Horizon 2020 Research and Innovation Proramme (Sustainable Food Security - Resilient and Resource - Efficient Value Chains) - 728018
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity

  • Baenas, Isabel
  • Miranda-Olivos, Romina
  • Granero, Roser
  • Solé Morata, Neus, 1988-
  • Sánchez, Isabel
  • Pastor, Antonio
  • Pino-Gutiérrez, Amparo del
  • Codina, Ester
  • Tinahones Madueño, Francisco José
  • Fernández-Formoso, José A.
  • Vilarrasa, Nuria
  • Guerrero-Pérez, Fernando
  • Lopez-Urdiales, Rafael
  • Virgili, Núria
  • Soriano-Mas, Carles
  • Jiménez Murcia, Susana
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
Background: Anandamide (AEA) and 2-arachidonoylglycerol (2-AG) play a pivotal role in stimulating motivational behavior toward food and energy metabolism. Aberrant functioning of the endocannabinoid system has been observed in extreme weight conditions (EWCs), suggesting it may influence pathophysiology. Then, we aimed to analyze fasting AEA and 2-AG plasma concentrations among individuals with EWC (i.e., anorexia nervosa [AN] and obesity with and without eating disorders [EDs]) compared with healthy controls (HCs), and its association with clinical variables and body mass index (BMI). Methods: The sample included 113 adult women. Fifty-seven belonged to the obesity group, 37 without EDs (OB-ED) and 20 with ED (OB+ED classified within the binge spectrum disorders), 27 individuals from the AN group, and 29 from the HC group. Peripheral blood samples, several clinical variables, and BMI were evaluated. Results: Unlike 2-AG, AEA concentrations showed significant differences between groups (p < 0.001). Increased AEA was observed in the OB-ED and OB+ED compared with both HC and AN group, respectively. Likewise, AEA was differentially associated with emotional dysregulation, general psychopathology, food addiction, and BMI in all clinical groups. Conclusions: These results support the interaction between biological and clinical factors contributing to delineating vulnerability pathways in EWC that could help fit personalized therapeutic approaches., We thank CERCA Programme / Generalitat de Cataluny a for institutional support. This manuscript and research were supported by grants from the Delegación del Gobierno para el Plan Nacional sobre Drogas (2021I031), Ministerio de Ciencia e Innovación (PDI2021-124887OB-I00), Instituto de Salud Carlos III (ISCIII) (FIS PI20/00132) and cofounded by FEDER funds/European Regional Development Fund (ERDF), a way to build Europe. CIBER Obn, CIBERSAM, and CIBERDEM are initiatives of ISCIII. Additional funding was received by AGAUR- Generalitat de Catalunya (2021-SGR-00824 and 2021 SGR 00253) and European Union’s Horizon 2020 research and innovation program under Grant agreement no. 728018 (H2020-SFS-2016-2, Eat2beNice), no. 847879 (PRIME/H2020, Prevention and Remediation of Insulin Multi morbidity in Europe) and no. 101080219 (eprObes). This study has also been funded by Instituto de Salud Carlos III through the grant CM21/00172 (IB) (Co-funded by European Social Fund. ESF investing in your future). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021-Programme). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metformin use and cognitive function in older adults with type 2 diabetes following a mediterranean diet intervention

  • Soldevila-Domenech, Natalia
  • Cuenca Royo, Aida Ma, 1981-
  • Babio, Nancy
  • Forcano, Laura
  • Nishi, Stephanie
  • Vintró Alcaraz, Cristina
  • Gómez Martínez, Carlos
  • Jiménez Murcia, Susana
  • Fernández-Carrión, Rebeca
  • Gomis González, Maria, 1988-
  • Alvarez-Sala, Andrea
  • Carlos, Silvia
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Díez Espino, Javier
  • Castañer, Olga
  • Fernández Aranda, Fernando
  • Salas Salvadó, Jordi
  • Torre Fornell, Rafael de la
Background and Purpose: Both adherence to the Mediterranean diet (MedDiet) and the use of metformin could benefit the cognitive performance of individuals with type 2 diabetes, but evidence is still controversial. We examined the association between metformin use and cognition in older adults with type 2 diabetes following a MedDiet intervention. Methods: Prospective cohort study framed in the PREDIMED-Plus-Cognition sub-study. The PREDIMED-Plus clinical trial aims to compare the cardiovascular effect of two MedDiet interventions, with and without energy restriction, in individuals with overweight/obesity and metabolic syndrome. The present sub-study included 487 cognitively normal subjects (50.5% women, mean ± SD age of 65.2 ± 4.7 years), 30.4% of them (N = 148) with type 2 diabetes. A comprehensive battery of neurocognitive tests was administered at baseline and after 1 and 3 years. Individuals with type 2 diabetes that exhibited a good glycemic control trajectory, either using or not using metformin, were compared to one another and to individuals without diabetes using mixed-effects models with inverse probability of treatment weights. Results: Most subjects with type 2 diabetes (83.1%) presented a good and stable glycemic control trajectory. Before engaging in the MedDiet intervention, subjects using metformin scored higher in executive functions (Cohen's d = 0.51), memory (Cohen's d = 0.38) and global cognition (Cohen's d = 0.48) than those not using metformin. However, these differences were not sustained during the 3 years of follow-up, as individuals not using metformin experienced greater improvements in memory (β = 0.38 vs. β = 0.10, P = 0.036), executive functions (β = 0.36 vs. β = 0.02, P = 0.005) and global cognition (β = 0.29 vs. β = -0.02, P = 0.001) that combined with a higher MedDiet adherence (12.6 vs. 11.5 points, P = 0.031). Finally, subjects without diabetes presented greater improvements in memory than subjects with diabetes irrespective of their exposure to metformin (β = 0.55 vs. β = 0.10, P < 0.001). However, subjects with diabetes not using metformin, compared to subjects without diabetes, presented greater improvements in executive functions (β = 0.33 vs. β = 0.08, P = 0.032) and displayed a higher MedDiet adherence (12.6 points vs. 11.6 points, P = 0.046). Conclusions: Although both metformin and MedDiet interventions are good candidates for future cognitive decline preventive studies, a higher adherence to the MedDiet could even outweigh the potential neuroprotective effects of metformin in subjects with diabetes., Study resulting from the following grants: SLT006/17/00246, SLT002/16/00045 and SLT006/17/00077 funded by the Department of Health of the Generalitat de Catalunya by the calls Acció instrumental de programes de recerca orientats en l'àmbit de la recerca i la innovació en salut and Pla estratègic de recerca i innovació en salut (PERIS). We thank CERCA Programme/Generalitat de Catalunya for institutional support. This project was funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research-with competitive grants leaded by JS-S and Josep Vidal for the periods 2014–2016, 2015–2017, 2017–2019, and 2018–2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, ERDF, a way to build Europe) [grants: PI13/00233, PI13/00728, PI13/01123, PI13/00462, PI16/00533, PI16/00366, PI16/01094, PI16/00501, PI17/01167, PI19/00017, PI19/00781, PI19/01032, PI19/00576]; the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council [Advanced Research Grant 2014–2019; agreement #340918] granted to Miguel Ángel Martínez-González; the Recercaixa (number 2013ACUP00194) grant to JS-S. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2; Ref 728018; and PRIME/H2020-SC1-BHC-2018-2020; Ref: 847879), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. This work is also partially supported by ICREA under the ICREA Academia programme. This work was supported by grants from DIUE de la Generalitat de Catalunya 2017 SGR 138 from the Departament d'Economia i Coneixement de la Generalitat de Catalunya (Spain). NS-D has received the FI 2021 predoctoral grant (FI_B2021/00104) from the Agency for Management of University and Research Grants (AGAUR) of the Generalitat de Catalunya. CV-A was supported by a predoctoral Grant of the Ministerio de Educación, Cultura y Deporte (FPU16/01453). AA-S has received a post-doctoral grant from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Valencia (APOSTD/2020/003). The Physiopathology of Obesity and Nutrition Networking Biomedical Research Center (CIBEROBN) is an initiative of ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

  • Mallorquí-Bagué, Nuria
  • Cuenca Royo, Aida Ma, 1981-
  • Castañer, Olga
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabetes with executive function (EF); (b) the effect of BMI on both type 2 diabetes and EF; (c) the association between glycaemia control and EF in type 2 diabetes. 6823 older individuals with overweight/obesity and metabolic syndrome participating in the PREDIMED-PLUS study, were assessed with a battery of cognitive tests and a medical interview. ANOVA showed a significantly worse performance on EF in type 2 diabetes vs. non-diabetic individuals. Two complementary models were displayed: (1) in the whole sample, the presence of type 2 diabetes, depressive symptoms and BMI had a direct negative effect on EF, while apnoea had an indirect negative effect; (2) in the diabetes subsample, higher illness duration was associated with worse performance in EF. Participants with type 2 diabetes and HbA1c<53 mmol/mol displayed better cognitive performance when compared to those with HbA1c≥53 mmol/mol. Our results provide a controlled comprehensive model that integrates relevant neuropsychological and physical variables in type 2 diabetes. The model suggests that, to improve treatment adherence and quality of life once diabetes has been diagnosed, cognitive decline prevention strategies need to be implemented while monitoring depressive symptoms, BMI and glycaemia control., This project is funded by Instituto de Salud Carlos III (ISCIII), the Spanish Government Official Agency for funding biomedical research - with competitive grants for the periods 2014–2016, 2015–2017, 2017–2019 and 2018–2020, through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund [grants: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728 PI13/01090 PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926] and the European Research Council [Advanced Research Grant 2014–2019; agreement #340918]. Additional grants: Acciones Especiales from ISCIIII, Consejería-Salud, Junta -Andalucía [PI0458/2013, PS0358/2016], Recercaixa-grant 2013 [2013ACUP00194], a SEMERGEN grant, International Nut & Dried Fruit Council – FESNAD No. 201302. Fundación Patrimonio Comunal Olivarero is providing the necessary amounts of olive oil. Nuts were initially and only partially provided by Pistachios Growers and Almond Board of California, for the pilot study. This research was also partially funded by EU-H2020 Grant (Eat2beNICE/H2020-SFS-2016–2; Ref 728018), PI14/00290 y PI17/1167(Co-funded by European Regional Development Fund, ERDF, a way to build Europe), PERIS (Generalitat de Catalunya, SLT006/17/00077), Grant PROMETEO/2017/017 (Generalitat Valenciana) and Grant FEA/SEA 2017 for Primary Care Research. We thank CERCA Programme/Generalitat de Catalunya for institutional support. ML-M is supported by a predoctoral Grant of the Ministerio de Educación, Cultura y Deporte (FPU15/02911). None of these funding sources plays any role in the design, collection, analysis, or interpretation of the data or in the decision to submit manuscripts for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differential expression of miR-1249-3p and miR-34b-5p between vulnerable and resilient phenotypes of cocaine addiction

  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Cormand, Bru
  • Martín García, Elena, 1975-
  • Maldonado, Rafael, 1961-
Cocaine addiction is a complex brain disorder involving long-term alterations that lead to loss of control over drug seeking. The transition from recreational use to pathological consumption is different in each individual, depending on the interaction between environmental and genetic factors. Epigenetic mechanisms are ideal candidates to study psychiatric disorders triggered by these interactions, maintaining persistent malfunctions in specific brain regions. Here we aim to study brain-region-specific epigenetic signatures following exposure to cocaine in a mouse model of addiction to this drug. Extreme subpopulations of vulnerable and resilient phenotypes were selected to identify miRNA signatures for differential vulnerability to cocaine addiction. We used an operant model of intravenous cocaine self-administration to evaluate addictive-like behaviour in rodents based on the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition criteria to diagnose substance use disorders. After cocaine self-administration, we performed miRNA profiling to compare two extreme subpopulations of mice classified as resilient and vulnerable to cocaine addiction. We found that mmu-miR-34b-5p was downregulated in the nucleus accumbens of vulnerable mice with high motivation for cocaine. On the other hand, mmu-miR-1249-3p was downregulated on vulnerable mice with high levels of motor disinhibition. The elucidation of the epigenetic profile related to vulnerability to cocaine addiction is expected to help find novel biomarkers that could facilitate the interventions to battle this devastating disorder., This work was supported by the Spanish “Ministerio de Economía y Competitividad-MINECO” (#SAF2017-84060-R-AEI/FEDER-UE), the Spanish “Instituto de Salud Carlos III, RETICS-RTA” (#RD12/0028/0023), the “Generalitat de Catalunya, AGAUR” (#2017 SGR-669), “ICREA-Acadèmia” (#2015) and the Spanish “Ministerio de Sanidad, Servicios Sociales e Igualdad”, “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I068) to RM; “Fundació La Marató-TV3” (#2016/20-30), “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2019I006) and NEURON-ERA-NET: MCIN/AEI/UE - PCI2021-122073-2A to E.M-G.; Spanish “Ministerio de Ciencia, Innovación y Universidades” (#RTI2018–100968-B-100), Spanish “Ministerio de Ciencia e Innovación (#PID2021-1277760B-100), “AGAUR-Generalitat de Catalunya” (#2017-SGR-738), “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2017I050) and ICREA Acadèmia 2021 to BC and “Plan Nacional Sobre Drogas of the Spanish Ministry of Health” (#PNSD-2020I042) to N.F-C. The research leading to these results was also supported by the European Union H2020 Program [H2020/2014–2020] under grant agreements no 667302 (CoCA) and 728018 (Eat2beNICE) and by the “ECNP network on ADHD across the lifespan” to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and NF-C by “Centro de Investigación Biomédica en Red de Enfermedades Raras” (CIBERER).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Contribution of cardio-vascular risk factors to depressive status in the PREDIMED-PLUS Trial. A cross-sectional and a 2-year longitudinal study

  • Martín-Peláez, Sandra
  • Lassale, Camille
  • Malcampo, Mireia
  • Val, José Luis del
  • Chillarón Jordan, Juan José
  • Sánchez Villegas, Almudena
Background: Cardio-vascular disease and depression are thought to be closely related, due to shared risk factors. The aim of the study was to determine the association between cardio-vascular risk (CVR) factors and depressive status in a population (55-75 years) with metabolic syndrome (MetS) from the PREDIMED-Plus trial. Methods and findings: Participants were classified into three groups of CVR according to the Framingham-based REGICOR function: (1) low (LR), (2) medium (MR) or (3) high/very high (HR). The Beck Depression Inventory-II (BDI-II) was used to assess depressive symptoms at baseline and after 2 years. The association between CVR and depressive status at baseline (n = 6545), and their changes after 2 years (n = 4566) were evaluated through multivariable regression models (logistic and linear models). HR women showed higher odds of depressive status than LR [OR (95% CI) = 1.78 (1.26, 2.50)]. MR and HR participants with total cholesterol <160 mg/mL showed higher odds of depression than LR [OR (95% CI) = 1.77 (1.13, 2.77) and 2.83 (1.25, 6.42) respectively)] but those with total cholesterol ≥280 mg/mL showed lower odds of depression than LR [OR (95% CI) = 0.26 (0.07, 0.98) and 0.23 (0.05, 0.95), respectively]. All participants decreased their BDI-II score after 2 years, being the decrease smaller in MR and HR diabetic compared to LR [adjusted mean±SE = -0.52±0.20, -0.41±0.27 and -1.25±0.31 respectively). MR and HR participants with total cholesterol between 240-279 mg/mL showed greater decreases in the BDI-II score compared to LR (adjusted mean±SE = -0.83±0.37, -0.77±0.64 and 0.97±0.52 respectively). Conclusions: Improving cardiovascular health could prevent the onset of depression in the elderly. Diabetes and total cholesterol in individuals at high CVR, may play a specific role in the precise response. International Standard Randomized Controlled Trial (ISRCTN89898870)., This research was also partially funded by: Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); Generalitat Valenciana (PROMETEO/2017/017); SEMERGEN, CIBEROBN, FEDER and ISCIII (CB06/03); EU-H2020 Grants (Eat2beNICE/h2020-sfs-2016-2, ref.728018; PRIME/h2020-SC1-BHC-2018-2020, ref: 847879). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the funding sources took part in the design, collection, analysis or interpretation of the data or in the decision to submit the manuscript for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differences in total and differential white blood cell counts and in inflammatory parameters between psychiatric inpatients with and without recent consumption of cannabinoids, opioids, or cocaine: A retrospective single-center study

  • Llorca-Bofí, Vicent
  • Mur, Maria
  • Font Font, Maria
  • Palacios Garrán, Roberto
  • Sellart, Maite
  • del Agua, Enrique
  • Arteaga-Henriquez, Gara
Cannabinoids; Inflammation; Neutrophils, Cannabinoides; Inflamació; Neutròfils, Cannabinoides; Inflamación; Neutrófilos, Several drugs of abuse may exert their action by modulating the immune system. Despite this, individuals using substances of abuse are often excluded from immunopsychiatry studies. We conducted a retrospective, single-center study to examine differences in circulating immune/inflammatory parameters (i.e., total and differential white blood cell (WBC) counts, neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte (MLR) ratio, platelet-to-lymphocyte ratio, and C-reactive protein) between psychiatric inpatients with a positive urine test to cannabinoids, opioids, or cocaine, and those with negative toxicology. A total of 927 inpatients were included. Patients with positive toxicology (n = 208) had significantly higher WBC counts (P < 0.001, η2p = 0.02), as well as increased neutrophils (P = 0.002, η2p = 0.01), monocytes (P < 0.001, η2p = 0.02), lymphocytes (P < 0.001, η2p = 0.02), and eosinophils (P = 0.01, η2p = 0.01) compared to those with negative toxicology (n = 719). The increase in neutrophil counts was particularly evident in patients who tested positive for cannabinoids (n = 168; P < 0.001, η2p = 0.02). In contrast, eosinophil counts were particularly increased in the cocaine-positive subgroup (n = 27; P = 0.004, η2p = 0.01). Patients with a positive urine test to opioids (n = 13) were characterized by a significantly lower MLR (P = 0.03, η2p = 0.005). The type of psychiatric diagnosis moderated the differences in neutrophil counts between patients with a positive and negative toxicology to cannabinoids. Notably, significantly higher neutrophil counts were found only in patients diagnosed with a psychotic disorder (P < 0.001, η2p = 0.03). Taken together, our findings suggest that drugs of abuse may differently impact the immune/inflammatory response system in individuals diagnosed with psychiatric conditions. Specifically, recent cannabinoids use may be associated with an acute activation of the inflammatory response system, particularly in individuals with a psychotic disorder, while cocaine and opioid use may be associated with eosinophilia and a decrease in the MLR, respectively, regardless of the primary psychiatric diagnosis., GA-H was supported by the European Commission, and funded by the European's Union Horizon 2020 research and innovation program under grant agreement numbers 728018 and 754740.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Water intake, hydration status and 2-year changes in cognitive performance: a prospective cohort study

  • Nishi, Stephanie
  • Fitó Colomer, Montserrat
  • Castañer, Olga
  • Salas Salvadó, Jordi
Background Water intake and hydration status have been suggested to impact cognition; however, longitudinal evidence is limited and often inconsistent. This study aimed to longitudinally assess the association between hydration status and water intake based on current recommendations, with changes in cognition in an older Spanish population at high cardiovascular disease risk. Methods A prospective analysis was conducted of a cohort of 1957 adults (aged 55–75) with overweight/obesity (BMI between ≥ 27 and < 40 kg/m2) and metabolic syndrome from the PREDIMED-Plus study. Participants had completed bloodwork and validated, semiquantitative beverage and food frequency questionnaires at baseline, as well as an extensive neuropsychological battery of 8 validated tests at baseline and 2 years of follow-up. Hydration status was determined by serum osmolarity calculation and categorized as < 295 mmol/L (hydrated), 295–299.9 mmol/L (impending dehydration), and ≥ 300 mmol/L (dehydrated). Water intake was assessed as total drinking water intake and total water intake from food and beverages and according to EFSA recommendations. Global cognitive function was determined as a composite z-score summarizing individual participant results from all neuropsychological tests. Multivariable linear regression models were fitted to assess the associations between baseline hydration status and fluid intake, continuously and categorically, with 2-year changes in cognitive performance. Results The mean baseline daily total water intake was 2871 ± 676 mL/day (2889 ± 677 mL/day in men; 2854 ± 674 mL/day in women), and 80.2% of participants met the ESFA reference values for an adequate intake. Serum osmolarity (mean 298 ± 24 mmol/L, range 263 to 347 mmol/L) indicated that 56% of participants were physiologically dehydrated. Lower physiological hydration status (i.e., greater serum osmolarity) was associated with a greater decline in global cognitive function z-score over a 2-year period (β: − 0.010; 95% CI − 0.017 to − 0.004, p-value = 0.002). No significant associations were observed between water intake from beverages and/or foods with 2-year changes in global cognitive function. Conclusions Reduced physiological hydration status was associated with greater reductions in global cognitive function over a 2-year period in older adults with metabolic syndrome and overweight or obesity. Future research assessing the impact of hydration on cognitive performance over a longer duration is needed. Trial registration International Standard Randomized Controlled Trial Registry, ISRCTN89898870. Retrospectively registered on 24 July 2014, This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the European Research Council (Advanced Research Grant 2014–2019; agreement #340918) granted to MÁM-G.; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO 17/2017 and PROMETEO 21/2021 grant from the Generalitat Valenciana; the SEMERGEN grant; and the Juan de la Cierva-Incorporación research grant (IJC2019-042420-I) of the Spanish Ministry of Economy, Industry and Competitiveness and European Social Funds. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2) and the Horizon 2020 PRIME study (Prevention and Remediation of Insulin Multimorbidity in Europe; grant agreement #847879). S.K.N. is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). CG-M is supported by a predoctoral grant from the University of Rovira I Virgili (2020PMF-PIPF-37). IP-G is supported by a predoctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 17/01925). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Ciencia y Sociedad Digital, Generalitat Valenciana, Fondo Social Europeo-FSE. CB is supported by a Juan de la Cierva postdoctoral grant from Ministerio de Ciencia, Innovación y Universidades. JS-S, the senior author of this paper, was partially supported by ICREA under the ICREA Academia program. Publication of this work is supported by a conference award grant from Hydration for Health presented by the Danone Global Research & Innovation Center (#2022-08514) awarded to S.K.N. for being the conference attendee voted recipient of the Early Career Researcher Award. None of the funding sources took part in the design, collection, analysis, interpretation of the data; writing of the report; or the decision to submit the manuscript for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Faecal microbiota composition and impulsivity in a cohort of older adults with metabolic syndrome

  • Konstanti, Prokopis
  • Gómez Martínez, Carlos
  • Muralidharan, Jananee
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Tinahones Madueño, Francisco José
  • Torres-Collado, Laura
  • Coltell, Oscar
  • Castañer, Olga
  • Moreno-Indias, Isabel
  • Atzeni, Alessandro
  • Ruiz-Canela, Miguel
  • Salas Salvadó, Jordi
  • Belzer, Clara
Impulsivity is an important determinant of human behaviour, affecting self-control, reasonable thinking and food choices. Recent evidence suggests a role for gut microbiota in human behaviour, but the relationship between gut microbiota and impulsive behaviours remains largely unexplored. To address this knowledge gap, the present study aims to explore the associations between faecal microbiota composition with trait and behavioural impulsivity, in a subcohort of the PREDIMED-Plus trial, including older adults presenting overweight/obesity. Fecal samples (n = 231) were profiled for their microbiota composition using 16 S rRNA amplicon sequencing and impulsivity was determined through four different assessments. Adherence to different dietary patterns was estimated through questionnaires. Beta diversity analyses showed a significant association with the Conner's Performance Test (CPT) in multivariate-adjusted models, and, in total, 13 bacterial genera associated with CPT. Erysipelotrichaceae UCG 003 showed the highest association with CPT and known butyrate producers such as Butyricicoccus spp., Roseburia spp., and Eubacterium hallii were among the identified bacteria. The bacteria Lachnospiraceae UCG 001, Anaerostipes and Blautia were associated with CPT and also the adherence to healthy and unhealthy plant-based diets. In addition, functional analysis showed a significant negative association between the CPT and the glucuronate and galacturonate metabolic pathways. From the other impulsivity assessments, two more associations were identified, for the genus Phascolarctobacterium with the Stroop test, and the genus Lachnospiraceae GAG 54 with the positive urgency subscore of UPPS-P Impulsive Behaviour Scale. Overall, our findings suggest potential links between the faecal microbiota composition and function with behavioural impulsive inattention as determined by the CPT., This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2, Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020, Ref: 847879) and by the Generalitat Valenciana: Grant PROMETEO 21/2021. Carlos Gómez-Martínez receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); Dr. Salas-Salvadó gratefully acknowledges the financial support by ICREA under the ICREA Academia program.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study

  • Mallorquí-Bagué, Núria
  • Lozano Madrid, María
  • Toledo Atucha, Estefanía
  • Corella Piquer, Dolores
  • Salas Salvadó, Jordi
  • Cuenca Royo, Aida
  • Vioque, Jesús
  • Romaguera, Dora
  • Martínez, J. Alfredo, 1957-
  • Wärnberg, Julia
  • López Miranda, José
  • Estruch Riba, Ramon
  • Bueno Cavanillas, Aurora
  • Alonso Gómez, Ángel M.
  • Tur Marí, Josep A. (Josep Antoni)
  • Tinahones, Francisco J.
  • Serra Majem, Lluís
  • Martín Sánchez, Vicente
  • Lapetra, José
  • Vázquez, Clotilde
  • Pintó Sala, Xavier
  • Vidal i Cortada, Josep
  • Daimiel, Lidia
  • Gaforio, José J.
  • Matía Martín, Pilar
  • Ros Rahola, Emilio
  • Granero, Roser
  • Buil Cosiales, Pilar
  • Barragán, Rocío
  • Bulló, Mònica
  • Castañer, Olga
  • García de la Hera, Manuela
  • Yáñez, Aina M.
  • Abete, Itziar
  • García Ríos, Antonio
  • Ruiz Canela, Miguel
  • Díaz López, Andrés
  • Jiménez-Murcia, Susana
  • Martínez-González, Miguel Ángel, 1957-
  • Torre Fornell, Rafael de la
  • Fernández Aranda, Fernando
This study cross-sectionally examines in the elderly population: (a) the association of type 2 diabetes with executive function (EF); (b) the effect of BMI on both type 2 diabetes and EF; (c) the association between glycaemia control and EF in type 2 diabetes. 6823 older individuals with overweight/obesity and metabolic syndrome participating in the PREDIMED-PLUS study, were assessed with a battery of cognitive tests and a medical interview. ANOVA showed a significantly worse performance on EF in type 2 diabetes vs. non-diabetic individuals. Two complementary models were displayed: (1) in the whole sample, the presence of type 2 diabetes, depressive symptoms and BMI had a direct negative effect on EF, while apnoea had an indirect negative effect; (2) in the diabetes subsample, higher illness duration was associated with worse performance in EF. Participants with type 2 diabetes and HbA1c<53 mmol/mol displayed better cognitive performance when compared to those with HbA1c≥53 mmol/mol. Our results provide a controlled comprehensive model that integrates relevant neuropsychological and physical variables in type 2 diabetes. The model suggests that, to improve treatment adherence and quality of life once diabetes has been diagnosed, cognitive decline prevention strategies need to be implemented while monitoring depressive symptoms, BMI and glycaemia control.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Shared genetic background between children and adults with attention deficit/hyperactivity disorder

  • Rovira, Paula
  • Demontis, Ditte
  • Sánchez Mora, Cristina
  • Zayats, Tetyana
  • Klein, Marieke
  • Roth Mota, Nina
  • Weber, Heike
  • Garcia-Martínez, Iris
  • Pagerols Teixidó, Mireia
  • Vilar, Laura
  • Arribas, Lorena
  • Richarte, Vanesa
  • Corrales, Montserrat
  • Fadeuilhe, Christian
  • Bosch, Rosa
  • Español, Gemma
  • Grevet, Eugenio Horacio
  • Halmøy, Anne
  • Hutz, Mara
  • Knappskog, Per M.
  • Lundervold, Aastri J.
  • Rovaris, Diego Luiz
  • Santos da Silva, Bruna
  • Sprooten, Emma
  • ADHD Working Group of the Psychiatric Genomics Consortium
  • Arias Vasquez, Alejandro
  • Sonuga-Barke, Edmund
  • Asherson, Philip
  • Bau, Claiton Henrique Dotto
  • Buitelaar, Jan K.
  • Cormand Rifà, Bru
  • Faraone, Stephen V.
  • Haavik, Jan
  • Johansson, Stefan E.
  • Kuntsi, Jonna
  • Larsson, Henrik
  • Lesch, Klaus-Peter
  • Reif, Andreas
Attention deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by age-inappropriate symptoms of inattention, impulsivity, and hyperactivity that persist into adulthood in the majority of the diagnosed children. Despite several risk factors during childhood predicting the persistence of ADHD symptoms into adulthood, the genetic architecture underlying the trajectory of ADHD over time is still unclear. We set out to study the contribution of common genetic variants to the risk for ADHD across the lifespan by conducting meta-analyses of genome-wide association studies on persistent ADHD in adults and ADHD in childhood separately and jointly, and by comparing the genetic background between them in a total sample of 17,149 cases and 32,411 controls. Our results show nine new independent loci and support a shared contribution of common genetic variants to ADHD in children and adults. No subgroup heterogeneity was observed among children, while this group consists of future remitting and persistent individuals. We report similar patterns of genetic correlation of ADHD with other ADHD-related datasets and different traits and disorders among adults, children, and when combining both groups. These findings confirm that persistent ADHD in adults is a neurodevelopmental disorder and extend the existing hypothesis of a shared genetic architecture underlying ADHD and different traits to a lifespan perspective.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

  • Koller, Dora
  • Mitjans, Marina
  • Kouakou, Manuela
  • Friligkou, Eleni
  • Cabrera-Mendoza, Brenda
  • Deak, Joseph
  • Soler Artigas, María
  • Llonga, Natalia
  • Ribases, Marta
  • Ramos-Quiroga, Josep Antoni
Attention-deficit hyperactivity disorder; Pleiotropy; Substance use disorders, Trastorn per dèficit d'atenció amb hiperactivitat; Pleiotropia; Trastorns per consum de substàncies, Trastorno por déficit de atención con hiperactividad; Pleiotropía; Trastornos por consumo de sustancias, We characterized the genetic architecture of the attention-deficit hyperactivity disorder-substance use disorder (ADHD-SUD) relationship by investigating genetic correlation, causality, pleiotropy, and common polygenic risk. Summary statistics from genome-wide association studies (GWAS) were used to investigate ADHD (Neff = 51,568), cannabis use disorder (CanUD, Neff = 161,053), opioid use disorder (OUD, Neff = 57,120), problematic alcohol use (PAU, Neff = 502,272), and problematic tobacco use (PTU, Neff = 97,836). ADHD, CanUD, and OUD GWAS meta-analyses included cohorts with case definitions based on different diagnostic criteria. PAU GWAS combined information related to alcohol use disorder, alcohol dependence, and the items related to alcohol problematic consequences assessed by the alcohol use disorders identification test. PTU GWAS was generated a multi-trait analysis including information regarding Fagerström Test for Nicotine Dependence and cigarettes per day. Linkage disequilibrium score regression analyses indicated positive genetic correlation with CanUD, OUD, PAU, and PTU. Genomic structural equation modeling showed that these genetic correlations were related to two latent factors: one including ADHD, CanUD, and PTU and the other with OUD and PAU. The evidence of a causal effect of PAU and PTU on ADHD was stronger than the reverse in the two-sample Mendelian randomization analysis. Conversely, similar strength of evidence was found between ADHD and CanUD. CADM2 rs62250713 was a pleiotropic SNP between ADHD and all SUDs. We found seven, one, and twenty-eight pleiotropic variants between ADHD and CanUD, PAU, and PTU, respectively. Finally, OUD, CanUD, and PAU PRS were associated with increased odds of ADHD. Our findings demonstrated the contribution of multiple pleiotropic mechanisms to the comorbidity between ADHD and SUDs., The authors acknowledge support from the Horizon 2020 Marie Sklodowska-Curie Individual Fellowship from the European Commission (101028810), the National Institutes of Health (R33 DA047527, R21 DC018098, RF1 MH132337, K99 AG078503, T32 MH014276, T32 AA02825, K01 DA051759), Veterans Affairs Office of Research & Development (5IK2BX005058 and CX001849-01), Alzheimer's Association Research Fellowship (AARF-22-967171), American Foundation for Suicide Prevention (PDF-1-022-21), the Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR, 2021-SGR-01093), grants RYC-2017-21636 and RYC2021-033573-I funded by MCIN/AEI/10.13039/501100011033 and by the European Union “NextGenerationEU”/PRTR” Ramón y Cajal contract (RYC-2017-21636) and One Mind. BC received financial support from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (PID2021-1277760B-I100), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093), ICREA Academia 2021, ‘Fundació La Marató de TV3’ (202218-31), and the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA), 728018 (Eat2beNICE), and 841899 (GRASAD). We thank the participants and the investigators involved in the UK Biobank, Million Veteran Program, and the Psychiatric Genomics Consortium for making their data publicly available. This publication does not represent the views of the Department of Veterans Affairs or the United States Government.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis

  • Gómez Pérez, Ana María
  • Ruiz Limón, Patricia
  • Salas Salvadó, Jordi
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Atzeni, Alessandro
  • Torres-Collado, Laura
  • Álvarez-Sala, Andrea
  • Martínez, María Ángeles
  • Goday Arnó, Albert
  • Benaiges Foix, David
  • García-Gavilán, Jesús Francisco
  • Bernal López, María Rosa
  • Moreno-Indias, Isabel
  • Tinahones Madueño, Francisco José
To evaluate the changes in the gut microbiota associated with changes in the biochemical markers of nonalcoholic fatty liver disease (NAFLD) after a lifestyle intervention with the Mediterranean diet. Participants (n = 297) from two centers of PREDIMED-Plus trial (Prevención con Dieta Mediterránea) were divided into three different groups based on the change tertile in the Hepatic Steatosis Index (HSI) or the Fibrosis-4 score (FIB-4) between baseline and one year of intervention. One-year changes in HSI were: tertile 1 (T1) (-24.9 to -7.51), T2 (-7.5 to -1.86), T3 (-1.85 to 13.64). The most significant differences in gut microbiota within the year of intervention were observed in the T1 and T3. According to the FIB-4, participants were categorized in non-suspected fibrosis (NSF) and with indeterminate or suspected fibrosis (SF). NSF participants showed higher abundances of Alcaligenaceae, Bacteroidaceae, Bifidobacteriaceae, Clostridiaceae, Enterobacteriaceae, Peptostreptococcaceae, Verrucomicrobiaceae compared to those with SF. Then, participants were divided depending on the FIB-4 tertile of change: T1 (-89.60 to -5.57), T2 (-5.56 to 11.4), and T3 (11.41 to 206.24). FIB-4 T1 showed a decrease in Akkermansia and an increase in Desulfovibrio. T2 had an increase in Victivallaceae, Clostridiaceae, and Desulfovibrio. T3 showed a decrease in Enterobacteriaceae, and an increase in Sutterella, Faecalibacterium, and Blautia. A relation between biochemical index changes of NAFLD/NASH (HSI and FIB-4) and gut microbiota changes were found. These observations highlight the importance of lifestyle intervention in the modulation of gut microbiota and the management of metabolic syndrome and its hepatic manifestations., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (three coordinated FIS projects lead by JS-S: PI13/00462, PI16/00501 and PI19/00576; two led by JV: PI17/01441, PI14/01206; three led by AG: PI13/00233, PI16/00533, PI19/00017; and two led by MRBL: PI14/00696 and PI17/00855); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant (OBN16PE01) to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S. DC obtained grant from the Generalitat Valenciana (PROMETEO 2017/17 and PROMETEO 2021/21) and Grant from the Ministry of Science and Innovation/ISCIII (reference: PI19/00781). Eat2beNICE project (European Union’s Horizon 2020 research and innovation programme under grant agreement No 728018). PRL was supported by a “Sara Borrell” postdoctoral contract (CD19/00216) from the ISCIII-Madrid (Spain), co-financed by the Fondo Europeo de Desarrollo Regional-FEDER. IMI was supported by the “Miguel Servet Type II” program (CPII21/00013) of the ISCIII-Madrid (Spain), co-financed by the FEDER. AMGP was supported by a research contract from Servicio Andaluz de Salud (B-0033–2014). AA-S has received a post-doctoral grant (APOSTD/2020/164) from the Consellería de Innovación, Generalitat Valenciana. MRBL is supported by Miguel Servet II program (CPII/00014) from ISCIII and by Nicolás Monardes program (C1-0005-2020) from Servicio Andaluz de Salud, both cofunded by FEDER funds. This work is partially supported by ICREA under the ICREA Academia programme. Food companies Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) donated extra virgin olive oil; and the Almond Board of California (Modesto, CA, USA), American Pistachio Growers (Fresno, CA, USA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA, USA) donated nuts for the PREDIMED-Pilot study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Characterisation of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Vicente García, Cristina
  • Mirra, Serena
  • Burguera Hernández, Demian
  • Fernàndez Castillo, Noèlia
  • Ferrán, José Luis
  • López Mayorga, Macarena
  • Alaiz Noya, Marta
  • Suárez Pereira, Irene
  • Antón Galindo, Ester
  • Ulloa Darquea, Fausto Alexander
  • Herrera Úbeda, Carlos
  • Cuscó, Pol
  • Falcón Moya, Rafael
  • Rodríguez Moreno, Antonio
  • D'Aniello, Salvatore
  • Cormand Rifà, Bru
  • Marfany i Nadal, Gemma
  • Soriano García, Eduardo
  • Carrión, Ángel M.
  • Carvajal, Jaime J.
  • Garcia Fernández, Jordi
Background One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Reduced cue-induced reinstatement of cocaine-seeking behavior in Plcb1 +/- mice

  • Cabana-Domínguez, Judit
  • Martín García, Elena, 1975-
  • Gallego-Roman, Ana
  • Maldonado, Rafael, 1961-
  • Fernández-Castillo, Noèlia
  • Comand, Bru
Cocaine addiction causes serious health problems, and no effective treatment is available yet. We previously identified a genetic risk variant for cocaine addiction in the PLCB1 gene and found this gene upregulated in postmortem brains of cocaine abusers and in human dopaminergic neuron-like cells after an acute cocaine exposure. Here, we functionally tested the contribution of the PLCB1 gene to cocaine addictive properties using Plcb1+/- mice. First, we performed a general phenotypic characterization and found that Plcb1+/- mice showed normal behavior, although they had increased anxiety and impaired short-term memory. Subsequently, mice were trained for operant conditioning, self-administered cocaine for 10 days, and were tested for cocaine motivation. After extinction, we found a reduction in the cue-induced reinstatement of cocaine-seeking behavior in Plcb1+/- mice. After reinstatement, we identified transcriptomic alterations in the medial prefrontal cortex of Plcb1+/- mice, mostly related to pathways relevant to addiction like the dopaminergic synapse and long-term potentiation. To conclude, we found that heterozygous deletion of the Plcb1 gene decreases cue-induced reinstatement of cocaine-seeking, pointing at PLCB1 as a possible therapeutic target for preventing relapse and treating cocaine addiction., This work was supported by the Spanish ‘Ministerio de Economía y Competitividad-MINECO’ (#SAF2017-84060-RAEI/FEDER-UE), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I068) to RM, ‘Fundació La Marató-TV3’ (#2016/20-30) and ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006) to EMG, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100), Spanish ‘Ministerio de Economía y Competitividad’ (#SAF2015-68341-R), ‘AGAURGeneralitat de Catalunya’ (#2017-SGR-738) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (#PNSD-2017I050) to BC and (#PNSD-2020I042) to NFC. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE). JCD was supported by the H2020 CoCA and Eat2beNICE projects
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Characterization of an eutherian gene cluster generated after transposon domestication identifies Bex3 as relevant for advanced neurological functions

  • Navas Pérez, Enrique
  • Cuscó Pons, Pol, 1987-
  • García Fernàndez, Jordi
Background: One of the most unusual sources of phylogenetically restricted genes is the molecular domestication of transposable elements into a host genome as functional genes. Although these kinds of events are sometimes at the core of key macroevolutionary changes, their origin and organismal function are generally poorly understood. Results: Here, we identify several previously unreported transposable element domestication events in the human and mouse genomes. Among them, we find a remarkable molecular domestication that gave rise to a multigenic family in placental mammals, the Bex/Tceal gene cluster. These genes, which act as hub proteins within diverse signaling pathways, have been associated with neurological features of human patients carrying genomic microdeletions in chromosome X. The Bex/Tceal genes display neural-enriched patterns and are differentially expressed in human neurological disorders, such as autism and schizophrenia. Two different murine alleles of the cluster member Bex3 display morphological and physiopathological brain modifications, such as reduced interneuron number and hippocampal electrophysiological imbalance, alterations that translate into distinct behavioral phenotypes. Conclusions: We provide an in-depth understanding of the emergence of a gene cluster that originated by transposon domestication and gene duplication at the origin of placental mammals, an evolutionary process that transformed a non-functional transposon sequence into novel components of the eutherian genome. These genes were integrated into existing signaling pathways involved in the development, maintenance, and function of the CNS in eutherians. At least one of its members, Bex3, is relevant for higher brain functions in placental mammals and may be involved in human neurological disorders., Major financial support for this research was received from Spanish “Ministerio de Ciencia, Innovación y Universidades.” Grants BFU2015-68655-P and BFU2017-861152-P to J.G.F., RTI2018-100968-B-I00, 2017-SGR-738, H2020/2014-2020 under grant agreements n°667302, n°643051, and n°728018 to B.C., PGC2018-098229-B-I00 to J.L.F., BES-2016-077374 to E.A.-G., CVI-7290 Junta de Andalucía to A.R.M., SAF2016-80937-R (Ministerio de Economía y Competitividad/FEDER) to G.M., Institutional Grant MDM-2016-0687 (Maria de Maeztu Excellence Unit, Department of Gene Regulation and Morphogenesis at CABD) and BFU2017-83150-P to J.J.C, BFU2017-89780-R and P12-CTS-2257 to A.M.C. and SAF2016-76340-R and María de Maeztu Excellence Unit, Institute of Neurosciences to E.S.. E.N.P. held an FPI pre-doctoral fellowship (Spanish “Ministerio de Ciencia, Innovación y Universidades”).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metabolic, Affective and Neurocognitive Characterization of Metabolic Syndrome Patients with and without Food Addiction. Implications for Weight Progression

  • Camacho Barcia, Lucía
  • Munguía, Lucero
  • Lucas, Ignacio
  • Torre Fornell, Rafael de la
  • Salas Salvadó, Jordi
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Granero, Roser
  • Jiménez-Murcia, Susana
  • González Monje, Inmaculada
  • Esteve Luque, Virginia
  • Cuenca Royo, Aida
  • Gómez Martínez, Carlos
  • Paz Graniel, Indira
  • Forcano, Laura
  • Fernández Aranda, Fernando
According to the food addiction (FA) model, the consumption of certain types of food could be potentially addictive and can lead to changes in intake regulation. We aimed to describe metabolic parameters, dietary characteristics, and affective and neurocognitive vulnerabilities of individuals with and without FA, and to explore its influences on weight loss progression. The sample included 448 adults (55-75 years) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus cognition sub-study. Cognitive and psychopathological assessments, as well as dietary, biochemical, and metabolic measurements, were assessed at baseline. Weight progression was evaluated after a 3-year follow up. The presence of FA was associated with higher depressive symptomatology, neurocognitive decline, low quality of life, high body mass index (BMI), and high waist circumference, but not with metabolic comorbidities. No differences were observed in the dietary characteristics except for the saturated and monounsaturated fatty acids consumption. After three years, the presence of FA at baseline resulted in a significantly higher weight regain. FA is associated with worse psychological and neurocognitive state and higher weight regain in adults with metabolic syndrome. This condition could be an indicator of bad prognosis in the search for a successful weight loss process.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Shared genetic architecture between attention-deficit/hyperactivity disorder and lifespan

  • Vilar-Ribó, Laura
  • Cabana-Domínguez, Judit
  • Martorell, Lourdes
  • Ramos-Quiroga, Josep Antoni
  • Sanchez-Roige, Sandra
  • Palmer, Abraham A.
  • Vilella, Elisabet
  • Ribasés, Marta
  • Muntané, Gerard
  • Soler Artigas, María
There is evidence linking ADHD to a reduced life expectancy. The mortality rate in individuals with ADHD is twice that of the general population and it is associated with several factors, such as unhealthy lifestyle behaviors, social adversity, and mental health problems that may in turn increase mortality rates. Since ADHD and lifespan are heritable, we used data from genome-wide association studies (GWAS) of ADHD and parental lifespan, as proxy of individual lifespan, to estimate their genetic correlation, identify genetic loci jointly associated with both phenotypes and assess causality. We confirmed a negative genetic correlation between ADHD and parental lifespan (rg = −0.36, P = 1.41e−16). Nineteen independent loci were jointly associated with both ADHD and parental lifespan, with most of the alleles that increased the risk for ADHD being associated with shorter lifespan. Fifteen loci were novel for ADHD and two were already present in the original GWAS on parental lifespan. Mendelian randomization analyses pointed towards a negative causal effect of ADHD liability on lifespan (P = 1.54e−06; Beta = −0.07), although these results were not confirmed by all sensitivity analyses performed, and further evidence is required. The present study provides the first evidence of a common genetic background between ADHD and lifespan, which may play a role in the reported effect of ADHD on premature mortality risk. These results are consistent with previous epidemiological data describing reduced lifespan in mental disorders and support that ADHD is an important health condition that could negatively affect future life outcomes., This work was supported by the Agència de Gestió d’Ajuts Universitaris i de Recerca (AGAUR, 2017SGR-00444 and 2017SGR-1461), the Instituto de Salud Carlos III (PI18/01788, P19/01224, PI20/00041, PI21/00612, PI22/00464, FI18/00285 to LVR and CP22/00128 to MSA), the Ministry of Science, Innovation and Universities (IJC2018-035346-I to MSA and RYC2021-031324-I to JCD); the European Regional Development Fund (ERDF), the European Union H2020 Programme (H2020/2014–2020) under grant agreements no. 728018 (Eat2beNICE), no. 848228 (DISCOvERIE) and no. 2020604 (TIMESPAN) and the ECNP Network ‘ADHD across the Lifespan’ and “la Marató de TV3” (202228-30 and 202228-31). SSR was supported by funds from the California Tobacco-Related Disease Research Program (TRDRP; Grant Number T29KT0526 and T32IR5226), and NIH/NIDA DP1DA054394. AAP was supported by NIH grant P50DA037844 and R01AA029688 and Tobacco-Related Disease Research Program Grant number: 28IR-0070.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Physical activity shifts gut microbiota structure in aged subjects with overweight/obesity and metabolic syndrome

  • Ruiz Limón, Patricia
  • Muralidharan, Jananee
  • Gómez Pérez, Ana María
  • Murri, Mora
  • Vioque, Jesus
  • Corella, Dolores
  • Fitó Colomer, Montserrat
  • Vidal, Josep
  • Salas-Salvadó, Jordi
  • Torres-Collado, Laura
  • Coltell, Oscar
  • Atzeni, Alessandro
  • Castañer, Olga
  • Bulló, Mònica
  • Bernal López, María Rosa
  • Moreno-Indias, Isabel
  • Tinahones Madueño, Francisco José
We aimed to identify how physical activity (PA), within the context of a Mediterranean diet, affects metabolic variables and gut microbiota in older individuals with overweight/obesity and metabolic syndrome. Observational analysis was conducted as part of the PREDIMED-Plus study with 152 males and 145 females with overweight/obesity and metabolic syndrome. General assessments, anthropometric and biochemical measurements, and gut microbial 16S rRNA sequencing data were analyzed at baseline and 1-year of follow-up. Participants were stratified by tertiles of 1-year change in total PA-related energy expenditure ranging from -98.77 to 1099.99 METs (min/week). The total PA percentage of change was reduced in tertile 1 (-44.83 ± 24.94), increased in tertile 2 (28.96 ± 23.33) and tertile 3 (273.64 ± 221.42). Beta diversity analysis showed differences in the gut microbiota population within each tertile group. Significant differences were found at phylum, family, and genus levels in the gut microbiota of the three tertile groups at baseline and 1-year timepoint. Tertile 3, the group with the greatest increase in PA, was characterized by increases in their levels of Sutterella, Bilophila, and Lachnospira bacteria as well as a reduction in Collinsella. Moreover, this tertile showed a different pattern in its predicted metabolic capacities to the other groups. Our results have demonstrated that changes in PA such as lifestyle and Mediterranean diet induces specific variations in the gut microbiota profile. This modulation of gut microbiome populations and their metabolic capacities may contribute to the health of the aged individuals with overweight/obesity and metabolic syndrome., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (three coordinated FIS projects lead by JS-S: PI13/00462, PI16/00501 and PI19/00576; two led by JV: PI17/01441, PI14/01206; and two led by MRBL: PI14/00696 and PI17/00855); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant (OBN16PE01) to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S. DC obtained grant from the Generalitat Valenciana (PROMETEO 2017/17) and Grant from the Ministry of Science and Innovation/Instituto de Salud Carlos III (reference: PI19/00781). Eat2beNICE project (European Union's Horizon 2020 research and innovation programme under grant agreement No 728018). PRL was supported by a "Sara Borrell" postdoctoral contract (CD19/00216) from the ISCIII-Madrid (Spain), co-financed by the Fondo Europeo de Desarrollo Regional-(FEDER). IMI was supported by the "Miguel Servet Type II" program (CPII21/00013) of the ISCIII-Madrid (Spain), co-financed by the FEDER. JM and AA were supported by the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 713679, cofunded from the Universitat Rovira i Virgili (URV) and Fundació Catalunya La Pedrera. OCN was supported by Juan Rodés program JR17/00022 and PI20/00012. MM is supported by Miguel Servet I program (CP17/00133) from ISCIII and cofunded by FEDER. AMGP was supported by a research contract from Servicio Andaluz de Salud (B-0033-2014). MRBL is supported by Miguel Servet II program (CPII/00014) from ISCIII and by Nicolás Monardes program (C1-0005-2020) from Servicio Andaluz de Salud, both cofunded by FEDER. This work is partially supported by ICREA. Food companies Hojiblanca (Lucena, Spain) and Patrimonio Comunal Olivarero (Madrid, Spain) donated extra virgin olive oil; and the Almond Board of California (Modesto, CA, USA), American Pistachio Growers (Fresno, CA, USA), and Paramount Farms (Wonderful Company, LLC, Los Angeles, CA, USA) donated nuts for the PREDIMED-Pilot study.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Impulsivity is longitudinally associated with healthy and unhealthy dietary patterns in individuals with overweight or obesity and metabolic syndrome within the framework of the PREDIMED-Plus trial

  • Gómez Martínez, Carlos
  • Babio, Nancy
  • Júlvez Calvo, Jordi
  • Nishi, Stephanie
  • Fernández Aranda, Fernando
  • Martínez-González, Miguel Ángel, 1957-
  • Cuenca Royo, Aida Ma, 1981-
  • Fernández, Rebeca
  • Jiménez Murcia, Susana
  • Torre Fornell, Rafael de la
  • Pintó Sala, Xavier
  • Bloemendaal, Mirjam
  • Fitó Colomer, Montserrat
  • Corella, Dolores
  • Arias, Alejandro
  • Salas Salvadó, Jordi
Un erratum d'aquest article s'ha publicat a Int J Behav Nutr Phys Act. 2022 Nov 23;19(1):140. DOI: 10.1186/s12966-022-01373-2, Background: Few studies have analyzed the associations between impulsivity and dietary patterns. Some of them have shown a cross-sectional inverse relationship between impulsivity and healthy diet scores, whereas others reported a positive association with unhealthy dietary assessments. We aimed to examine longitudinal associations of impulsivity trait with adherence to healthy and unhealthy dietary patterns in older participants at high risk of cardiovascular disease over 3 years of follow-up. Methods: A 3-year prospective cohort analysis within the PREDIMED-Plus-Cognition study conducted in 4 PREDIMED-Plus study centers was performed. The PREDIMED-Plus study aimed to test the beneficial effect of a lifestyle intervention on the primary prevention of cardiovascular disease. The participants with overweight or obesity and metabolic syndrome included in the present study (n = 462; mean age of 65.3 years; 51.5% female) completed both the UPPS-P Impulsive Behavior Scale (range: 0-236 points) and the 143-item Food Frequency Questionnaire at baseline, 1-year and 3-years of follow-up. Ten diet scores assessing healthy and unhealthy dietary patterns were evaluated. Linear mixed models were performed adjusting by several confounders to study the longitudinal associations between impulsivity trait and adherence to dietary pattern scores over 3 years of follow-up (also assessing interactions by sex, age, and intervention group). Results: Impulsivity were negatively associated with adherence to the Healthy Plant-Based [β = -0.92 (95%CI -1.67, -0.16)], Mediterranean [β = -0.43 (95%CI -0.79, -0.07)], Energy-Restricted Mediterranean [β = -0.76 (95%CI -1.16, -0.37)], Alternative Healthy Eating Index [β = -0.88 (95%CI -1.52, -0.23)], Portfolio [β = -0.57 (95%CI -0.91, -0.22)], and DASH [β = -0.50 (95%CI -0.79, -0.22)] diet scores over 3 years of follow-up, whereas impulsivity was positively related with adherence to the unhealthy Western diet [β = 1.59 (95%CI 0.59, 2.58)] over time. An interaction by intervention group was found, with those participants in the intervention group with high impulsivity levels having lower adherence to several healthy dietary patterns. Conclusions: Heightened impulsivity was longitudinally associated with lower adherence to healthy dietary patterns and higher adherence to the Western diet over 3 years of follow-up. Furthermore, nutritional intervention programs should consider impulsivity as a relevant factor for the intervention success. Trial registration: Name of registry: Effect of an energy-restricted Mediterranean diet, physical activity and behavioral intervention on the primary prevention of cardiovascular disease. Trial registration number: ISRCTN 89,898,870. Date of registration: 05/28/2014., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 and PROMETEO 21/2021 grants from the Generalitat Valenciana, and the grant PID2019-108858RB-I00 funded by AEI 10.13039/501100011033 and by “ERDF A way of making Europe” to DC; the SEMERGEN grant; None of the funding sources took part in the design, collection, analysis, interpretation of the data, or writing the report, or in the decision to submit the manuscript for publication. We thank CERCA Programme/Generalitat de Catalunya for institutional support and partial support was also provided by SLT006/17/00246, funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS)”. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016–2, Ref 728018; and PRIME/ H2020-SC1-BHC-2018–2020, Ref: 847879). CG-M receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); JS-S, senior author of this paper, is partially supported by ICREA under the ICREA Academia program. SKN is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR, MFE-171207). JJ holds the Miguel Servet-II contract (CPII19/00015) awarded by the Instituto de Salud Carlos III (co-funded by the European Social Fund “Investing in your future”).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Gut microbiota signatures of vulnerability to food addiction in mice and humans

  • Samulenaite, Solveiga
  • García Blanco, Alejandra
  • Mayneris Perxachs, Jordi
  • Domingo Rodriguez, Laura, 1992-
  • Cabana-Domínguez, Judit
  • Fernàndez-Castillo, Noèlia
  • Gago-García, Edurne
  • Pineda-Cirera, Laura
  • Burokas, Aurelijus, 1982-
  • Espinosa-Carrasco, José
  • Arboleya, Silvia
  • Latorre, Jessica
  • Stanton, Catherine
  • Hosomi, Koji
  • Kunisawa, Jun
  • Cormand, Bru
  • Fernández Real, Jose M.
  • Maldonado, Rafael, 1961-
  • Martín García, Elena, 1975-
Objective: Food addiction is a multifactorial disorder characterised by a loss of control over food intake that may promote obesity and alter gut microbiota composition. We have investigated the potential involvement of the gut microbiota in the mechanisms underlying food addiction. Design: We used the Yale Food Addiction Scale (YFAS) 2.0 criteria to classify extreme food addiction in mouse and human subpopulations to identify gut microbiota signatures associated with vulnerability to this disorder. Results: Both animal and human cohorts showed important similarities in the gut microbiota signatures linked to food addiction. The signatures suggested possible non-beneficial effects of bacteria belonging to the Proteobacteria phylum and potential protective effects of Actinobacteria against the development of food addiction in both cohorts of humans and mice. A decreased relative abundance of the species Blautia wexlerae was observed in addicted humans and of Blautia genus in addicted mice. Administration of the non-digestible carbohydrates, lactulose and rhamnose, known to favour Blautia growth, led to increased relative abundance of Blautia in mice faeces in parallel with dramatic improvements in food addiction. A similar improvement was revealed after oral administration of Blautia wexlerae as a beneficial microbe. Conclusion: By understanding the crosstalk between this behavioural alteration and gut microbiota, these findings constitute a step forward to future treatments for food addiction and related eating disorders., This work was supported by La Caixa Health #LCF/PR/HR22/52420017, the Spanish 'Ministerio de Ciencia, Innovación y Universidades (MICIU), Agencia Estatal de Investigación (AEI)' (PID2020- 120029GB-I00/MICIU/AEI/10.13039/501100011033, RD21/0009/0019), the Spanish ‘Instituto de Salud Carlos III, RETICS-RTA’ (#RD12/0028/0023), the ‘Generalitat de Catalunya, AGAUR’ (#2017 SGR-669), 'La Marató de TV3' #20221830, ‘ICREA-Acadèmia’ (#2015) and the Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I068) to RM, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2019I006, #PNSD-2023I040) and Spanish Ministerio de Ciencia e Innovación (ERA-NET) PCI2021-122073-2A to EM-G. Spanish-MINECO (#SAF2017-84060-R-AEI/FEDER-UE) to LD-R, Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (#RTI2018-100968-B-100, #PID2021-127776OB-I00), ‘AGAUR-Generalitat de Catalunya’ (#2017-SGR-738, #2021-SGR-01093) and Spanish ‘Ministerio de Sanidad, Servicios Sociales e Igualdad, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2017I050) to BC, ‘Plan Nacional Sobre Drogas of the Spanish Ministry of Health’ (#PNSD-2020I042) to NF-C and the European Regional Development Fund (project No 01.2.2-LMT-K-718-03-0099) under grant agreement with the Research Council of Lithuania (LMTLT) to AB. The research leading to these results has also received funding from the European Union H2020 Program [H2020/2014-2020] under grant agreements Nos 667302 (CoCA), 643051 (MiND) and 728018 (Eat2beNICE), 'La Marató de TV3' #20221831 and from the Catalan Government (ICREA Academia Award 2021) to BC. JC-D was supported by the H2020 CoCA and Eat2beNICE projects and EG-G by projects of the Spanish Ministries (#PNSD-2020I042 and #PID2021-127776OB-I00). This work was partially supported by Instituto de Salud Carlos III through the projects PI20/01090 and PI23/00575 to JM-P and PI18/01022 and PI21/01361 to JMF-R (co-funded by European Regional Development Fund. “A way to make Europe”). It was also supported through the project CNS2023-144218 funded by MCIN/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR to JM-P. The work has also received funding from ”la Caixa” Foundation under the grant agreement LCF/PR/HR22/52420017 and support from Generalitat de Catalunya (ICREA Academia Award 2021 and 2021 SGR 01263) to JMF-R. IDIBGI is a CERCA centre from the 'CERCA Programme/Generalitat de Catalunya'.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Impulsive personality traits predicted weight loss in individuals with type 2 diabetes after 3 years of lifestyle interventions

  • Testa, Giulia
  • Camacho Barcia, Lucía
  • Gómez Martínez, Carlos
  • Mora-Maltas, Bernat
  • Torre Fornell, Rafael de la
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Granero, Roser
  • Cuenca Royo, Aida Ma, 1981-
  • Jiménez Murcia, Susana
  • Babio, Nancy
  • Fernández-Carrión, Rebeca
  • Esteve Luque, Virginia
  • Forcano, Laura
  • Ni, Jiaqi
  • Malcampo, Mireia
  • De Las Heras-Delgado, Sara
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
  • Fernández Aranda, Fernando
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA1c), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA1c. In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control., This work was supported by the official Spanish Institutions for funding scientific biomedical research, CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN) and Instituto de Salud Carlos III (ISCIII), through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund (six coordinated FIS projects leaded by JS-S and JVi, including the following projects: PI13/00673, PI13/00492, PI13/00272, PI13/01123, PI13/00462, PI13/00233, PI13/02184, PI13/00728, PI13/01090, PI13/01056, PI14/01722, PI14/00636, PI14/00618, PI14/00696, PI14/01206, PI14/01919, PI14/00853, PI14/01374, PI14/00972, PI14/00728, PI14/01471, PI16/00473, PI16/00662, PI16/01873, PI16/01094, PI16/00501, PI16/00533, PI16/00381, PI16/00366, PI16/01522, PI16/01120, PI17/00764, PI17/01183, PI17/00855, PI17/01347, PI17/00525, PI17/01827, PI17/00532, PI17/00215, PI17/01441, PI17/00508, PI17/01732, PI17/00926, PI19/00957, PI19/00386, PI19/00309, PI19/01032, PI19/00576, PI19/00017, PI19/01226, PI19/00781, PI19/01560, PI19/01332, PI20/01802, PI20/00138, PI20/01532, PI20/00456, PI20/00339, PI20/00557, PI20/00886, PI20/01158); the Especial Action Project entitled: Implementación y evaluación de una intervención intensiva sobre la actividad física Cohorte PREDIMED-Plus grant to JS-S; the Recercaixa (number 2013ACUP00194) grant to JS-S; grants from the Consejería de Salud de la Junta de Andalucía (PI0458/2013, PS0358/2016, PI0137/2018); the PROMETEO/2017/017 grant from the Generalitat Valenciana; the SEMERGEN grant. We thank CERCA Programme/Generalitat de Catalunya for institutional support. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/H2020-SFS-2016-2; Ref 728018; and PRIME/H2020-SC1-BHC-2018-2020; Ref: 847879). J.S-S. is partially supported by ICREA under the ICREA Academia program. J.N. is supported by a pre-doctoral grant from Ministerio de Ciencia, Innovación y Universidades (FPU 20/00385). RG is supported by the Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021-Programme). None of the funding sources took part in the design, collection, analysis, or interpretation of the data or in the decision to submit the manuscript for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Cross-disorder genetic analyses implicate dopaminergic signaling as a biological link between Attention-Deficit/Hyperactivity Disorder and obesity measures

  • Roth Mota, Nina
  • Poelmans, Geert
  • Klein, Marieke
  • Torrico, Bàrbara
  • Fernàndez Castillo, Noèlia
  • Cormand Rifà, Bru
  • Reif, Andreas
  • Franke, Barbara
  • Arias Vasquez, Alejandro
Attention-Deficit/Hyperactivity Disorder (ADHD) and obesity are frequently comorbid, genetically correlated, and share brain substrates. The biological mechanisms driving this association are unclear, but candidate systems, like dopaminergic neurotransmission and circadian rhythm, have been suggested. Our aim was to identify the biological mechanisms underpinning the genetic link between ADHD and obesity measures and investigate associations of overlapping genes with brain volumes. We tested the association of dopaminergic and circadian rhythm gene sets with ADHD, body mass index (BMI), and obesity (using GWAS data of N = 53,293, N = 681,275, and N = 98,697, respectively). We then conducted genome-wide ADHD-BMI and ADHD-obesity gene-based meta-analyses, followed by pathway enrichment analyses. Finally, we tested the association of ADHD-BMI overlapping genes with brain volumes (primary GWAS data N = 10,720-10,928; replication data N = 9428). The dopaminergic gene set was associated with both ADHD (P = 5.81 × 10−3) and BMI (P = 1.63 × 10−5); the circadian rhythm was associated with BMI (P = 1.28 × 10−3). The genome-wide approach also implicated the dopaminergic system, as the Dopamine-DARPP32 Feedback in cAMP Signaling pathway was enriched in both ADHD-BMI and ADHD-obesity results. The ADHD-BMI overlapping genes were associated with putamen volume (P = 7.7 × 10−3; replication data P = 3.9 × 10−2) a brain region with volumetric reductions in ADHD and BMI and linked to inhibitory control. Our findings suggest that dopaminergic neurotransmission, partially through DARPP-32-dependent signaling and involving the putamen, is a key player underlying the genetic overlap between ADHD and obesity measures. Uncovering shared etiological factors underlying the frequently observed ADHD-obesity comorbidity may have important implications in terms of prevention and/or efficient treatment of these conditions.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Pleiotropic contribution of rbfox1 to psychiatric and neurodevelopmental phenotypes in two zebrafish models

  • Antón Galindo, Ester
  • Adel, Maja R.
  • García González, Judit
  • Leggieri, Adele
  • López Blanch, Laura
  • Irimia Martínez, Manuel
  • Norton, William H. J.
  • Brennan, Caroline H.
  • Fernàndez-Castillo, Noèlia
  • Cormand, Bru
RBFOX1 is a highly pleiotropic gene that contributes to several psychiatric and neurodevelopmental disorders. Both rare and common variants in RBFOX1 have been associated with several psychiatric conditions, but the mechanisms underlying the pleiotropic effects of RBFOX1 are not yet understood. Here we found that, in zebrafish, rbfox1 is expressed in spinal cord, mid- and hindbrain during developmental stages. In adults, expression is restricted to specific areas of the brain, including telencephalic and diencephalic regions with an important role in receiving and processing sensory information and in directing behaviour. To investigate the contribution of rbfox1 to behaviour, we used rbfox1sa15940, a zebrafish mutant line with TL background. We found that rbfox1sa15940 mutants present hyperactivity, thigmotaxis, decreased freezing behaviour and altered social behaviour. We repeated these behavioural tests in a second rbfox1 mutant line with a different genetic background (TU), rbfox1del19, and found that rbfox1 deficiency affects behaviour similarly in this line, although there were some differences. rbfox1del19 mutants present similar thigmotaxis, but stronger alterations in social behaviour and lower levels of hyperactivity than rbfox1sa15940 fish. Taken together, these results suggest that mutations in rbfox1 lead to multiple behavioural changes in zebrafish that might be modulated by environmental, epigenetic and genetic background effects, and that resemble phenotypic alterations present in Rbfox1-deficient mice and in patients with different psychiatric conditions. Our study, thus, highlights the evolutionary conservation of rbfox1 function in behaviour and paves the way to further investigate the mechanisms underlying rbfox1 pleiotropy on the onset of neurodevelopmental and psychiatric disorders., Major financial support for this research was received by BC from the Spanish ‘Ministerio de Ciencia, Innovación y Universidades’ (RTI2018-100968-B-100, PID2021-1277760B-I100), the ‘Ministerio de Sanidad, Servicios Sociales e Igualdad/Plan Nacional Sobre Drogas’ (PNSD-2017I050 and PNSD-2020I042), ‘Generalitat de Catalunya/AGAUR’ (2021-SGR-01093), ICREA Academia 2021, ‘Fundació La Marató de TV3’ (202218-31) and the European Union H2020 Program [H2020/2014-2020] under grant agreements n° 667302 (CoCA) and Eat2beNICE (728018), and received by CHB from the NIH (USA) (5 U01 DA044400-05). E.A-G was supported by the Ministerio de Economía y Competitividad (Spanish Government), the EU H2020 program (Eat2beNICE-728018) and a Margarita Salas postdoctoral grant. M.R.A. was supported by a doctoral scholarship of the ‘Studienstiftung des Deutschen Volkes’. J.G-G. was supported by the Queen Mary Principal’s Research Studentship in the School of Biological and Chemical Sciences.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Metabolic, affective and neurocognitive characterization of metabolic syndrome patients with and without food addiction. Implications for weight progression

  • Camacho Barcia, Lucía
  • Munguía, Lucero
  • Lucas, Ignacio
  • Torre Fornell, Rafael de la
  • Salas Salvadó, Jordi
  • Pintó Sala, Xavier
  • Corella, Dolores
  • Granero, Roser
  • Jiménez Murcia, Susana
  • González Monje, Inmaculada
  • Esteve Luque, Virginia
  • Cuenca Royo, Aida Ma, 1981-
  • Gómez Martínez, Carlos
  • Paz-Graniel, Indira
  • Forcano, Laura
  • Fernández Aranda, Fernando
According to the food addiction (FA) model, the consumption of certain types of food could be potentially addictive and can lead to changes in intake regulation. We aimed to describe metabolic parameters, dietary characteristics, and affective and neurocognitive vulnerabilities of individuals with and without FA, and to explore its influences on weight loss progression. The sample included 448 adults (55-75 years) with overweight/obesity and metabolic syndrome from the PREDIMED-Plus cognition sub-study. Cognitive and psychopathological assessments, as well as dietary, biochemical, and metabolic measurements, were assessed at baseline. Weight progression was evaluated after a 3-year follow up. The presence of FA was associated with higher depressive symptomatology, neurocognitive decline, low quality of life, high body mass index (BMI), and high waist circumference, but not with metabolic comorbidities. No differences were observed in the dietary characteristics except for the saturated and monounsaturated fatty acids consumption. After three years, the presence of FA at baseline resulted in a significantly higher weight regain. FA is associated with worse psychological and neurocognitive state and higher weight regain in adults with metabolic syndrome. This condition could be an indicator of bad prognosis in the search for a successful weight loss process., We thank CERCA Programme/Generalitat de Catalunya for institutional support and partial support was also provided by SLT006/17/00246, funded by the Department of Health of the Generalitat de Catalunya by the calls “Acció instrumental de programes de recerca orientats en l’àmbit de la recerca i la innovació en salut” and “Pla estratègic de recerca i innovació en salut (PERIS)”. This research was also partially funded by EU-H2020 Grants (Eat2beNICE/ H2020-SFS-2016-2; Ref 728018; and PRIME/ H2020-SC1-BHC-2018-2020; Ref: 847879). IP-G receives a grant from the Spanish Ministry of Education, Culture and Sports (FPU 17/01925). C.G.-M. receives a predoctoral grant from the University of Rovira i Virgili (2020PMF-PIPF-37); J.S-S. is partially supported by ICREA under the ICREA Academia program.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Exploring the contribution to ADHD of genes involved in Mendelian Disorders presenting with hyperactivity and/or inattention

  • Fernàndez Castillo, Noèlia
  • Cabana Domínguez, Judit
  • Kappel, Djenifer B.
  • Torrico Avilés, Bàrbara
  • Weber, Heike
  • Lesch, Klaus-Peter
  • Lao, Oscar
  • Reif, Andreas
  • Cormand Rifà, Bru
Attention-deficit hyperactivity disorder (ADHD) is a complex neurodevelopmental disorder characterized by hyperactivity, impulsivity, and/or inattention, which are symptoms also observed in many rare genetic disorders. We searched for genes involved in Mendelian disorders presenting with ADHD symptoms in the Online Mendelian Inheritance in Man (OMIM) database, to curate a list of new candidate risk genes for ADHD.We explored the enrichment of functions and pathways in this gene list, and tested whether rare or common variants in these genes are associated with ADHD or with its comorbidities. We identified 139 genes, causal for 137 rare disorders, mainly related to neurodevelopmental and brain function. Most of these Mendelian disorders also present with other psychiatric traits that are often comorbid with ADHD. Using whole exome sequencing (WES) data from 668 ADHD cases, we found rare variants associated with the dimension of the severity of inattention symptoms in three genes: KIF11, WAC, and CRBN. Then, we focused on common variants and identified six genes associated with ADHD (in 19,099 cases and 34,194 controls): MANBA, UQCC2, HIVEP2, FOPX1, KANSL1, and AUH. Furthermore, HIVEP2, FOXP1, and KANSL1 were nominally associated with autism spectrum disorder (ASD) (18,382 cases and 27,969 controls), as well as HIVEP2 with anxiety (7016 cases and 14,475 controls), and FOXP1 with aggression (18,988 individuals), which is in line with the symptomatology of the rare disorders they are responsible for. In conclusion, inspecting Mendelian disorders and the genes responsible for them constitutes a valuable approach for identifying new risk genes and the mechanisms of complex disorders.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Impulsive Personality Traits Predicted Weight Loss in Individuals with Type 2 Diabetes after 3 Years of Lifestyle Interventions

  • Testa, Giulia
  • Camacho Barcia, Lucía
  • Gómez Martínez, Carlos
  • Mora Maltas, Bernat
  • Torre, Rafael de la
  • Pintó Sala, Xavier
  • Corella Piquer, Dolores
  • Granero, Roser
  • Cuenca-royo, Aida
  • Jiménez-Murcia, Susana
  • Babio, Nancy
  • Fernández Carrión, Rebeca
  • Esteve Luque, Virginia
  • Forcano, Laura
  • Ni, Jiaqi
  • Malcampo, Mireia
  • Heras Delgado, Sara de las
  • Fitó Colomer, Montserrat
  • Salas Salvadó, Jordi
  • Fernández Aranda, Fernando
Impulsivity has been associated with type 2 diabetes (T2D) and may negatively impact its management. This study aimed to investigate impulsive personality traits in an older adult population with T2D and their predicting role in long-term weight control and glycemic management, through glycated hemoglobin (HbA(1c)), following 3 years of intervention with a Mediterranean diet. The Impulsive Behavior Scale (UPPS-P) was administered as a measure of impulsive traits at baseline. Results showed higher total baseline scores of UPPS-P, and higher positive urgency in individuals with T2D, compared with those without T2D. The regression analysis in patients with T2D showed that sensation seeking and lack of perseverance predicted weight loss at follow-up. By contrast, impulsive traits did not predict follow-up levels of HbA(1c). In conclusion, the present findings suggest that higher impulsive traits in individuals with T2D seem to affect long-term weight control, but not glycemic control.